Institutes
Refine
Year of publication
Document Type
- Article (1573) (remove)
Language
- English (1573) (remove)
Has Fulltext
- yes (1573)
Is part of the Bibliography
- no (1573)
Keywords
- COVID-19 (39)
- SARS-CoV-2 (35)
- inflammation (29)
- Video (18)
- prostate cancer (15)
- Epilepsy (14)
- Inflammation (14)
- ADHD (12)
- Cancer (12)
- autophagy (12)
- bladder cancer (12)
- Capsule endoscopy (11)
- cancer (11)
- Genetics (10)
- data science (10)
- radical prostatectomy (10)
- tumor microenvironment (10)
- Small bowel (9)
- glioblastoma (9)
- macrophage (9)
- stroke (9)
- Apoptosis (8)
- Endoscopy (8)
- Mortality (8)
- Surgery (8)
- apoptosis (8)
- breast cancer (8)
- epilepsy (8)
- hypoxia (8)
- immunotherapy (8)
- survival (8)
- Angiogenesis (7)
- Immunology (7)
- Quality of life (7)
- Radiotherapy (7)
- Seizure (7)
- Treatment (7)
- chemotherapy (7)
- children (7)
- endothelial cells (7)
- mortality (7)
- oxidative stress (7)
- Balloon enteroscopy (6)
- Depression (6)
- Enteroscopy (6)
- Magnetic resonance imaging (6)
- Medical research (6)
- Outcome (6)
- TAVI (6)
- angiogenesis (6)
- artificial intelligence (6)
- glioma (6)
- machine learning (6)
- microRNA (6)
- osteoarthritis (6)
- proliferation (6)
- risk factors (6)
- targeted therapy (6)
- thrombosis (6)
- vaccination (6)
- Biomarker (5)
- Bipolar disorder (5)
- Breast cancer (5)
- Comorbidity (5)
- EEG (5)
- Epidemiology (5)
- Heart failure (5)
- Herb induced liver injury (5)
- Hypoxia (5)
- Immunotherapy (5)
- NADPH oxidase (5)
- Omicron (5)
- Postural control (5)
- Prostate cancer (5)
- Risk factors (5)
- aging (5)
- biomarker (5)
- colorectal cancer (5)
- coronavirus (5)
- digital medicine (5)
- fMRI (5)
- gene therapy (5)
- integrins (5)
- iron deficiency (5)
- lung cancer (5)
- mTOR (5)
- machine-learning (5)
- miRNA (5)
- outcome (5)
- pain (5)
- prevalence (5)
- 177Lu-PSMA-617 (4)
- Adenocarcinoma (4)
- Alcohol (4)
- Animal models (4)
- Antiviral therapy (4)
- Aortic stenosis (4)
- Calliphoridae (4)
- Drug induced liver injury (4)
- Elderly (4)
- Endoscopic retrograde cholangiopancreatography (4)
- Endothelial cells (4)
- Forensic entomology (4)
- Glioma (4)
- Hepatotoxicity (4)
- Herbal hepatotoxicity (4)
- IntelliCage (4)
- MRI (4)
- Machine learning (4)
- Melanoma (4)
- Neurology (4)
- Oncology (4)
- PCR (4)
- PSMA (4)
- Physical activity (4)
- Prevalence (4)
- ROS (4)
- Rare diseases (4)
- Stroke (4)
- Translational research (4)
- acute myeloid leukemia (4)
- bibliometrics (4)
- child (4)
- diabetes (4)
- drug resistance (4)
- elderly (4)
- epidemiology (4)
- extracellular matrix (4)
- growth (4)
- haemophilia treatment (4)
- hepatocellular carcinoma (4)
- infection (4)
- iron (4)
- liver (4)
- macrophage polarization (4)
- macrophages (4)
- metastasis (4)
- metastatic prostate cancer (4)
- microglia (4)
- mitochondria (4)
- neuropathic pain (4)
- patients (4)
- phosphorylation (4)
- polypharmacy (4)
- quality of life (4)
- reactive oxygen species (4)
- systematic review (4)
- thrombolysis (4)
- tooth loss (4)
- treatment (4)
- treatment centres (4)
- 3D printing (3)
- ACLF (3)
- AML (3)
- ARDS (3)
- Acute kidney injury (3)
- Acute lymphoblastic leukemia (3)
- Acute myeloid leukemia (3)
- Adhesion (3)
- Angiography (3)
- Artificial intelligence (3)
- Ataxia telangiectasia (3)
- Autism spectrum disorder (3)
- Autopsy (3)
- Biochemistry (3)
- Brain (3)
- Burden of illness (3)
- COMP (3)
- Cardiovascular diseases (3)
- Cell biology (3)
- Chronic hepatitis C (3)
- Cirrhosis (3)
- Classification (3)
- Clinical decision support systems (3)
- Cochlear implant (3)
- Collagen (3)
- Colorectal cancer (3)
- Complications (3)
- Computer-assisted diagnosis (3)
- Critical care (3)
- Data science (3)
- Dental implant (3)
- Dental students (3)
- Diagnosis (3)
- Diagnostic markers (3)
- ER stress (3)
- Edema (3)
- Endocrinology (3)
- Epigenetics (3)
- Extracellular vesicles (3)
- Fasting (3)
- Gene regulation (3)
- Glioblastoma (3)
- HBV (3)
- Health care (3)
- Healthcare costs (3)
- Healthy adults (3)
- HoLEP (3)
- Human behaviour (3)
- Hypertension (3)
- Immunohistochemistry (3)
- Incidence (3)
- Induction chemotherapy (3)
- Interleukin (3)
- Lung failure (3)
- Macrophages (3)
- Major depressive disorder (3)
- Metabolomics (3)
- Microbiology (3)
- Microwave ablation (3)
- Molecular biology (3)
- Multianalyte detection (3)
- NK cells (3)
- NSCLC (3)
- Neuroscience (3)
- Non-coding RNA (3)
- Pain (3)
- Pandemic (3)
- Parkinson’s disease (3)
- Patient blood management (3)
- Patient safety (3)
- Peri-implantitis (3)
- Pneumonia (3)
- Polypharmacy (3)
- Pre-analytics (3)
- Proteomics (3)
- Pulmonary embolism (3)
- Rectal cancer (3)
- Registry (3)
- Rhabdomyosarcoma (3)
- Rheumatoid arthritis (3)
- Safety (3)
- Sport (3)
- Status epilepticus (3)
- Suicide (3)
- Survival (3)
- Systematic review (3)
- TIPS (3)
- Transfusion (3)
- Trauma (3)
- Tumor microenvironment (3)
- Ultrasound (3)
- VEGF (3)
- Vaccination (3)
- adhesion (3)
- adverse events (3)
- anemia (3)
- animal model (3)
- antiviral therapy (3)
- aortic stenosis (3)
- bleeding (3)
- brain metastases (3)
- cartilage (3)
- chronic kidney disease (3)
- cirrhosis (3)
- cognition (3)
- colon cancer (3)
- critical care (3)
- curcumin (3)
- dentate gyrus (3)
- depression (3)
- diagnosis (3)
- epigenetics (3)
- ergonomics (3)
- exosomes (3)
- external beam radiotherapy (3)
- extracellular vesicles (3)
- flow cytometry (3)
- functional outcome (3)
- gene expression (3)
- haemophilia care (3)
- heart (3)
- heart failure (3)
- hematopoietic stem cell transplantation (3)
- hemorrhage (3)
- hepatitis C virus (3)
- hippocampus (3)
- immune cells (3)
- immunity (3)
- immunohistochemistry (3)
- influenza (3)
- innate immunity (3)
- liver cirrhosis (3)
- liver transplantation (3)
- lncRNA (3)
- long non-coding RNA (3)
- magnetic resonance imaging (3)
- mesenchymal stromal/stem cells (3)
- metabolomics (3)
- multimorbidity (3)
- multiple sclerosis (3)
- neurodegeneration (3)
- nociception (3)
- obesity (3)
- outcomes (3)
- overall survival (3)
- oxidative phosphorylation (3)
- p53 (3)
- pediatric (3)
- periodontitis (3)
- platelets (3)
- polytrauma (3)
- portal hypertension (3)
- primary care (3)
- proteomics (3)
- psoriasis (3)
- public health (3)
- quantitative MRI (3)
- radiotherapy (3)
- seizure (3)
- sphingolipids (3)
- sphingosine 1-phosphate (3)
- sphingosine-1-phosphate (3)
- stress (3)
- sulforaphane (3)
- supportive periodontal therapy (3)
- synaptic plasticity (3)
- tissue engineering (3)
- toll-like receptor (3)
- trauma (3)
- traumatic brain injury (3)
- tyrosine kinase inhibitor (3)
- yeast (3)
- 3D rapid prototyping (2)
- ADAM15 (2)
- ALK (2)
- ATM (2)
- Abort (2)
- Accidental reaction (2)
- Acuris (2)
- Addiction (2)
- Age estimation (2)
- Aging (2)
- Allergen avoidance (2)
- Alzheimer’s disease (2)
- Anandamide (2)
- Anemia (2)
- Animal model (2)
- Anti-IgE (2)
- Antibiotics (2)
- Aspergillus (2)
- Ataxia-telangiectasia (2)
- Attention-deficit/hyperactivity disorder (2)
- Attitude (2)
- Autologous biomaterial (2)
- Autophagy (2)
- BA.1 (2)
- BAG3 (2)
- BCOR (2)
- BMNC (2)
- BNT162b2 (2)
- BPH (2)
- Bacterial infection (2)
- Behavior (2)
- Bibliometrics (2)
- Bile duct stone (2)
- Biomedical informatics (2)
- Biopsy (2)
- Biorecognition strategies (2)
- Bladder cancer (2)
- Bleeding (2)
- Blood (2)
- Blood loss estimation (2)
- Blow flies (2)
- Body modification (2)
- Bone density (2)
- Bone marrow (2)
- C-reactive protein (2)
- CD14 (2)
- COVID 19 (2)
- COVID-19 surveillance (2)
- CRM (2)
- CSM (2)
- CT (2)
- Calpain (2)
- Cancer-specific mortality (2)
- Cardiovascular magnetic resonance (2)
- Case report (2)
- Cell culture (2)
- Cell death (2)
- Cell death and immune response (2)
- Cerebellum (2)
- Cesarean section (2)
- Chemoradiotherapy (2)
- Child (2)
- Cholangiography (2)
- Cholangiopancreatography (2)
- Chronic kidney disease (2)
- Clinical Trials and Observations (2)
- Cochlear implantation (2)
- Cognition (2)
- Colonoscopy (2)
- Comparative analysis (2)
- Computational models (2)
- Computer software (2)
- Corona (2)
- Covid-19 (2)
- Cryoelectron microscopy (2)
- DMEK (2)
- DNA methylation (2)
- Deep brain stimulation (2)
- Development (2)
- Diagnostic algorithm (2)
- Differential diagnosis (2)
- Directly acting antiviral agent (2)
- Dopamine (2)
- Double-balloon enteroscopy (2)
- Dravet syndrome (2)
- Drug hepatotoxicity (2)
- Drugs (2)
- Dynamic MRI (2)
- EET (2)
- EGFR (2)
- EWSR1 (2)
- Education (2)
- Emotion regulation (2)
- Encephalopathy (2)
- Endocannabinoid (2)
- Endocannabinoids (2)
- Endoscopic retrograde (2)
- Endothelium (2)
- Enterscopy (2)
- Entscheidungsassistenz (2)
- Environmental support (2)
- EphB4 (2)
- Epicutaneous immunotherapy (2)
- Epidemiology and End Results (2)
- Epileptische Anfälle (2)
- Evidence-based medicine (2)
- Exercise (2)
- Exosomes (2)
- Extracellular matrix (2)
- FFLU (2)
- FHIR (2)
- Feedback (2)
- Fibronectin (2)
- Forensic medicine (2)
- Function (2)
- GEMs (2)
- Gene Regulation (2)
- Gene expression (2)
- Gene fusion (2)
- Genetics research (2)
- Geographic variation (2)
- Geriatric patients (2)
- Germany (2)
- Gleason score (2)
- Glucose (2)
- HCV (2)
- HIV (2)
- HL7 FHIR (2)
- HNSCC (2)
- Healthcare resource utilization (2)
- Heart (2)
- Hepatitis C (2)
- Hepatitis C virus (2)
- Hepatocellular carcinoma (2)
- High oblique sagittal osteotomy (2)
- Hippocampus (2)
- ISR (2)
- Identification (2)
- Immunogenicity (2)
- Infection (2)
- Infections (2)
- Innate Immunity (2)
- Insulin signalling (2)
- Intensive care treatment (2)
- Intensive care units (2)
- Interferon (2)
- Interleukin-1 (2)
- Interleukin-6 (2)
- Iron (2)
- Ketogenic diet (2)
- L-DOPA (2)
- Labor and delivery (2)
- Legs (2)
- Leptin (2)
- Lipidomics (2)
- Local therapy (2)
- Long-term potentiation (2)
- Low-molecular-weight heparin (2)
- Lucilia sericata (2)
- Lymphectasia (2)
- Machine-learning (2)
- Macrophage polarization (2)
- Medical consultation (2)
- Medical diagnostics (2)
- Medical risk factors (2)
- Medizinstudenten (2)
- Memory (2)
- Mental health (2)
- Metabolic diseases (2)
- Migration (2)
- Mitochondria (2)
- Mitochondrial dysfunction (2)
- Model (2)
- Molecular autopsy (2)
- Molecular neuroscience (2)
- Monocytes (2)
- Morphology (2)
- Multidetector computed tomography (2)
- Musculoskeletal system (2)
- Myeloid Neoplasia (2)
- Myocardial infarction (2)
- NADH dehydrogenase (2)
- NAFLD (2)
- NASH (2)
- NCCN (2)
- NCoR1 (2)
- NF-κB (2)
- NS5A (2)
- Neurodegeneration (2)
- Neuron (2)
- Next-generation sequencing (2)
- Nrf2 (2)
- Nucleic acid biomarkers (2)
- OXA-48 (2)
- Obesity (2)
- Oral immunotherapy (2)
- Orthognathic surgery (2)
- Orthopaedics (2)
- Osteoporosis (2)
- Outcomes (2)
- PD-L1 (2)
- Pathogenesis (2)
- Pathologic complete response (2)
- Patient needs (2)
- Patientenbedürfnisse (2)
- Patterns of care (2)
- Pediatric (2)
- Pelargonium sidoides (2)
- Penile cancer (2)
- Penile carcinomas (2)
- Periodontal treatment (2)
- Person-Umwelt-Passung (2)
- Person-environment fit (2)
- Phagocytosis (2)
- Physiology (2)
- Plasticity (2)
- Platelet-rich fibrin (2)
- Point-of-care testing (2)
- Polytrauma (2)
- Portal hypertension (2)
- Post-mortem interval (2)
- Preclinical research (2)
- Predictive coding (2)
- Predictive markers (2)
- Pregnancy (2)
- Preterm birth (2)
- Prevention (2)
- Primary health care (2)
- Prognostic tool (2)
- Prophylaxis (2)
- Protein biomarkers (2)
- Pseudomonas aeruginosa (2)
- Psoriasis (2)
- Psychedelics (2)
- Psychology (2)
- RCT (2)
- RNA (2)
- RNA therapeutics (2)
- RNAseq (2)
- Radiation (2)
- Radical prostatectomy (2)
- Radiomics (2)
- Reactive oxygen species (2)
- Redoxin (2)
- Rehabilitation (2)
- Rescue medication (2)
- Research Article (2)
- Respiratory distress syndrome (2)
- Reward (2)
- Ribavirin (2)
- S1P receptors (2)
- SARS-CoV-2 monitoring (2)
- SARS-CoV-2 testing (2)
- SCC (2)
- SPM (2)
- SV2A (2)
- Schizophrenia (2)
- Sensitivity (2)
- Sex (2)
- Signaling (2)
- Specificity (2)
- Spine (2)
- Squamous cell carcinoma (2)
- Standard endoscopy (2)
- Standard value (2)
- Standardization (2)
- Stem cell (2)
- Sudden death (2)
- Superficial vein thrombosis (2)
- Supported decision making (2)
- Surveillance (2)
- Synaptic transmission (2)
- Systemic inflammation (2)
- Systemic therapy (2)
- T-cell (2)
- TGF-β (2)
- TSC (2)
- Teaching (2)
- Telemedicine (2)
- Temozolomide (2)
- Tight junctions (2)
- Tomography (x-ray computed) (2)
- Tooth loss (2)
- Training (2)
- Treatment outcome (2)
- Type 2 diabetes (2)
- Undergraduate medical education (2)
- Unterstützung der Umwelt (2)
- Upper body posture (2)
- Usability (2)
- Uteroglobin (2)
- Variant histology (2)
- Vascular endothelial growth factor (VEGF) (2)
- Visual estimation (2)
- Volume therapy (2)
- Wearable cardioverter-defibrillator (2)
- Women (2)
- Wounds (2)
- acute coronary syndromes (2)
- adaptation (2)
- adipose-derived stromal/stem cells (2)
- adult (2)
- age (2)
- alcohol use disorder (2)
- algorithm (2)
- animal experiments (2)
- antibiotic resistance (2)
- antiseizure medication (2)
- atherosclerosis (2)
- attention (2)
- bacteria (2)
- biliary stricture (2)
- bioenergetics (2)
- biomarkers (2)
- biopsy cores (2)
- blood pressure (2)
- blood transfusion (2)
- bone (2)
- bone regeneration (2)
- bortezomib (2)
- brain cancer (2)
- brain metastasis (2)
- cabozantinib (2)
- campesterol (2)
- cancer specific survival (2)
- cancer treatment (2)
- cancer-specific mortality (2)
- cardiolipin (2)
- cardiovascular disease (2)
- caregivers (2)
- cell cycle (2)
- cell migration (2)
- ceramides (2)
- cerebral hemorrhage (2)
- cerebral venous thrombosis (2)
- cerebrospinal fluid (2)
- cervical cancer (2)
- cesarean section (2)
- chemoradiotherapy (2)
- childhood acute myeloid leukemia (2)
- cholestanol (2)
- cholesterol absorption (2)
- cholesterol synthesis (2)
- clinical trial (2)
- clinical trials (2)
- co-infection (2)
- coagulopathy (2)
- complementary medicine (2)
- complexome profiling (2)
- complication (2)
- computed tomography (2)
- confinement (2)
- constipation (2)
- contemporary (2)
- dental implant (2)
- deubiquitinase (DUB) (2)
- dexamethasone (2)
- diabetes mellitus (2)
- diabetic nephropathy (2)
- diagnostic algorithm (2)
- disease burden (2)
- dopamine (2)
- dysphagia (2)
- efficacy (2)
- electrophysiology (2)
- endovascular treatment (2)
- ephrinB2 (2)
- epidermal growth factor receptor (2)
- epithelial to mesenchymal transition (2)
- everolimus (2)
- executive function (2)
- exercise (2)
- fall (2)
- fibrosis (2)
- follow-up (2)
- furcation involvement class III (2)
- fusion biopsy (2)
- general practice (2)
- glycolysis (2)
- guided bone regeneration (2)
- homeostatic plasticity (2)
- hyperglycemia (2)
- immune checkpoint inhibitors (2)
- immune response (2)
- in vitro (2)
- infections (2)
- inflammatory bowel disease (2)
- insulin (2)
- integrative medicine (2)
- intermediate risk (2)
- invasion (2)
- iron metabolism (2)
- kidney (2)
- kidney cancer (2)
- kinematic analysis (2)
- lathosterol (2)
- leptin (2)
- levetiracetam (2)
- lifestyle intervention (2)
- lipids (2)
- lipocalin-2 (2)
- lipoxygenase (2)
- liver fibrosis (2)
- localized prostate cancer (2)
- lockdown (2)
- long-term success (2)
- long-term tooth survival (2)
- low molecular weight heparin (2)
- low-glycaemic meal replacement (2)
- lymph node dissection (2)
- mRNA (2)
- mast cells (2)
- medical students (2)
- melanoma (2)
- metabolism (2)
- metastatic castration-resistant prostate cancer (2)
- mice (2)
- monitoring (2)
- monocytes (2)
- motility (2)
- multicentre study (2)
- multidetector computed tomography (2)
- multiple myeloma (2)
- musculoskeletal disorders (2)
- ncRNA (2)
- neural oscillations (2)
- neurocognitive (2)
- neutralization (2)
- neutralizing antibodies (2)
- next-generation sequencing (2)
- niche (2)
- nitric oxide (2)
- nivolumab (2)
- occupational infections (2)
- olfaction (2)
- oligomerisation (2)
- other-cause mortality (2)
- out-patient paediatrics (2)
- pandemic (2)
- patient blood management (2)
- pediatric patients (2)
- pediatric surgery (2)
- penile cancer (2)
- pentose phosphate pathway (2)
- perception (2)
- peri-implant diseases (2)
- peri-implantitis (2)
- periodontitis stage III and IV (2)
- phagocytosis (2)
- pharmacokinetics (2)
- physical activity (2)
- pneumonia (2)
- post-translational modifications (2)
- postoperative pain (2)
- prediction (2)
- predictive (2)
- predictor (2)
- preeclampsia (2)
- prevention (2)
- primary cilium (2)
- primary prostate cancer (2)
- process evaluation (2)
- prognosis (2)
- prognostic (2)
- prostaglandin E (2)
- prostaglandins (2)
- prostate carcinoma cells (2)
- proteasome (2)
- protein-protein interaction (2)
- protein-rich (2)
- pulmonary embolism (2)
- questionnaire (2)
- radiation (2)
- radical cystectomy (2)
- radical prostatecomy (2)
- receptor (2)
- refractory (2)
- regenerative medicine (2)
- relapse (2)
- renal cell carcinoma (2)
- residual myometrial thickness (2)
- resistance mutation (2)
- resistant cell lines (2)
- resolution of inflammation (2)
- respiratory chain (2)
- respiratory tract infection (2)
- rheumatoid arthritis (2)
- risk group (2)
- salvage therapy (2)
- scaffold (2)
- second-line (2)
- serine protease (NS3-4A) (2)
- serum (2)
- simulation training (2)
- sitosterol (2)
- smooth muscle cells (2)
- soft tissue (2)
- speech perception (2)
- spinal dural leaks (2)
- spine head (2)
- status epilepticus (2)
- stereotactic radiosurgery (2)
- strength training (2)
- sub-lineage (2)
- subchondral bone (2)
- superficial siderosis (2)
- surgery (2)
- synaptopodin (2)
- systematic biopsy (2)
- systemic antibiotics (2)
- temozolomide (2)
- temporal lobe epilepsy (2)
- therapeutics (2)
- therapy (2)
- thymus (2)
- total hip replacement (2)
- transcription factor (2)
- triple-negative breast cancer (2)
- tumor necrosis factor (2)
- tumor-associated macrophages (2)
- tyrosine kinase inhibitors (2)
- ubiquitin (2)
- ubiquitination (2)
- upgrading (2)
- urinary incontinence (2)
- urological cancer (2)
- vaccine (2)
- vascular biology (2)
- very high risk (2)
- viruses (2)
- walking (2)
- weight reduction (2)
- working memory (2)
- Ärztliche Aufklärung (2)
- (lyso)phospholipids (1)
- (sub-) luxation (1)
- 1-propanol (1)
- 1H NMR; Conformational Properties (1)
- 2-AG (1)
- 2-Arachidonoyl glycerol (1)
- 2-deoxy-d-glucose (1)
- 223Radium-dichloride (1)
- 2′,3′-cGAMP (1)
- 3 mm RAS instruments (1)
- 3 mm instruments (1)
- 3-hydroxyisovaleryl carnitine (1)
- 3-year survival (1)
- 3D culture (1)
- 3D gait analysis (1)
- 3D laparoscopy (1)
- 3D printing using composite resin (1)
- 3D printing using zirconia (1)
- 3D-models (1)
- 3D-printing (1)
- 3T3-L1 mouse fibroblasts (1)
- 4-fluoroamphetamine (1)
- 5-lipoxygenase (1)
- 9-aminoacridine (1)
- A498 cells (1)
- AAA+ disaggregase (1)
- ABC transporter (1)
- ABCB5 (1)
- ACE inhibitor (1)
- ACL (1)
- ACT-777991 (1)
- ACTH (1)
- ADAMTS13 (1)
- ADCC (1)
- ADGRE1 (1)
- AGMO (1)
- AIDS (1)
- AKT (1)
- AKT signaling (1)
- AKT-mTOR pathway (1)
- ALD (1)
- ALDH2 (1)
- AMP-activated kinase (AMPK) (1)
- AO-PCCF (1)
- APT-CEST (1)
- ASPECTS (1)
- AT1 receptor antagonist (1)
- ATG3 (1)
- ATG4 (1)
- ATG8 (1)
- ATP (1)
- AU-rich element (1)
- Abductor pollicis longus (1)
- Ablation (1)
- Ablation Techniques (1)
- Abrasion (1)
- Abusive head trauma (AHT) (1)
- Accidents (1)
- Accumulated degree days (1)
- Acidic Amino Acids (1)
- Acinetobacter baumannii (1)
- Acquired resistance (1)
- Actaea cimicifuga (1)
- Activated partial thromboplastin time (1)
- Active middle ear implants (1)
- Activities of daily living (1)
- Acute (1)
- Acute Myeloid Leukemia (AML) (1)
- Acute appendicitis (1)
- Acute decompensation (1)
- Acute elbow dislocation (1)
- Acute inflammation (1)
- Acute kidney failure (1)
- Acute myeloid leukaemia (1)
- Acute respiratory distress syndrom (1)
- Acute-on-chronic liver failure (1)
- Acute-on-chronic subdural hematoma (1)
- Adeno associated virus (1)
- Adherence (1)
- Adhesins (1)
- Adiposity (1)
- Administrative claims data (1)
- Adult neurogenesis (1)
- Adult-onset ADHD (1)
- Adults (1)
- Advanced stage (1)
- Adverse drug reaction (1)
- Adverse effects (1)
- Aedes aegypti (1)
- Aedes albopictus (1)
- Aeroplysinin-1 (1)
- Affect (1)
- Affective Misattribution Procedure (1)
- Affinity Chromatography (1)
- Affinity Labeling (1)
- Ag-RDT (1)
- Aganglionosis (1)
- Age determination (1)
- Ageing (1)
- Aggression (1)
- Airport-related emissions (1)
- Akt-mTOR pathway (1)
- Akt-mTOR signaling (1)
- Aktivierte partielle Thromboplastinzeit (1)
- Albumin (1)
- Albumin ratio (1)
- Algorithms (1)
- All-oral therapy (1)
- Allogeneic (1)
- Alpha power (1)
- Alpha-fetoprotein (AFP) (1)
- Alzheimer's disease (1)
- Ambient air (1)
- Amblyopia (1)
- Ambulatory Assessment (1)
- Amino acids (1)
- Amisulpride (1)
- Amitriptyline (1)
- Amniotic fluid (1)
- Amphetamine (1)
- Anaemia (1)
- Anakinra (1)
- Anal cancer (1)
- Analgesia (1)
- Analogue modelling (1)
- Analysis tool (1)
- Anatomy (1)
- Anderson–Fabry (1)
- Anemia management (1)
- Angiectasia (1)
- Angiodysplasia (1)
- Angiomyolipoma (1)
- Angststörungen (1)
- Animal disease models (1)
- Animal experiment (1)
- Anion and Zwitterion Transport (1)
- Anomalous venous atrial connections (1)
- Anorexia Nervosa (1)
- Anschlussheilbehandlung (1)
- Anti-inflammatory (1)
- Anti-rheumatic agents (1)
- Anti-seizure medication (1)
- Antibiotic steward-ship (1)
- Antibodies (1)
- Antibody avidity (1)
- Antibody therapy (1)
- Anticholinergic (1)
- Anticoagulant (1)
- Anticoagulation (1)
- Anticonvulsant (1)
- Anticonvulsants (1)
- Antigen test (1)
- Antigennachweis (1)
- Antimicrobial treatment (1)
- Antineoplastic agents (1)
- Antioxidant (1)
- Antioxidants (1)
- Antiproliferative (1)
- Antiretroviral therapy (1)
- Anwendbarkeit (1)
- Anxiety (1)
- Anxiolytic pharmacological therapy (1)
- Aortic aneurysm (1)
- Aortic input function (1)
- Aperiodic (1)
- Aphantasia (1)
- Apixaban (1)
- Apoptotic cell death (1)
- Appendectomy (1)
- Ara h2-specific IgE (1)
- ArchT (1)
- Archaebacterial Lipids (1)
- Aromatase inhibitors (1)
- Arrhythmia syndromes (1)
- Arteria ophthalmica (1)
- Arteriovenous malformation (1)
- Arthroplasty (1)
- Artificial feeding bioassays (1)
- Asparaginase (1)
- Aspirin (1)
- Astrocytoma (1)
- Ataxia (1)
- Ataxia score (1)
- Athlete (1)
- Atm (1)
- Atomoxetine (1)
- Atrial Fibrillation (1)
- Atrial fibrillation (1)
- Atrial fibrillation classification (1)
- Attention (1)
- Attention Deficit Hyperactivity Disorder (ADHD) (1)
- Attention deficit (1)
- Attention-Deficit/Hyperactivity Disorder (ADHD) (1)
- Attentional bias (1)
- Auditory rehabilitation (1)
- Auditory system (1)
- Autism (1)
- Autism Spectrum disorder (1)
- Autoimmune response (1)
- Autoimmune vasculopathy (1)
- Autoimmunity (1)
- Automated sRNA analysis (1)
- Axiography (1)
- Ayahuasca (1)
- Ayurveda (1)
- Ayurvedic herbal products (1)
- Azan (1)
- B cell cancer (1)
- B cells (1)
- B-cell (1)
- B-cell transcription factors (1)
- B.1.1.529 (1)
- B.1.1.7 (1)
- B.1.617.1 (1)
- B.1.617.2 (1)
- B3GNT2 (1)
- BA.4 (1)
- BA.5 (1)
- BCORL1 (1)
- BCX7353 (1)
- BEACOPP (1)
- BET proteins (1)
- BEZ235 (1)
- BH3 mimetics (1)
- BMC (1)
- BMI (1)
- BMP4 (1)
- BNT2b2 (1)
- BPO (1)
- BPTF (1)
- BRD4 (1)
- Bacillus subtilis (1)
- Back scan (1)
- Bacteraemia (1)
- Bacteria (1)
- Bacteria-host interaction (1)
- Bacterial abundance (1)
- Bacterial adhesion (1)
- Bacterial leakage (1)
- Balance (1)
- Ballon-assisted enteroscopy (1)
- Balloon-expandable TAVI (1)
- Bamlanivimab (1)
- Barrier (1)
- Bartonella adhesin A (1)
- Bartonella grahamii (1)
- Bartonella henselae (1)
- Bartonella schoenbuchensis (1)
- Basal ganglia (1)
- Beckwith–Wiedemann syndrome (1)
- Beginners (1)
- Behandlungspfad (1)
- Behavioral tests (1)
- Behavioural ecology (1)
- Benign enlargement of the subarachnoid spaces (BESS) (1)
- Benign prostatic hyperplasia (1)
- Berotralstat (1)
- Bevacizumab (1)
- Biceps brachii (1)
- Big Five (1)
- Biglycan (1)
- Bilateral sagittal split osteotomy (1)
- Billroth II gastroenterostomy (1)
- Billroth papillotome (1)
- Billroth’s operation-II (1)
- Bio safety (1)
- Bioenergetics (1)
- Biofilm (1)
- Biological profile (1)
- Biological sciences (1)
- Biomarker Discovery Study (1)
- Biomarkers (1)
- Biophysical models (1)
- Biophysics (1)
- Birth (1)
- Birth weight (1)
- Bis-azido-NAD+ Analog (1)
- Black cohosh (1)
- Black cohosh induced liver injury (1)
- Bleeding Risk (1)
- Blindness (1)
- Blocked occlusion (1)
- Blood coagulation disorder (1)
- Blood loss (1)
- Blood loss calculator (1)
- Blood loss formula (1)
- Blood management (1)
- Blood plasma (1)
- Blood pressure (1)
- Blood sample handling (1)
- Blood sampling (1)
- Bloodstream infections (1)
- Blutspenderscreening (1)
- Blutung (1)
- Blutungskontrolle (1)
- Blutübertragbare Virusinfektionen (1)
- Body sway (1)
- Bone cement implantation syndrome (1)
- Bone conduction devices (1)
- Bone defect (1)
- Bone diseases, Metabolic (1)
- Bone dust (1)
- Bone marrow aspiration (1)
- Bone metastases (1)
- Bone regeneration (1)
- Bone remodelling (1)
- Bone substitute (1)
- Bone tissue engineering (1)
- Bone tumor (1)
- Borrelia burgdorferi (1)
- Bowel obstruction (1)
- Brachial artery (1)
- Brachytherapy (1)
- Bradycardia (1)
- Brain DNA methylation (1)
- Brain asymmetry (1)
- Brain injuries (1)
- Brain metastasis (1)
- Brain tumor (1)
- Brain tumor surgery (1)
- Breast cancer survivers (1)
- Breast conserving surgery (1)
- Brodalumab (1)
- Burkholderia arboris (1)
- Burkitt’s lymphoma (1)
- Burns (1)
- C1 inhibitor (1)
- CAD-CAM (1)
- CAD/ CAM crown (1)
- CAD/CAM (1)
- CAD/CAM crown (1)
- CAM (1)
- CAPON (1)
- CAR (1)
- CBC (1)
- CCC-2 (1)
- CCL2 (1)
- CD16 (1)
- CD34+ cell enumeration (1)
- CD34 + cells (1)
- CD36 (1)
- CD4+ T cells (1)
- CD40 (1)
- CD44 (1)
- CD47 (1)
- CD62L (1)
- CD62p+Exosomes (1)
- CD8+ T cells (1)
- CDH13 (1)
- CDI (1)
- CDK-cyclin axis (1)
- CDK2 (1)
- CDK4/6 inhibitors (1)
- CDK9 (1)
- CEST EPI (1)
- CHEPs (1)
- CHRDL1 (1)
- CIM (1)
- CIOMS (1)
- CK2α (1)
- CLIF-C ACLF score (1)
- CLIF-C ACLF-R score (1)
- CLOCC (1)
- CMR (1)
- CNDAC (1)
- CNS tumor (1)
- COPD (1)
- COVID (1)
- COVID 19 pandemic (1)
- COVID-19 epitope signatures (1)
- COVID-19 pandemic (1)
- COVID-19 vaccination (1)
- COVID-19, Primary care (1)
- COVID‐19 (1)
- CQL (1)
- CRBN (1)
- CRISPR screen (1)
- CRISPR/Cas (1)
- CRP (1)
- CRPC (1)
- CRT (1)
- CT dual-energy computed tomography (1)
- CTGF (1)
- CTLA-4 (1)
- CXCL12 (1)
- CXCR3 antagonism (1)
- CXCR4 (1)
- CYP450 (1)
- CaMPARI (1)
- Cabozantinib (1)
- Caenorhabditis elegans (1)
- Calcium (1)
- Calcium calmodulin kinase (1)
- Calcium gluconate (1)
- Calprotectin (1)
- Cancer development (1)
- Cancer genomics (1)
- Cancer progression (1)
- Cancer survivors (1)
- Cancer therapy (1)
- Cancer-specific survival (1)
- Candida (1)
- Capnography (1)
- Capsaicin (1)
- Capsule endoscopy, video (1)
- Carbapenemase (1)
- Cardiac arrest (1)
- Cardiac biomarkers (1)
- Cardiac implantable electronic devices (1)
- Cardiac infarction (1)
- Cardiac rehabilitation (1)
- Cardiac remodeling (1)
- Cardiac resynchronization therapy (1)
- Cardio-oncology (1)
- Cardiology (1)
- Cardiotoxicity (1)
- Cardiovascular biology (1)
- Cardiovascular disease (1)
- Cardiovascular disease risk (1)
- Cardiovaskuläre Erkrankungen (1)
- Care home (1)
- Carotid injury (1)
- Cartilage (1)
- Cartilage Biology (1)
- Casirivimab (1)
- Caspase-8 (1)
- Catheters (1)
- Catumaxomab (1)
- Causality assessment. (1)
- Cell Biology (1)
- Cell Death (1)
- Cell Metabolism (1)
- Cell Migration (1)
- Cell Signaling (1)
- Cell Surface Receptor (1)
- Cell division (1)
- Cell surface proteoglycans (1)
- Cell-based Assays (1)
- Cellular Immune Response (1)
- Cellular energy metabolism (1)
- Cellular network formation (1)
- Cement gap (1)
- Centers for Disease Control and Prevention (1)
- Central Europe (1)
- Ceramides (1)
- Cerebral hypoperfusion (1)
- Cerebral oxygen saturation (1)
- Cerebrospinal Fluid (1)
- Cerebrospinal fluid (1)
- Cerebrovascular disorders (1)
- Cezanne (1)
- ChAdOx1-S (1)
- Chaperone (1)
- Chemoprevention (1)
- Chemotherapy (1)
- Chikungunya (1)
- Child abuse (1)
- Child and adolescent psychotherapy (1)
- Chimeric Antigen Receptor (CAR) (1)
- Cholinergic (1)
- Chondrocytes (1)
- Chrna7 knockout (1)
- Chromodomains (1)
- Chronic inflammation (1)
- Chronic lymphocytic leukemia (1)
- Cine (1)
- Circadian (1)
- Circulating MiRNA (1)
- Clavien–Dindo classification (1)
- Click chemistry (1)
- Climate inequity (1)
- Clinical Global Impression of Change (1)
- Clinical efficacy (1)
- Clinical genetics (1)
- Clinical management (1)
- Clinical pathway (1)
- Clinical pharmacology (1)
- Clinical phenotype (1)
- Clinical practice guidelines (1)
- Clinical trial (1)
- Clinical trials (1)
- Clip (1)
- ClpB (1)
- Coagulation (1)
- Cochleaimplantation (1)
- Coenzyme Analogue (1)
- Coenzyme Binding (1)
- Coeval folding and boudinage (1)
- Cognitive (1)
- Cognitive behavioural therapy (1)
- Cognitive dysfunction (1)
- Cognitive enhancers of exposure therapy (1)
- Cognitive impairment (1)
- Coherent infomax (1)
- Cohort studies (1)
- Cold hardiness (1)
- Cold tolerance (1)
- Colloids (1)
- Colonic neoplasms (1)
- Colony stimulating factor 1 receptor (1)
- Colorimetric blood loss estimation (1)
- Combined surgical therapy (1)
- Combustion (1)
- Comorbidities (1)
- Complete response (1)
- Completed suicide (1)
- Complex Formation (1)
- Complex decongestive therapy (1)
- Complex elbow fractures (1)
- Complicated stage (1)
- Comprehensive complication index (1)
- Compression stocking (1)
- Computational biophysics (1)
- Computational neuroscience (1)
- Computational sRNA analysis (1)
- Computational science (1)
- Computed Tomography (1)
- Computed tomography imaging (1)
- Computed tomography, X-ray (1)
- Computer hardware (1)
- Computer science (1)
- Computer-Assisted (1)
- Computer-unterstützte (1)
- Concurrent CNS diseases (1)
- Cone-beam computed tomography (1)
- Confinement (1)
- Congenital (1)
- Congenital diaphragmatic hernia (1)
- Connective tissue (1)
- Connectivity (1)
- Connectomics (1)
- Conometric connection (1)
- Consensus document (1)
- Consensus statement (1)
- Conservative treatment (1)
- Constipation (1)
- Constitution (1)
- Constriction (1)
- Contingent Negative Variation, CNV (1)
- Continuous Performance Test, CPT (1)
- Continuous renal replacement therapy (1)
- Contrast agent (1)
- Control (1)
- Conventional and unconventional ubiquitination (1)
- Convolutional Neural Networks (1)
- Cooperation (1)
- Copy number (1)
- Corneal tomography (1)
- Corona pandemic (1)
- Corona virus (1)
- Coronary artery disease (1)
- Coronary heart disease (1)
- Coronaviruses (1)
- Cortical degeneration (1)
- Cortical thickness (1)
- Cost-effectiveness (1)
- Costs (1)
- Course (1)
- Craniomaxillofacial injuries (1)
- Cre-recombinase (1)
- Crisis (1)
- Critical size (1)
- Crohn’s disease (1)
- Cross-frequency coupling (1)
- Cue-P3 (1)
- Culex pipiens (1)
- Culex pipiens biotypes pipiens/molestus (1)
- Culicidae (1)
- Culture positive (1)
- Curcumis sativus (1)
- Custom-made mouthguard (1)
- Cyanoacrylate (1)
- Cyclin T1 (1)
- Cyclosporin A (1)
- CysLTR1 (1)
- Cystatin C (1)
- Cytochrome P450 (1)
- Cytochrome P450 enzymes (1)
- Cytokines (1)
- Cytokines Induction (1)
- Cytotoxicity (1)
- D-amino acid oxidase (1)
- DAA (1)
- DBS (1)
- DC-NK cell interaction (1)
- DCK (1)
- DNA (1)
- DNA Adducts (1)
- DNA integrity (1)
- DNA mismatch repair (1)
- DNA-PK (1)
- DNA-based identification (1)
- DPPIV (1)
- DST (1)
- DVI (1)
- DWI (1)
- Dark triad (1)
- Data preprocessing (1)
- Data processing (1)
- Data reduction (1)
- Data structure detection (1)
- Daubert criteria (1)
- De-isolation (1)
- Dead space (1)
- Decision support (1)
- Decontamination (1)
- Decorin (1)
- Deep learning (1)
- Deep neural network (1)
- Deep vein thrombosis (1)
- Defibrillation (1)
- Deformation oblique layer (1)
- Degradation (1)
- Degrader design (1)
- Dehydrogenase (1)
- Dehydrogenases (1)
- Dendritic Cells (1)
- Dengue (1)
- Density equalizing mapping (1)
- Density-equalizing mapping (1)
- Dental Tissues (1)
- Dental air (1)
- Dental casts (1)
- Dental education (1)
- Dental implants (1)
- Dental practice (1)
- Dentists (1)
- Depression stigma (1)
- Dermatitis (1)
- Detection (1)
- Detection workflow (1)
- Developmental Biology (1)
- Developmental programming (1)
- Developmental trajectory (1)
- Developmentally adapted cognitive processing therapy (1)
- Device (1)
- Dexamethasone (1)
- Dexterity (1)
- Diagnose (1)
- Diagnostic dye (1)
- Diagnostic error (1)
- Diagnostic imaging (1)
- Diagnostic test (1)
- Diagnostic tests (1)
- Diet (1)
- Dietary HDAC inhibitor (1)
- Dietary supplements (1)
- Dieulafoy’s lesion (1)
- Differential Thermoanalysis (1)
- Difficult Airway Management (1)
- Diffusion magnetic resonance imaging (1)
- Digital (1)
- Digital pathology (1)
- Digital subtraction angiography (1)
- Digital workshops (1)
- Dimethyltryptamine (1)
- Diphtheria (1)
- Diptera (1)
- Direct measurement (1)
- Direct oral anticoagulation (1)
- Direct-acting antivirals (1)
- Disaster victim identification (1)
- Discitis (1)
- Discovery (1)
- Disease progression (1)
- Diseases (1)
- Disintegration (1)
- Dislocations of the knee (1)
- Distribution limits (1)
- Dizygotic ectopic (1)
- Dome-and-basin structure (1)
- Donor screening (1)
- Dorsal root ganglia (1)
- Dose response (1)
- Dot-probe task (1)
- Double balloon enteroscopy (1)
- Double-blind placebo-controlled trial (1)
- Downgrading (1)
- Dravet (1)
- Droplets (1)
- Drospirenon (1)
- Drug addiction (1)
- Drug resistance (1)
- Drug susceptibility testing (1)
- Drug targets (1)
- Drug therapy (1)
- Dual-energy computed tomography (1)
- Duodenum (1)
- Dural onlays (1)
- Dysfibrinogenämia (1)
- Dysfunctional social assumptions (1)
- Dysphagia (1)
- D’Amico classification (1)
- E-health (1)
- EBRT (1)
- ECMO (1)
- EGFRvIII mutation (1)
- EHL concentrates (1)
- ELISA (1)
- EMR1 (1)
- EMT (1)
- ENIGMA (1)
- EP300 (1)
- EQ5D5L (1)
- EQA scheme (1)
- ER-phagy (1)
- ERAL1 (1)
- ERK inhibitor (1)
- ERK1/2 signaling (1)
- ESBL (1)
- ESR Spectroscopy (1)
- ESR and Infrared Studies (1)
- Early (prenatal and postnatal) life experiences (1)
- Early setting (1)
- Ebola (1)
- Eccentric fixation (1)
- Ecological Momentary Assessment (EMA) (1)
- Ectopic pregnancy (1)
- Ectopic varices (1)
- Edoxaban (1)
- Effective half-life (1)
- Efficacy (1)
- Efficiency (1)
- Ejection fraction (1)
- Elderly trauma patient (1)
- Electric stimulation (1)
- Electrical stimulation (1)
- Electroconvulsive Therapy (1)
- Electroencephalography (1)
- Electrophysiology (1)
- Ellipticine (1)
- Elternurteil (1)
- Emergency room (1)
- Emergency treatment (1)
- Emotional intelligence (1)
- Empathy (1)
- Ena/VASP proteins (1)
- Encephalitis Viruses (1)
- Endocrine system and metabolic diseases (1)
- Endocrine therapy (1)
- Endogenous retroviruses (ERV) (1)
- Endoluminal (1)
- Endometrial carcinoma (1)
- Endomicroscopy (1)
- Endorectal (1)
- Endoscopic papillotomy (1)
- Endoscopic retrograde cholangiography (1)
- Endoscopic sphincterotomy (1)
- Endoscopic treatment (1)
- Endoscopic ultrasound (1)
- Endothelial (1)
- Endothelial progenitor cells (1)
- Endothelial protein C receptor (1)
- Endothelial-to-mesenchymal transition (1)
- Energy (1)
- Energy metabolism (1)
- Energy-efficiency (1)
- Engraftment (1)
- Enterobacterales (1)
- Enterobacteriaceae (1)
- Environmental biotechnology (1)
- Environmental enrichment (1)
- Environmental impacts (1)
- Environmental sciences (1)
- EpCAM positive tumor (1)
- Ephrin-B2–EphB4 (1)
- Epidural abscess (1)
- Epilepsiezentren (1)
- Epilepsy center (1)
- Epilepsy centers (1)
- Epileptic seizures (1)
- Epileptischer Anfall (1)
- Epithelialization (1)
- Epithelioma Cells (1)
- Epsilon (1)
- Equity (1)
- ErbB-signaling (1)
- Erythrophagocytosis (1)
- Estimated glomerular filtration rate (1)
- Eukaryotic sRNA (1)
- Europe (1)
- Euthymic phase (1)
- Evaluation (1)
- Event related potentials (1)
- Event-related potential (1)
- Everolimus (1)
- Evidence-based (1)
- Evidence-based dentistry (1)
- Evidence-based drug discovery (1)
- Evidenz (1)
- Evidenzbasiert (1)
- Ewing sarcoma (1)
- Ewing-like (1)
- Exemestane (1)
- Exercise challenge (1)
- Exercise training (1)
- Exercise-induced asthma (1)
- Exhaled nitric oxide (1)
- Exoscope (1)
- Exosomal cytokines (1)
- Expansion (1)
- Expectation violation (1)
- Expert Systems (1)
- Expertensysteme (1)
- Explicit (1)
- External beam radiotherapy (1)
- Extracellular matrix proteins (1)
- Extracorporeal devices (1)
- Extraprostatic (1)
- Exudates and transudates (1)
- F4/80 (1)
- FABP (1)
- FAM134 (1)
- FAP (1)
- FAPI PET (1)
- FBK-R23 (1)
- FDG-PET/CT (1)
- FF-ATP synthase dimer (1)
- FFP3 respirator (1)
- FGFR (1)
- FHIR Search (1)
- FIH1 (1)
- FOXO1 (1)
- FOXO3 (1)
- FPR (1)
- FSME-Virus (1)
- FTMT (1)
- FXR (1)
- Face masks (1)
- Facial nerve (1)
- FactorXIII Val34Leu polymorphism (1)
- Faktor V Leiden Mutation (1)
- Faktor XIII Val34Leu Polymorphismus (1)
- Fall (1)
- Falls (1)
- Famines (1)
- Fast Healthcare Interoperability Resources (1)
- Feasibility (1)
- Feasibility studies (1)
- Female subjects (1)
- Ferritinophagy (1)
- Ferroptosis (1)
- Fertility counseling (1)
- Fetal heart (1)
- Fibroblast (1)
- Fibrous dysplasia (1)
- Filariasis (1)
- Filariosis (1)
- Filgrastim (1)
- Filler (1)
- Finevo (1)
- Flavin mononucleotide (1)
- Fluid overload (1)
- Fluid therapy (1)
- Fluorescence (1)
- Focal Adhesion Kinase (1)
- Focal onset seizure (1)
- Follicular lymphoma (1)
- Follow-up treatment (1)
- Follow-ups (1)
- Fondaparinux (1)
- Food and Drug Administration (1)
- Forced expiratory volume in 1 s (1)
- Forensic examination (1)
- Forensic experts (1)
- Forensic pathology (1)
- Fracture (1)
- Fracture models (1)
- Fracture type (1)
- Frameshift (1)
- Frontobasal (1)
- Fruit fly (1)
- Frühsommermeningoenzephalitis (1)
- Fuchs endothelial dystrophy (1)
- Fukushima (1)
- Functional characterization (1)
- Functional connectivity (1)
- Functional electrical stimulation (1)
- Functional outcomes (1)
- G-CSF (1)
- G207 (1)
- G2A (1)
- G3BP1 (1)
- GD2 (1)
- GFR (1)
- GIIb/IIIa-receptor (1)
- GLA deficiency (1)
- GMP (1)
- GPCR (1)
- GPR4 (1)
- GRAND-SLAM (1)
- GSH (1)
- GTP cyclohydrolase (1)
- Gait analysis (1)
- Ganglionic (1)
- Gan–Dou–Fu–Mu decoction (GDFMD) (1)
- Gastric adenoma (1)
- Gastric cancer (1)
- Gastric motility (1)
- Gastritis (1)
- Gastroenterology (1)
- Gastrointestinal bleeding (1)
- Gastroschisis (1)
- Gaussian graphical models (1)
- Gender (1)
- Gene (1)
- Gene ontology (1)
- Gene sequencing (1)
- Gene therapy (1)
- Gene/Regulation (1)
- General Practitioner (1)
- General practice (1)
- Generalized procrustes analysis (1)
- Genetic heart disease (1)
- Genetic loci (1)
- Genetic networks (1)
- Genetic syndromes (1)
- Genetic techniques (1)
- Genome editing (1)
- Genome-wide association study (1)
- Genomic medicine (1)
- Geographical disparities (1)
- Gerinnungsfaktor XIII (1)
- Gestagen-Monopräparate (1)
- Gesundheitspolitische Zuständigkeit (1)
- Gezielte Therapie (1)
- Glabella (1)
- Glaucoma (1)
- Gleason Grade Group (1)
- Gleason Grade group (1)
- Gleason grade group (1)
- Glioblastoma survival (1)
- Global networking (1)
- Global warming (1)
- Glomerulosclerosis (1)
- Glycolysis (1)
- Gradient boosting (1)
- Grading (1)
- Graft (1)
- Graft quality (1)
- Gram-negative bacteria (1)
- Granulocytes (1)
- Graph theory (1)
- Graphical LASSO (1)
- Graves’ disease (1)
- Gravimetric method (1)
- Greenhouse effect (1)
- Groin pain (1)
- Guidance (1)
- Guide profession (1)
- Guided bone regeneration (GBR) (1)
- Guided tissue regeneration (GTR) (1)
- Gut (1)
- Gut bacteria (1)
- GvL (1)
- H1N1 (1)
- HADS (1)
- HAE (1)
- HARS2 (1)
- HBsAg (1)
- HCC (1)
- HCC marker (1)
- HCMV (1)
- HDAC4 (1)
- HDR-brachytherapy (1)
- HEOR (1)
- HER2 (1)
- HES (1)
- HIF (1)
- HIF-1α (1)
- HIF-2 (1)
- HIF-2α (1)
- HIF-2α, erythropoietin (1)
- HIPPO signalling (1)
- HIV protease inhibitors (1)
- HNPCC (1)
- HOLEP (1)
- HOSO (1)
- HOTAIR (1)
- HPO (1)
- HPV infection (1)
- HPV-positive OPSCC (1)
- HRCT (1)
- HSC (1)
- HSCT (1)
- HSP (hereditary spastic paraplegia) (1)
- HSV type specific antibodies (1)
- HSV-1 (1)
- HSV-typenspezifische Antikörper (1)
- HVPG (1)
- Haematocrit (1)
- Haematologic diseases (1)
- Haemodialysis (1)
- Haemophilia (1)
- Haemophilie A (1)
- Halogenobenzimidazoles (1)
- Hard-tissue trauma (1)
- Hardware erosion (1)
- Hawaii Department of Health (1)
- HeLa cells (1)
- Head and neck cancer (1)
- Head bandage (1)
- Head neck cancer (1)
- Health care workers (1)
- Health policy (1)
- Health sciences (1)
- Health services (1)
- Health surveys (1)
- Health technology assessment (1)
- Healthcare (1)
- Healthcare personnel (1)
- Healthcare resource utilisation (1)
- Healthcare structure (1)
- Healthy Living Index (HLI) (1)
- Healthy men (1)
- Healthy stem cell donors (1)
- Heart defects (1)
- Heart rate (1)
- Heart transplantation (1)
- Heartrate (1)
- Heat Shock Protein (HSP) (1)
- Heat shock protein 27 (1)
- Hematologic adverse events (1)
- Hematoma (1)
- Hematopoietic stem cell (1)
- Hematopoietic stem cell transplant (1)
- Hematotoxicity (1)
- Hemispheric specialization (1)
- Hemobilia (1)
- Hemodynamics (1)
- Hemosiderin (1)
- Heparan Sulfate (1)
- Heparinsensitivität (1)
- Hepatic stellate cell (1)
- Hepatitis (1)
- Hepatitis C antibodies (1)
- Hepatitis C antigens (1)
- Hepatocellular carcinoma (HCC) (1)
- Herbal medicine (1)
- Herbalife products (1)
- Herbs induced liver injury (1)
- Hereditary angioedema (1)
- Herniated disk (1)
- Herpes Zoster Infektion (1)
- Heterogeneity (1)
- Heterologous prime-boost (1)
- Heterotopic pregnancy (1)
- Hierarchical drift-diffusion modeling (1)
- Hig1 (1)
- High altitude (1)
- High-risk prostate cancer (1)
- Highwire (1)
- Himalayas (1)
- Hip hemiarthroplasty (1)
- Hip revision (1)
- Hippocampal excitability (1)
- Hirschsprung disease (1)
- Hispanic–Latino race/ethnicity (1)
- Histological analysis (1)
- Histology (1)
- Hodgkin lymphoma (1)
- Holmium laser enucleation (1)
- Home Care Services [MeSH] (1)
- Honolulu Queen’s Medical Center (1)
- Hormonal (1)
- Hormone receptor positive breast cancer (1)
- Hospital (1)
- Human chorionic villi mesenchymal stromal cells (1)
- Human primary proximal tubular cells (1)
- Human retroelements (1)
- Hyaluronan (1)
- Hydrofluoric acid (1)
- Hydromineral (1)
- Hydroxyethyl starch (1)
- Hymenoptera venom allergy (1)
- Hyperactivity (1)
- Hyperscanning (1)
- Hypertensive disorders in pregnancy (1)
- Hypoxia inducible factor 1 alphal (1)
- Hypoxia-inducible factor-1α (HIF-1α) (1)
- Hörrehabilitation (1)
- IAP (1)
- IAP Proteins (1)
- IAP-IAP (1)
- ICAM-1 (1)
- ICD (1)
- ICG (1)
- ICH M13A draft guideline (1)
- IDH mutation (1)
- IFN-β (1)
- IFT (1)
- IGF-1 (1)
- IGF1 (1)
- IL-17 (1)
- IL-17A (1)
- IL-1b (1)
- IL-1β (1)
- IL-33 (1)
- INR (1)
- IPSS (1)
- IR (1)
- IRF-3 (1)
- IVUS (1)
- Idelalisib (1)
- Identifier (1)
- Identifikation (1)
- Identifizierung von Katastrophenopfern (1)
- IgA deficiency (1)
- Ileostomy (1)
- Ileus (1)
- Image processing (1)
- Imagery (1)
- Imdevimab (1)
- Immune cells (1)
- Immune checkpoint inhibitors (1)
- Immune complex vasculitis (1)
- Immune paralysis (1)
- Immune status (1)
- Immunity (1)
- Immunoassay (1)
- Immunodeficiency (1)
- Immunogenetics (1)
- Immunoglobulins (1)
- Immunomodulatory agents (1)
- Immunophenotyping (1)
- Immunosuppression (1)
- Immuno‑histochemistry (1)
- Impfraten (1)
- Impfstoff (1)
- Impfung (1)
- Implant osseointegration (1)
- Implantable cardioverter-defibrillator (1)
- Implicit (1)
- Implicit Processing (1)
- Implicit Association Test (1)
- Implicit motives (1)
- Impoverishment (1)
- Impulse generator (1)
- Imrt (1)
- In vitro (1)
- In vivo (1)
- In vivo electrophysiology (1)
- In-Hospital Emergencies (1)
- In-TIPS thrombosis (1)
- Inactivation (1)
- IncX (1)
- Incidence rate (1)
- Incidental prostate cancer (1)
- Incontinence (1)
- Indication for fertility preservation (1)
- Indirect treatment comparison (ITC) (1)
- Individual differences (1)
- Individualized therapy (1)
- Indocyanine green (1)
- Indonesia (1)
- Inducible nitric oxide synthase (iNOS) (1)
- Induction therapy (1)
- Inequality (1)
- Inflammasome (1)
- Inflammatory bowel disease (1)
- Inflammatory fibroid polyp (1)
- Inflammatory pattern (1)
- Influenza vaccination (1)
- Information theory (1)
- Infrared Raman (1)
- Inguinal hernia (1)
- Inguinal pain (1)
- Inherited arrhythmic syndrome (1)
- Injuries (1)
- Injury (1)
- Injury Severity Score (ISS) (1)
- Innate immunity (1)
- Inpatient hospital cases (1)
- Insulin (1)
- Insulin resistance (1)
- Integrated Pulmonary Index (1)
- Integration (1)
- Integrative Network Analysis (1)
- Integrin (1)
- Intensive care (1)
- Intention attribution (1)
- Interaction (1)
- Interferon-α (1)
- Interferon-λ, (1)
- Interleukin-10 (1)
- Interleukin-22 (1)
- Interleukin-36 (1)
- Intermediate-risk (1)
- International normalized ratio (1)
- Internet-based therapy (1)
- Interoperability (1)
- Interposition (1)
- Interpretation Bias (1)
- Intersectoral care (1)
- Interstitial pneumonia (1)
- Intervention (1)
- Intervention development (1)
- Interventional oncological treatment (1)
- Intervertebral disc displacement (1)
- Interview (1)
- Interviews (1)
- Intestinal fistula (1)
- Intestinal metaplasia (1)
- Intimal-medial thickness (1)
- Intraoperative blood salvage (1)
- Intraoperative procedure (1)
- Intraoperative test (1)
- Intravenous iron (1)
- Intrinsic Disorder (1)
- Intrinsic resistance (1)
- Intubation (1)
- Ionization State (1)
- Iron deficiency (1)
- Ischemia (1)
- Isocitrate dehydrogenase (1)
- Isoflurane (1)
- Isoforms (1)
- Isothermal amplification (1)
- Ixodes ricinus (1)
- JAK2V617F (1)
- JNK (1)
- Jaw (1)
- Jaw surgery (1)
- Joint actions (1)
- Joint loading (1)
- Jurkat (1)
- K-homology RNA-binding domain (1)
- K3EDTA plasma sampling (1)
- KCCQ (1)
- KCNQ1 (1)
- KLHL11 (1)
- KPS (1)
- Kallikrein inhibitor (1)
- Kappa (1)
- Kava (1)
- Kava hepatotoxicity (1)
- Keap1-Nrf2 (1)
- Ki-67 (1)
- Kidney diseases (1)
- Kidneys (1)
- Kindes- und Jugendalter (1)
- Knee joint sound (1)
- Knee osteoarthritis (1)
- Knee surgery (1)
- Knees (1)
- Kolorektales Karzinom (1)
- Kontrazeption (1)
- Körpermodifizierung (1)
- L1-norm SVM (1)
- LAMTOR1 (1)
- LARS2 (1)
- LASS (1)
- LC-MS-Based Clinical Research (1)
- LC-MS-based lipid mediator analysis (1)
- LCD-Array (1)
- LDHB (1)
- LEOSS (1)
- LPS (1)
- LQTS (1)
- LSCC (1)
- LSD1 (1)
- LSEC (1)
- Laborpersonal (1)
- Lactate Dehydrogenase (1)
- Laminin (1)
- LanCL2 (1)
- Landmark (1)
- Language delay (1)
- Large vessel occlusion (1)
- Laryngeal Tube (1)
- Laser interstitial thermal therapy (1)
- Lasers (1)
- Lateral flow antigen testing (1)
- Lateral flow immunoassay (1)
- Learning and memory (1)
- Lee type, functional outcome (1)
- Lee-type (1)
- Legal medicine (1)
- Legionella pneumophila (1)
- Leigh syndrome (1)
- Leishmaniasis (1)
- Lemperle (1)
- Lennox-Gastaut syndrome (1)
- Leukemia (1)
- Leukocyte depletion filter (1)
- Lifestyle (1)
- Ligand post-insertion (1)
- Lipedema (1)
- Lipid Transition Temperature (1)
- Lipid peroxidation (1)
- Lipid solution (1)
- Liposuction (1)
- Liquor cerebrospinalis (1)
- Liver (1)
- Liver Fibrosis (1)
- Liver Transplantation (1)
- Liver biopsy (1)
- Liver cancer (1)
- Liver fibrosis (1)
- Liver histology (1)
- Liver injury (1)
- LncRNA (1)
- Loa loa (1)
- Local field potential (1)
- Lockdown (1)
- Long interspersed nuclear elements (LINE) (1)
- Long non-coding RNA (1)
- Long non-coding RNAs (1)
- Long noncoding RNA (1)
- Long-COVID (1)
- Long-term continence (1)
- Long-term follow-up (1)
- Long-term results (1)
- Long-term-measurements (1)
- Longchain polyunsaturated fatty acids (1)
- Low grade glioma (1)
- Low-dose radiation therapy (1)
- Low-virulent infection (1)
- Lung cancer (1)
- Lung development (1)
- Lung neoplasms (1)
- Lung ultrasound (1)
- Lyme Disease (1)
- Lyme-Borreliose (1)
- Lymphangiectasia (1)
- Lymphocyte subpopulations (1)
- Lymphoma (1)
- Lymphoma Cells (1)
- Lymphopenia Mortality (1)
- Lysophosphatidic acids (1)
- M. Intracellulare (1)
- M. avium (1)
- M. avium complex (1)
- M. chimaera (1)
- M2-PK (1)
- MAP Kinases (MAPKs) (1)
- MAP kinase (1)
- MDD (1)
- MEIS (1)
- MEIS homeodomain protein (1)
- MEK inhibitor (1)
- MEN1 (1)
- MGMT (1)
- MGMT promoter (1)
- MID task (1)
- ML-IAP (1)
- MLH1 (1)
- MLKL (1)
- MMPs (1)
- MN1 (1)
- MR spectroscopy (1)
- MRI-negative epilepsy (1)
- MS (1)
- MT: Non-coding RNAs (1)
- MTHFR-Mutation (1)
- MTHFR-mutation (1)
- MTOR inhibitor (1)
- MTRasym (1)
- MUTARS® RS Cup System (1)
- MUTARS® RS cup system (1)
- MVPA (1)
- MYC (1)
- MYCBP2 (1)
- MYCN amplification (1)
- Machine Learning (1)
- Macrophage (1)
- Magnet dislocation (1)
- Magnetic resonance (1)
- Maintenance therapy (1)
- Major Depressive Disorder (1)
- Malaria (1)
- Malate Dehydrogenases (1)
- Malignancy (1)
- Malignant meningioma (1)
- Malnutrition (1)
- Management (1)
- Manchester scar scale (1)
- Marburg virus (1)
- Marginal integrity (1)
- Masking effect (1)
- Masquelet technique (1)
- Mass disaster (1)
- Massenkatastrophe (1)
- Mastoiditis (1)
- Matching-adjusted indirect comparison (MAIC) (1)
- Materials science (1)
- Maternal separation (1)
- Mathematical biosciences (1)
- Mathematical functions (1)
- Maxillofacial reconstruction (1)
- Maxillofacial surgery (1)
- Maxillofacial trauma (1)
- Mean erythrocyte volume (1)
- Mechanical ventilation (1)
- Median nerve (1)
- Medical Oncology (1)
- Medical history (1)
- Medical study (1)
- Meersseman test (1)
- Membrane proteins (1)
- Membrane-Phloretin Interaction (1)
- Meningioma (1)
- Mental disorder (1)
- Mental health and psychiatry (1)
- Mental health therapies (1)
- Meta-analysis (1)
- Metabolic dysfunction (1)
- Metabolic models (1)
- Metabolic syndrome (1)
- Metabolic vulnerabilities (1)
- Metabolism (1)
- Metabolomic profile (1)
- Metal clip (1)
- Metalloproteinases (1)
- Metastasis (1)
- Metastasis-directed therapy (1)
- Metastatic (1)
- Metastatic castration-resistant prostate cancer (1)
- Metformin (1)
- Methanol (1)
- Methicillin-resistant Staphylococcus aureus (1)
- Method validation (1)
- Methods (1)
- Methylation (1)
- Methylmercury Containing Inactivator (1)
- Methylphenidate (1)
- MiR-29 (1)
- MiSpEx-network (1)
- Michael acceptor (1)
- Micro computed tomography (1)
- MicroRNAs (1)
- Microbiology and Infectious Disease (1)
- Microbiology, Virology & Host Pathogen Interaction (1)
- Microbiome (1)
- Microenvironment (1)
- Microfilaremia (1)
- Microgap (1)
- Microglia (1)
- Microparticles (1)
- Microplastic (1)
- Microstructural impairment (1)
- Mid-intestinal bleeding (1)
- Migrant health (1)
- Mild hypoxia (1)
- Mineralization (1)
- Mini-monovision (1)
- Minimal invasive dentistry (1)
- Mitochondrial Apoptosis (1)
- Mitochondrial Metabolism (1)
- Mitochondrial Permeability Transition (1)
- Mitochondrial ROS (1)
- Mitochondrial Transport (1)
- Mitochondrial complex I (1)
- Mitosis (1)
- Mixed Lipid Phases (1)
- Mixed hearing loss (1)
- Mobilization (1)
- Model organisms (1)
- Molecular Biology (1)
- Molecular Chaperone (1)
- Molecular diagnosis (1)
- Molecular diagnostics (1)
- Molecular glue (1)
- Molecular mimicry (1)
- Molecular subtypes (1)
- Monetary incentive delay (1)
- Mongolian spot (1)
- Monitoring (1)
- Monoacylglycerol lipase (1)
- Monoclonal antibody (mAb) (1)
- Monocyte gene expression (1)
- Mood (1)
- Morbidity (1)
- Morphologie (1)
- Mosquito (1)
- Mosquito crop (1)
- Mosquito-plant interaction (1)
- Motility (1)
- Motivation (1)
- Motor-cognitive (1)
- Mountain (1)
- Mouse (1)
- Mouse models (1)
- Multi-Omics (1)
- Multi-motive grid (1)
- Multi-stakeholder approach (1)
- Multi-syndrome classification (1)
- Multidrug-resistance (1)
- Multidrug-resistant organisms (1)
- Multiligament instability (1)
- Multimedication (1)
- Multimodal Modeling (1)
- Multimorbidity (1)
- Multiparametric MRI (1)
- Multiplate (1)
- Multiple Transport Systems (1)
- Multiple sclerosis (1)
- Multiple-indication review (1)
- Multiplex immunoassay (1)
- Multiset independent component analysis (1)
- Multivariate analysis (1)
- Muscle (1)
- Muscle analysis (1)
- Muscle damage (1)
- Muscle pain (1)
- Musculoskeletal abnormalities (1)
- Musculoskeletal mechanics (1)
- Musculoskeletal problems (1)
- Mutations (1)
- Myalgia (1)
- Mycobacteria (1)
- Mycobacterium avium complex (1)
- Myiasis (1)
- Myocardial infarction (MI) (1)
- Myocardial injury (1)
- Myocardial perfusion (1)
- Myocardial remodeling (1)
- Myocarditis (1)
- N-glycosylation (1)
- N471D strumpellin knock-in mice (1)
- N501Y (1)
- NAD + Analogues (1)
- NAD+-Analogs (1)
- NADP+ Analogues (1)
- NAD⊕-Isomer (1)
- NCOA4 (1)
- NET (1)
- NF-kB (1)
- NF-κB pathway (1)
- NFkB (1)
- NFκB (1)
- NGS sequencing (1)
- NIRS (1)
- NIS (1)
- NK Receptor (1)
- NK cell (1)
- NK cell subsets (1)
- NK-92 (1)
- NLRP3 inflammasomes (1)
- NO (1)
- NOS-I (1)
- NOS1AP (1)
- NR4A2 (1)
- NR4A3 (1)
- NSBB (1)
- NTDs (1)
- NTM (1)
- NURF (1)
- NVBP (1)
- Nachweisverfahren (1)
- Nadelstichverletzungen (1)
- Nanoplastic (1)
- Natural Killer (NK) Cell (1)
- Natural killer cells (1)
- Necroptosis (1)
- Necrosis (Necrotic Death) (1)
- Necrotizing enterocolitis (1)
- Needs Assessment [MeSH] (1)
- Negative appendectomy rate (1)
- Neglected tropical diseases (1)
- Negligence (1)
- Nek1 (1)
- Neoadjuvant systemic therapy (1)
- Neoadjuvant treatment (1)
- Neonatal surgery outcome (1)
- Nephrectomy (1)
- Neural coding (1)
- Neural goal function (1)
- Neural stem cells (1)
- NeuroSAFE (1)
- Neurodegenerative syndromes (1)
- Neurodevelopmental disorder (1)
- Neuroendocrine tumor (1)
- Neuroepithelial (1)
- Neuroepithelial tumor (1)
- Neurofeedback (1)
- Neurofilament light chain (1)
- Neuroligins (1)
- Neuromuscular exercise (1)
- Neurooncology (1)
- Neuropilin (1)
- Neuropsychiatric disorders (1)
- Neurosurgery (1)
- Neurotransmitter (1)
- Neurovascular damage (1)
- Neurovascular lesion (1)
- Nevus of Ito (1)
- Nevus of Ota (1)
- New E3-ligase ligands (1)
- NfL (1)
- Niche (1)
- Nicotine (1)
- Nitric oxide (1)
- Non-Hodgkin lymphoma (1)
- Non-abusive head trauma (NAHT) (1)
- Non-apoptotic functions (1)
- Non-cylindrical folds (1)
- Non-diffractive EDOF-IOL (1)
- Non-expert MRI (1)
- Non-small cell lung cancer (1)
- Non-tuberculous mycobacteria (1)
- Non-vitamin K antagonist oral anticoagulants (1)
- Nonaerosolizing treatment (1)
- Nonoperative management (1)
- Nonpenetrating (1)
- Nontuberculous mycobacteria (1)
- Noradrenergic (1)
- Norepinephrine (1)
- Normative modeling (1)
- Notch signaling (1)
- Nox (1)
- Nox inhibition (1)
- Nox4 (1)
- Nrf-2 (1)
- Nukleinsäureamplifikationstest (NAT) (1)
- Null responder (1)
- Number of platelets (1)
- Nutrition (1)
- OA (1)
- OCT (1)
- OGR1 (1)
- OHIP-G14 (1)
- OHRQoL (1)
- ORP (1)
- OSA (1)
- OSCE (1)
- OTU domain-containing protein 7B (OTUD7B) (1)
- OXA-23 (1)
- OXA-484 (1)
- OXA-58 (1)
- OXPHOS (1)
- Oberflächenantigen-Mutante (1)
- Observational (1)
- Obsessive-compulsive disorder (1)
- Obstetrics and gynecology (1)
- Occlusion (1)
- Occlusion treatment (1)
- Occupational health (1)
- Ocular tuberculosis (1)
- Older adult (1)
- Older patient (1)
- Older patients (1)
- Olfactory groove meningioma (1)
- Olfactory system (1)
- Oligodendroglioma (1)
- Oligometastatic (1)
- Omega lipids (1)
- Omicron variant BA.1 (1)
- Omphalocele (1)
- Oncogenes (1)
- One-leg stand (1)
- Online Survey (1)
- Online education (1)
- Open Science (1)
- Open pulmonary tuberculosis (1)
- Ophthalmoplegia (1)
- Opinion (1)
- Opioid system (1)
- Opioids (1)
- Opportunistic infections (1)
- Optical phenomena (1)
- Oral and maxillofacial surgery (1)
- Oral anticoagulation (1)
- Oral food challenge (1)
- Oral immunotherapy (OIT) (1)
- Oral therapy (1)
- Orbital fracture (1)
- Organ failure (1)
- Organ injury (1)
- Organ preservation (1)
- Organ-confined (1)
- Orthodontic tooth movement (1)
- Oscillating saws (1)
- Ossifying fibroma (1)
- Osteoarthritis (1)
- Osteocalcin (1)
- Osteoporotic fractures (1)
- Otorhinolaryngological (1)
- Outcomes research (1)
- Outpatients (1)
- Ovarian cancer treatment (1)
- Over-the-scope clip (1)
- Overweight (1)
- Overwintering (1)
- Oxa1/YidC/Alb3 Membrane Insertases (1)
- Oxidative phosphorylation (1)
- OxyELITE Pro (1)
- Oxygen extraction fraction (1)
- P2X7 receptor (1)
- PAC-1 (1)
- PAD-test (1)
- PAM (1)
- PAPR (1)
- PATZ1 (1)
- PBBM (1)
- PBSC (1)
- PBX (1)
- PD-1 (1)
- PDPK1 (1)
- PFOA (1)
- PFOS (1)
- PGC-1α (1)
- PHR1 (1)
- PI3K (1)
- PI3K inhibitor (1)
- PI3K/mTor inhibition (1)
- PLAGL1 (1)
- PLGA (1)
- PMA (1)
- PMI (1)
- PML (1)
- PMMA (1)
- POCT (1)
- POR (1)
- PPAR (1)
- PPAR-γ (1)
- PPTC7 (1)
- PRF (1)
- PRG5 (1)
- PRNT (1)
- PROTAC (1)
- PRRT (1)
- PSA (1)
- PTEN (1)
- PTEN inducible kinase 1 (1)
- PTM (1)
- PV loop (1)
- PWI (1)
- PacBio SMRT sequencing (1)
- Pacemaker (1)
- Paediatric cancer (1)
- Paediatric trauma patients (1)
- Pain management (1)
- Pain scale MWA (1)
- Palacos reaction (1)
- Palliative Care [MeSH] (1)
- Pandemie (1)
- Papillon-Lefèvre syndrome (1)
- Paracoccus denitrificans (1)
- Parasympathetic (1)
- Parenteral nutrition (1)
- Parkinson's disease (1)
- Particle load reduction (1)
- Particle number size distribution (1)
- Particle size distribution (1)
- Particle toxicity (1)
- Particulate matter (1)
- Particulates (1)
- Pathogenicity (1)
- Pathogens (1)
- Pathology (1)
- Pathophysiology (1)
- Patient Outcome Assessment [MeSH] (1)
- Patient Reported Outcome Measures [MeSH] (1)
- Patient and public Involvement (1)
- Patient care (1)
- Patient information (1)
- Patient manikins (1)
- Patient outcome assessment (1)
- Patient participation (1)
- Patient perspective (1)
- Patient preference (1)
- Patient*inneninformation (1)
- Pediatric fracture (1)
- Pediatric oncology (1)
- Pediatric stem cell transplantation (1)
- Pediatric surgery (1)
- Pelargonium sidoides questionable hepatotoxicity (1)
- Pelvic (1)
- Pentose Pathway (1)
- Per1−/−-mice (1)
- Perceived stigma (1)
- Percutaneous endoscopic gastrostomy (1)
- Percutaneous pinning (1)
- Percutaneous ultrasound (1)
- Peri-implant disease (1)
- Periodic (1)
- Periodontal trauma (1)
- Periodontitis grades B and C (1)
- Peripheral blood smears (1)
- Periprocedural anticoagulation (1)
- Peritoneal macrophages (1)
- Peritumoural oedema (1)
- Peri‑implantitis (1)
- Peroxidase (1)
- Perrault syndrome (1)
- Persistence SARS-CoV-2 antibodies (1)
- Persistent organic pollutants (1)
- Personal medicine (1)
- Personal protective equipment (1)
- Personal stigma (1)
- Personalisierte translationale Therapie (1)
- Personality inventory (1)
- Personalized Medicine (1)
- Personalized medicine (1)
- Petri net (1)
- Peutz–Jeghers syndrome (1)
- Phalangeal fractures (1)
- Phantoms (imaging) (1)
- Pharmacokinetics (1)
- Pharmacology (1)
- Pharmacotherapy (1)
- Pharmacovigilance (1)
- Phase 3 (1)
- Phase 3 trial (1)
- Phase I clinical trial (1)
- Phase-reset (1)
- Phenotypic plasticity (1)
- Phenylketonuria (PKU) (1)
- Philadelphia chromosome-positive acute leukemia (1)
- Phlyctenule (1)
- Phosphohydrolases (1)
- Photoaffinity Labeling (1)
- Physical and mental health (1)
- Physical comorbidities (1)
- Physical self-perception (1)
- Physics (1)
- Physiotherapy (1)
- Placental organoids (1)
- Plasma (1)
- Plastic pollution (1)
- Plastics (1)
- Platelets (1)
- Play (1)
- Pleasure (1)
- Pneumocystis jirovecii (1)
- Podospora anserina (1)
- Point of care (1)
- Point-of-care wound diagnostics (1)
- Poly-Pore (1)
- Polygenic risk score (1)
- Polyposis syndrome (1)
- Polyunsaturated fatty acid mediators (1)
- Polyunsaturated fatty acids (1)
- Ponatinib (1)
- Population dynamics (1)
- Portal veins (1)
- Portuguese population (1)
- Positron emission tomography (1)
- Post mortem examination (1)
- Post mortem interval (1)
- Post-cesarean (1)
- Post-mortem genetic screening (1)
- Post-offence drinking (1)
- Post-thaw recovery (1)
- Post-traumatic stress disorder (1)
- Postmortem (1)
- Postmortem interval (1)
- Postoperative anatomy (1)
- Posttraumatic stress disorder (1)
- Postural sway (1)
- Posture analysis (1)
- Potassium iodide (1)
- Poverty (1)
- Powered air-purifying respirator (1)
- Praeklampsie (1)
- Pre-operative radiotherapy (1)
- Precision medicine (1)
- Prediction of locoregional recurrence (1)
- Predictive Modeling (1)
- Predictive model (1)
- Predictive processing (1)
- Predictors (1)
- Predominant polarity (1)
- Preeclampsia (1)
- Presbyopia (1)
- Pressure distribution (1)
- Pressure measuring plate (1)
- Preventive medicine (1)
- Primary care (1)
- Primary cilium (1)
- Primary molars (1)
- Primärversorgung (1)
- Principal component analysis (1)
- Prisoners (1)
- Prisons (1)
- Probability density (1)
- Probability distribution (1)
- Procedural skills (1)
- Proficiency testing (1)
- Prognostic markers (1)
- Prognostic models (1)
- Progranulin (1)
- Promoters (1)
- Propensity score matching (1)
- Protease inhibitor therapy (1)
- Protein (1)
- Protein Domains (1)
- Protein Expression (1)
- Protein Folding (1)
- Protein Motifs (1)
- Protein Targeting (1)
- Protein Translocation (1)
- Protein interactions (1)
- Protein-Lipid Interaction (1)
- Protein-Protein Interactions (1)
- Protein-translocation (1)
- Prothrombinmutation (1)
- Protocol (1)
- Proton density (1)
- Proximal (1)
- Prävention (1)
- Pseudophakia (1)
- Pseudoprogression (1)
- Psoriatic arthritis (1)
- Psychiatric disorders (1)
- Psychiatric traits (1)
- Psychiatry (1)
- Pteridine (1)
- Pulmonary edema (1)
- Pulmonary hypertension (1)
- Pulmonary hypoplasia (1)
- Pumpkin seeds (1)
- Purdue Pegboard (1)
- Pyogenic (1)
- Pyogenic spondylodiscitis (1)
- Qualitative Research [MeSH] (1)
- Qualitative research (1)
- Qualitative study (1)
- Quality control (1)
- Quality of Health Care [MeSH] (1)
- Quantitative (q)T2 mapping (1)
- Quantitative Imaging (1)
- Quantitative MRI (1)
- Quantitative magnetic resonance imaging (1)
- Quantra (1)
- Quarantine (1)
- Quasi-longitudinal study (1)
- Questionnaire (1)
- Quinolones (1)
- RAF (1)
- RARP (1)
- RAS (1)
- RAS pathway (1)
- RCC (1)
- RDoC (1)
- RESLES (1)
- RET (1)
- RGAG1 (1)
- RIP (1)
- RIPK1 (1)
- RMS (1)
- RNA chaperone (1)
- RNA sequencing (1)
- RNA stability (1)
- RNA therapy (1)
- RNA turnover (1)
- RNA virus (1)
- RNA-binding protein (1)
- RNA-sequencing (1)
- RNA/MicroRNA (1)
- RNAP II (1)
- RND (1)
- RNF4 (1)
- ROC analyses (1)
- ROC-Analysen (1)
- ROS1 (1)
- RT-PCR-detection (1)
- Rab7 (1)
- Rabbit (1)
- Race (1)
- Radiation Oncology (1)
- Radiation necrosis (1)
- Radiochemotherapy (1)
- Radiofrequency ablation (1)
- Radioiodine therapy (1)
- Radioiodine uptake test (1)
- Radiology (1)
- Radiosurgery (1)
- Ragulator complex (1)
- Ramadan (1)
- Ramucirumab (1)
- Random forest (1)
- Randomisation (1)
- Randomized Controlled Trial (1)
- Randomized controlled trial (1)
- Randomized controlled trials (1)
- Rcf1 (1)
- Reactogenicity (1)
- Ready-made mouthguard (1)
- Real world study (1)
- Real-time MRI (1)
- Real-time polymerase chain reaction (PCR) tests (1)
- Receptors/Nuclear (1)
- Recurrence (1)
- Recurrent episodes (1)
- Redox dependent epigenetic modifications (1)
- Redox-sensitive transcription factor (1)
- Redundancy (1)
- Referral (1)
- Refractive changes (1)
- Refractive lense exchange (1)
- Refractory ALL (1)
- Refractory AML (1)
- RegJoint™ (1)
- Region (1)
- Registries (1)
- Regret (1)
- Regulatory agencies. (1)
- Rehabilitation outcome (1)
- Rehabilitationsergebnis (1)
- Relapse surveillance (1)
- Relaxometry (1)
- Reliability (1)
- Renal cell carcinoma (1)
- Representative survey (1)
- Reproducibility (1)
- Reproducibility/stability (1)
- Research data (1)
- Research design (1)
- Research investment (1)
- Research patterns (1)
- Research validity (1)
- Resection (1)
- Residual myometrial thickness (1)
- Resilience (1)
- Respiratory infections (1)
- Response control (1)
- Responsibility of healthcare policy (1)
- Restenosis (1)
- Resting-state (1)
- Retinal diseases (1)
- Retinoic acid (1)
- Retrospective study (1)
- Return to work (1)
- Reverse electron transfer (1)
- Reward anticipation (1)
- Reward system (1)
- Rh Antigens (1)
- Rhabdomyoma (1)
- Rho-kinase (1)
- Ribosomal RNA (1)
- Ridge preservation (1)
- Riftia pachyptila (1)
- Risikofaktoren (1)
- Risikokommunikation (1)
- Risk assessment (1)
- Risk communication (1)
- Risk factor (1)
- Risk stratification (1)
- Risk-stratification (1)
- Rivaroxaban (1)
- Robotic-assisted radical prostatectomy (1)
- Rodents (1)
- Roussel Uclaf Causality Assess- ment Method (RUCAM) (1)
- Routinely Collected Health Data [MeSH] (1)
- S1P (1)
- S1P lyase (1)
- S1P5 (1)
- S1PR5 (1)
- S63845 (1)
- SAH (1)
- SAMHD1 (1)
- SARS CoV 2 (1)
- SARS coronavirus (1)
- SARS-CoV-2-specific T cells (1)
- SARS-CoV2 (1)
- SARS-CoV‑2 (1)
- SCA2 (1)
- SCCHN (1)
- SCD14 (1)
- SCN5A (1)
- SEC (1)
- SEC-ICP-DRC-MS (1)
- SEER (1)
- SELEX (1)
- SF-12 (1)
- SF-36 (1)
- SGPL1 (1)
- SGPL1 knockout cell line (1)
- SH- (S-S)-Groups (1)
- SH-SY5Y neuroblastoma cells (1)
- SIDS (1)
- SIRPalpha (1)
- SIRT1 (1)
- SKALE score (1)
- SLAM-seq (1)
- SLC6a3 (1)
- SLC7A11 (1)
- SLUG (1)
- SMOC1 (1)
- SNORD95 (1)
- SOD (1)
- SPG8 (1)
- SPPL3 (1)
- SSTI (1)
- STAT1 (1)
- STAT3 (1)
- SUD (1)
- SUDEP (1)
- SUMO (1)
- SVR (1)
- Safety culture (1)
- Safety perspectives (1)
- Salivary gland cancer (1)
- Salivary gland carcinoma (1)
- Sampling protocol (1)
- Sandfly (1)
- Sanger Sequencing (1)
- Sapacitabine (1)
- Sarcoma (1)
- Sarcophagidae (1)
- Satisfaction (1)
- Saudi Arabia (1)
- Scalp defect (1)
- Scanner models (1)
- Scheduling of radiotherapy (1)
- Scheimpflug imaging (1)
- Sclerotic glomeruli (1)
- Screening (1)
- Screening-ELISA (1)
- Screeningfragebogen (1)
- Scrofulous keratitis (1)
- Seasonal variation (1)
- Second donation (1)
- Sedation (1)
- Sedatives (1)
- Seizures (1)
- Self-esteem (1)
- Self-expandable TAVI (1)
- Self-renewal (1)
- Senescence (1)
- Separation of ADP-Binding Enzymes (1)
- Sepsis (1)
- Sequelae (1)
- Sequencing (1)
- Serious injured children (1)
- Serology (1)
- Serum (1)
- Serum biomarker (1)
- Shared information (1)
- Sharp injuries (1)
- Short bowel syndrome (1)
- Shoulder luxation (1)
- Side effect (1)
- Side effects (1)
- Siderosis (1)
- Signal Recognition Particle (1)
- Signal intensity (1)
- Signs and symptoms (1)
- Silver diamine fluoride (1)
- Simulated patients (1)
- Simulation training (1)
- Single nucleotide polymorphism (1)
- Single positive core biopsy (1)
- Single-cell RNA sequencing (1)
- Single-leg hop for distance (1)
- Single-treatment (1)
- Skeletal health (1)
- Skeletal joints (1)
- Skeletal muscles (1)
- Skull base (1)
- Sleep (1)
- Slow Cortical Potentials, SCP (1)
- Smac mimetics (1)
- Smad (1)
- Small Leucine-rich Proteoglycan (SLRP) (1)
- Small RNA analysis (1)
- Small vessel disease (1)
- Small-bowel endoscopy (1)
- Smoking habits (1)
- Smooth muscle cells (1)
- Social Phobia (1)
- Social brain (1)
- Social cognition (1)
- Social decision-making (1)
- Social determinants (1)
- Social differences (1)
- Social neuroscience (1)
- Socio-economic analysis (1)
- Sociocognitive predictors (1)
- Sociodemographic characteristics (1)
- Socioeconomic analysis (1)
- Socioeconomic indices (1)
- Socket healing (1)
- Socket preservation (1)
- Sodium chloride (1)
- Soft tissue healing (1)
- Soft tissue sarcoma (1)
- Solar insolation (1)
- Soluble epoxide hydrolase (1)
- Sonication (1)
- Sonography (1)
- Sparse models (1)
- Specific Synthesis (1)
- Speech discrimination (1)
- Sphk1 (1)
- Sphk2 (1)
- Spinal cord (1)
- Spinal fractures (1)
- Spinal injuries (1)
- Spinal surgery (1)
- Spine care (1)
- Spine fractures (1)
- Spine infection (1)
- Spinocerebellar ataxia type 2 (1)
- Spondylitis (1)
- Spondylodiscitis (1)
- Sports and exercise medicine (1)
- Sprachverstehen (1)
- Sputum smear-negative (1)
- Stability (1)
- Stage at presentation (1)
- Stakeholder participation (1)
- Standard dataset (1)
- Standard reference values (1)
- Static MRI (1)
- Statin (1)
- Stationäre Krankenhausfälle (1)
- Stem cell dose (1)
- Stem cell enumeration (1)
- Stereotactic ablative body radiotherapy (1)
- Sterols (1)
- Stigma (1)
- Stigma scale (1)
- Stimulant (1)
- Sting challenge (1)
- Stoppa approach (1)
- Streptomyces hydrogenans (1)
- Stress vulnerability/resilience genes (1)
- Striatum (1)
- Stroke Risk (1)
- Stroke genetics (1)
- Stroke unit (1)
- Structured written feedback (1)
- Sub-zero exposure (1)
- Subependymal giant cell astrocytoma (1)
- Subjective effects (1)
- Subventricular zone (1)
- Sudden Cardiac Death (SCD) (1)
- Sudden cardiac death (1)
- Sudden infant death syndrome (1)
- Sugar feeding (1)
- Suicidality (1)
- Suicide attempt (1)
- Sulfhydryl Groups (1)
- Sulphoraphane (1)
- Sunlight (1)
- Support vector machine (1)
- Supraglottic Airway Devices (1)
- Supratentorial (1)
- Surgical blood loss (1)
- Surgical education (1)
- Surgical oncology (1)
- Surgical site infection (1)
- Surgical therapy (1)
- Survey (1)
- Suspension (1)
- Sustained attention (1)
- Sustained virologic response (1)
- Sustained virological response (1)
- Swallowing (1)
- Syk Kinase (1)
- Symmetrical blocked occlusion (1)
- Sympathetic (1)
- Synapse (1)
- Synaptic organizer (1)
- Synaptosomal preparation (1)
- Syndecan-1 (1)
- Synergy (1)
- Synovial sarcoma (1)
- Synthetic biology (1)
- Syrian hamster (1)
- Systems & Computational Biology (1)
- T Cell Biology (1)
- T cell (1)
- T cell receptor (1)
- T cells (1)
- T helper cell differentiation (1)
- T-bet (1)
- T-cell development (1)
- T-cell receptor (1)
- T-cell receptor (TCR) (1)
- T-cells (1)
- T2 (1)
- TACE (1)
- TAM (1)
- TAMs (1)
- TB-therapy (1)
- TBI (1)
- TBK1 (1)
- TDAG8 (1)
- TGF-α (1)
- TGF-β1 (1)
- TGFB-induced factor homeobox 1 (1)
- TGIF (1)
- TGR(mREN2)27 (1)
- TIGAR (1)
- TIRADS (1)
- TLR4 (1)
- TME (1)
- TOR signalling (1)
- TRAIL (1)
- TRIMs (1)
- TRP Channels (1)
- TRP2 (1)
- TRPA1 (1)
- TRPM8 (1)
- TRPV4 (1)
- TSP-4 (1)
- TTFields (1)
- TTW nodules (1)
- TUR-P (1)
- TURP (1)
- TWNK (1)
- Taekwondoka (1)
- Tailored therapy (1)
- Takotsubo Syndrome (1)
- Tamoxifen (1)
- Tar (1)
- Targeted delivery (1)
- Targeted sequencing (1)
- Targeted therapies (1)
- Targeted therapy (1)
- Tattoo (1)
- Technical data (1)
- Tempo-parietal junction (1)
- Temporomandibular joint (1)
- Temporomandibular joint dysfunction (1)
- Terminal ileitis (1)
- Test assay (1)
- Testing (1)
- Tetanus (1)
- Tetrahydrobiopterin (1)
- Thalidomide (1)
- Theft (1)
- Therapeutic adherence (1)
- Therapeutic anticoagulation (1)
- Therapeutic competence (1)
- Therapie (1)
- Therapies (1)
- Therapy (1)
- Thermogenesis (1)
- Thermoplasma acidophilum Membranes; Tetraetherlipids (1)
- Thoracic trauma (1)
- Thorax (1)
- Thrombophilie (1)
- Thrombose (1)
- Thrombotic thrombocytopenic purpura (1)
- Thumb carpometacarpal joint osteoarthritis (1)
- Thyroid (1)
- Thyroid Cancer Cells (1)
- Tick-Borae (1)
- Tick-Born Diseases (1)
- Time of death (1)
- Time trend (1)
- Tissue engineering (1)
- Tissue expander (1)
- Tissue microarray (1)
- Tissue-specificity (1)
- Tobacco (1)
- Tocilizumab (1)
- Toll-like Receptor (TLR) (1)
- Toluidine blue (1)
- Tomography (1)
- Tooth Development (1)
- Tooth segmentation (1)
- Total elbow arthroplasty (1)
- Total hip arthroplasty (1)
- Touchscreen (1)
- Toxic liver disease (1)
- Toxicity (1)
- Toxins (1)
- Traditional Chinese Medicine (TCM) (1)
- Traditional Indian Medicine (1)
- Trafficking (1)
- Trail (1)
- Traits of medical students (1)
- Trajectories (1)
- Transarterial chemoembolization (1)
- Transcranial direct current stimulation (1)
- Transcription (1)
- Transcription factor (1)
- Transcription regulation (1)
- Transcriptional regulatory elements (1)
- Transcriptomics (1)
- Transdifferentiation (1)
- Transfer learning (1)
- Transfusion practice (1)
- Transgenic mice (1)
- Transitional fractures 3D printing (1)
- Transjugular Intrahepatic Portosystemic Shunt (1)
- Transjugular intrahepatic portosystemic shunt (1)
- Translation proteomics (1)
- Transplant logistics (1)
- Transplantation Centers (1)
- Transurethral resection of the prostate (1)
- Trauma centre (1)
- TraumaRegister DGU® (1)
- TraumaRegister DGU® (TR-DGU) (1)
- Traumatic brain injury (1)
- Traumatic dental injury (1)
- Traumatology (1)
- Travel regulations (1)
- Travel times (1)
- Treatment effectiveness (1)
- Treatment management (1)
- Treatment rates (1)
- Treatment response (1)
- Treg cell (1)
- Trimeric autotransporter adhesins (1)
- Trisomy 21 (1)
- Troponin (1)
- Truncating mutation (1)
- Truncus arteriosus (1)
- Tuberous sclerosis complex (1)
- Tumor cell (1)
- Tumor subtype (1)
- Tumor therapy (1)
- Tumour immunology (1)
- Type three hypersensitivity (1)
- Tyrosine kinase inhibitor (TKI) (1)
- Tyrosinemia (1)
- UBA domain (1)
- UGCG (1)
- UHPLC-MS (1)
- UPR (1)
- USP28 (1)
- USP32 (1)
- Ubiquitin Ligase (1)
- Ubiquitin ligase (1)
- Ubiquitin signaling (1)
- Ubiquitin-binding module (1)
- Ubiquitination (1)
- Ubiquitylation (1)
- Ulixertinib (1)
- Uncertainty (1)
- Undergraduate (1)
- Undergraduate education (1)
- Understanding (1)
- Undiagnosed patients (1)
- Unique information (1)
- Upgrading (1)
- Upper airway infection (1)
- Urachal cancer (1)
- Urachus carcinoma (1)
- Urethral cancer (1)
- Urinary continence (1)
- Urinary incontinence (1)
- Urine (1)
- Urologic tumors (1)
- Urological oncology (1)
- Uterus (1)
- V4 (1)
- VEGF receptor 2 internalization and signaling (1)
- VEGF receptors (1)
- VF (1)
- VGAT-ChR2 (1)
- VHL (1)
- VIM (1)
- VRE (1)
- VT (1)
- VUS (1)
- VX-2 (1)
- Vaccine (1)
- Vagus nerve (1)
- Vagus nerve stimulation (1)
- Validation (1)
- Validity (1)
- Valvular cardiomyopathy (1)
- Variant of concern (1)
- Variceal bleeding (1)
- Vascular cognitive disorder (VCD) – Paranoid hallucinatory syndrome – Late-onset trauma-related symptoms – Depression – Assertive community treatment (ACT) (1)
- Vascular disease (1)
- Vasculitis (1)
- Vasospasm (1)
- Venous Thromboembolism (1)
- Venous thromboembolism (1)
- Venous thrombosis (1)
- Ventilators (1)
- Ventricular arrhythmia (1)
- Ventricular arrhythmias (1)
- Ventricular tachyarrhythmia (1)
- Venöse Thrombose/Genetik (1)
- Versorgungsstruktur (1)
- Vertebral body (1)
- Vibroarthrography (1)
- Video rasterstereography (1)
- Videorasterstereography (1)
- Viral hepatitis (1)
- Viral infection (1)
- Viral load (1)
- Viral oncology (1)
- Virological testing (1)
- Virtual noncalcium reconstructions (1)
- Virtual patients (1)
- Virulence (1)
- Virus trapping (1)
- Virusisolierung (1)
- Viruslast (1)
- Visual quality (1)
- Volume reduction of thyroid nodules (1)
- Volunteer donor (1)
- Von Hippel–Landau (1)
- WASH complex subunit 5 (1)
- WIPI2 (1)
- WIPI2b (1)
- Wastewater-based epidemiology (WBE) (1)
- Water contamination (1)
- Watertight Dural closure (1)
- Weight distribution (1)
- Western Blotting (1)
- Western blot (1)
- Western diet (1)
- White blood cells (1)
- White matter hyperintensity (1)
- Whole slide images (1)
- Wilson disease (WD) (1)
- Winter survival (1)
- Working memory capacity (1)
- Wound healing (1)
- Wounds and injuries (1)
- X-ray computed (1)
- X-ray crystallography (1)
- XIAP (1)
- Yeast-2-Hybrid (1)
- Yoga (1)
- Zebrafish (1)
- Zeckenübertragene Erkrankungen (1)
- Zentrifugalanalysator (1)
- Zika Virus (1)
- Zika fever (1)
- Zuckerkandl’s tubercle (1)
- Zymosan-induced peritonitis (1)
- [18F]FET PET (1)
- aGVHD (1)
- abdominal aortic aneurysm (1)
- ablation (1)
- abscisic acid (1)
- abscopal effect (1)
- acarboxyprothrombin (1)
- accident (1)
- acetabular fracture (1)
- acetaminophen (1)
- acne inversa (1)
- acoustic radiation force impulse (1)
- acquired LQT syndrome (1)
- action (1)
- activated clotting time measurement (1)
- activated factor XIII (1)
- acute decompensation (1)
- acute infections (1)
- acute lymphoblastic leukemia (1)
- acute pain (1)
- acute respiratory distress syndrome (1)
- acute stroke (1)
- acute stroke care (1)
- acute-on-chronic liver failure (1)
- additive manufacturing (1)
- adenosine (1)
- adiabatic saturation (1)
- adipocytes (1)
- adipose-derived mesenchymal stem/stromal cells (1)
- adjuvant chemotherapy (1)
- adolescence (1)
- adolescent (1)
- adolescents (1)
- adrenergic therapy (1)
- advanced melanoma (1)
- adversity (1)
- aged (1)
- agent-based modeling (1)
- agent-based models (1)
- agility (1)
- agreeableness (1)
- air abrasive (1)
- albumin (1)
- alcohol (1)
- alcoholic fatty liver disease (1)
- alcoholic hepatitis (1)
- aligners (1)
- allogeneic donor (1)
- allogeneic hematological stem cell transplantation (1)
- allogeneic hematopoietic stem cell transplantation (1)
- allogeneic stem cell transplant (1)
- allostasis (1)
- alpha receptor (1)
- alpha-fetoprotein (1)
- alpha-galactosidase A deficiency (1)
- alpha-synuclein (1)
- alpha7 nicotinic acetylcholine receptor (1)
- alphaSynuclein (1)
- alteplase (1)
- alternative matrices (1)
- alternative splicing (1)
- alveolar ridge augmentation (1)
- amide proton transfer (1)
- amino acids (1)
- amisulpride (1)
- amphiregulin (1)
- amygdalin (1)
- amyotrophic lateral sclerosis (ALS) (1)
- anaemia walk-in clinic (1)
- anaplastic large cell lymphoma (1)
- anesthesia (1)
- aneurysm (1)
- angiokeratoma diffuse (1)
- animal models (1)
- anorectal malformation (1)
- anorexia nervosa (1)
- anti-CD3 antibody (1)
- anti-EGFR therapy (1)
- anti-HBc (1)
- anti-bacterial agents (1)
- anti-inflammatory agent (1)
- anti-neural autoantibodies (1)
- antiadhesive composites (1)
- antiangiogenic therapy (1)
- antiangiogenic therapy resistance (1)
- antibacterial composites (1)
- antibacterial therapy (1)
- antibiotic prophylactic therapy (1)
- antibiotic prophylaxis (1)
- antibiotics (1)
- anticipation (1)
- anticoagulant (1)
- anticoagulation (1)
- antiepileptic drug (1)
- antifungal agents (1)
- antifungal therapy (1)
- antigen detection (1)
- antihelix shaping (1)
- antimicrobial stewardship (1)
- antioxidant (1)
- antiviral agents (1)
- antiviral drugs (1)
- antiviral signaling (1)
- anxiety (1)
- anxiety disorders (1)
- aortic aneurysm (1)
- aortic root replacement (1)
- aortic valve repair (1)
- aortic valve stenosis (1)
- aortic valve-sparing (1)
- apex (1)
- aphrodisin (1)
- apical constriction (1)
- apical polarity (1)
- apolipoprotein B (1)
- aptamer (1)
- aptamer modeling (1)
- arachidonate 12/15-lipoxygenase (Alox12/15) (1)
- arachidonic acid (1)
- arachidonic acid (AA) (1)
- arbeitsbedingte Infektionen (1)
- arterial stiffness (1)
- articular cartilage (1)
- articular chondrocytes (1)
- artifacts (1)
- artificial feeding (1)
- artificial intelligence (AI) (1)
- aryl hydrocarbon receptor (1)
- asparaginyl endopepdidase (AEP) (1)
- aspiration (1)
- aspirin (1)
- assembly (1)
- assembly factor (1)
- asthma (1)
- asymptomatic temporal encephaloceles (1)
- at-risk mental state (1)
- ataxia (1)
- atezolizumab (1)
- atomic power (1)
- atopic dermatitis (1)
- atrial fibrillation (1)
- attachment (1)
- attachment loss (1)
- attention-deficit/hyperactivity disorder (ADHD) (1)
- atypical EGFR mutations (1)
- auditory (1)
- auditory cortex (1)
- auditory fMRI (1)
- augmentation (1)
- autism (1)
- autoantibodies (1)
- autobiographical memories (1)
- autogenous tooth roots (1)
- autoimmune encephalitis (1)
- autoimmune-mediated psychosis (1)
- automatic scene classification (1)
- autophagy inhibition (1)
- autophagy-dependent cell death (1)
- awake surgery (1)
- azacitidine (1)
- azoospermia (1)
- bacteremia (1)
- bacterial leakage (1)
- bacterial viability (1)
- bacteriophages (1)
- ball (1)
- bariatric surgery (1)
- basilar artery occlusion (BAO) (1)
- bats (1)
- behavior (1)
- behavioral inhibition (1)
- behavioural rhythms (1)
- benchmarking (1)
- benfooxythiamine (1)
- best medical treatment (1)
- beta-band activity (1)
- beta-blocker (1)
- beta-lactamases (1)
- beta2-adrenoceptor (1)
- bevacizumab (1)
- bibliometric analysis (1)
- bilateral (1)
- bile (1)
- bile acids (1)
- binocular vision (1)
- bio imaging (1)
- bioactive lipids (1)
- bioavailability (1)
- biochemical relapse free survival (1)
- bioequivalence (1)
- biofilm (1)
- bioimaging (1)
- bioinformatics (1)
- biologization (1)
- bioluminescence (1)
- biorelevant dissolution (1)
- biotin deficiency (1)
- bladder neck stenosis (1)
- blinatumomab (1)
- blood borne infection (1)
- blood cell mutations (1)
- blood coagulation (1)
- blood coagulation factor XIII (1)
- blood concentrates (1)
- blood culture (1)
- blood donor screening (1)
- blood-brain barrier (1)
- bloodborne viruses (1)
- bloodstream infections (1)
- blutübertragbare Infektionskrankheiten (1)
- body plethysmography (1)
- body sway (1)
- body weight distribution (1)
- bone augmentation (1)
- bone barrow (1)
- bone metastasis (1)
- bone tissue engineering (1)
- bone-regeneration (1)
- bowel dysfunction (1)
- bowel management (1)
- brachytherapy (1)
- brain (1)
- brain disorders (1)
- brain function (1)
- brain imaging (1)
- brain infection (1)
- brain networks (1)
- brain shift (1)
- brain signal complexity (1)
- brain tumor (1)
- breast tumor (1)
- bromodomain and extraterminal (BET) protein (1)
- bronchial epithelium (1)
- bulimia nervosa (1)
- buparlisib (1)
- burden of illness (1)
- burkholderia (1)
- burkholderia cepacia complex infections (1)
- bypass (1)
- c-MET (1)
- c-MYC (1)
- cAMP (1)
- cGMP (1)
- cabazitaxel (1)
- caesarean scar (1)
- caesarean section (1)
- calprotectin (1)
- calretinin (1)
- cancer cell metabolism (1)
- cancer immunotherapy (1)
- cancer information (1)
- cancer metastases (1)
- cancer surveillance (1)
- cancer therapy (1)
- cancer-associated fibroblasts (1)
- cancer-specific survival (1)
- cannabinoid receptors (1)
- cannabis (1)
- carbapenem resistance (1)
- carbapenemases (1)
- cardiac autonomic regulation (1)
- cardiac differentiation (1)
- cardiac magnetic resonance (1)
- cardiac regeneration (1)
- cardiac remodeling (1)
- cardiac reprogramming (1)
- cardiocerebral resuscitation (1)
- cardiomyocyte apoptosis (1)
- cardiomyocyte proliferation (1)
- cardiomyocytes (1)
- cardiopulmonary resuscitation (1)
- cardiothoracic surgery (1)
- cardiovascular management (1)
- cardiovascular system (1)
- casein kinase 2 (1)
- caspase-1 (1)
- castration resistance (1)
- cataract surgery (1)
- cataract surgery workflow (1)
- catecholamine excess (1)
- cathepsin L inhibitor (1)
- cell barrier integrity (1)
- cell culture (1)
- cell death (1)
- cell differentiation (1)
- cell heterogeneity (1)
- cell lines (1)
- cell proliferation regulating inhibitor of protein phosphatase 2A (1)
- cellular heterogeneity (1)
- cellular inflammatory response (1)
- cellular therapies (1)
- central nervous system (1)
- central spasticity (1)
- ceramide synthase (1)
- cerebral imaging (1)
- cerebral ischemia (1)
- cerebral metastasis (1)
- cerebral palsy (1)
- cerebral pseudoprogression (1)
- cerebral sinus and vein thrombosis (CVT) (1)
- cerebral vasospasm (CVS) (1)
- cerebrovascular disease (1)
- cerumen (1)
- cetuximab (1)
- channelrhodopsin (1)
- chaperone-mediated autophagy (1)
- chelator (1)
- chemokines (1)
- chemoprotection (1)
- chemorefractory metastatic colorectal cancer (1)
- chemoresistance (1)
- chemotaxis (1)
- chernobyl (1)
- childhood cancer (1)
- childhood epilepsy (1)
- children and adolescents (1)
- chimeric antigen receptor (CAR) (1)
- cholesterol (1)
- cholinergic system (1)
- chromaffin cell (1)
- chronic granulomatous disease (1)
- chronic hepatitis C (1)
- chronic hypoxia (1)
- chronic infections (1)
- chronic inflammation (1)
- chronic myeloid leukemia (1)
- circular RNA (1)
- classical Hodgkin lymphoma (1)
- classification (1)
- clear cell renal cell carcinoma (1)
- clear cell sarcoma (1)
- clear lens exchange (1)
- climate change genomics (1)
- clindamycin (1)
- clinical decision support (1)
- clinical decision-making (1)
- clinical high at-risk mental state (1)
- clinical immunology (1)
- clinical isolates (1)
- clinical outcome (1)
- clinical research (1)
- clinical stage (1)
- clinical study (1)
- clinical teaching (1)
- clinically important restrictions and symptoms (1)
- clinically relevant dissolution specifications (1)
- clonal haematopoiesis (1)
- clonal transfer (1)
- cluster analysis (1)
- cluttering (1)
- coagulation (1)
- cochlear implant (1)
- cochlear implants (1)
- cognitive ability (1)
- cognitive aging (1)
- cognitive impairment (CI) (1)
- cold atmospheric plasma (1)
- collagen (1)
- collagen membranes (1)
- collective cell migration (1)
- colon (1)
- colony formation (1)
- colorectal cancer (CRC) (1)
- combination therapy (1)
- combined modality therapy (1)
- comorbidities (1)
- comorbidity (1)
- complementary/alternative medicine (CAM) (1)
- complete response (1)
- complex coronary interventions (1)
- complex systems (1)
- compound screen (1)
- computational knowledge-discovery (1)
- computational pathology (1)
- computer-assisted (1)
- concordance (1)
- congenital diaphragmatic hernia (1)
- congenital disorders of autophagy (1)
- congenital duodenal obstruction (1)
- conical coupling (1)
- connective tissue growth factor (1)
- conometric connection (1)
- consensus (1)
- consensus classification (1)
- consensus data set (1)
- consensus paper (1)
- conservative dentistry (1)
- contamination (1)
- continuity of care (1)
- contraception (1)
- control of menstrual bleeding (1)
- convulsive seizures (1)
- coping (1)
- copper free strain-promoted azide alkyne cycloaddition (SPAAC) (1)
- core expression (1)
- cornea donor (1)
- corona virus (1)
- coronally advanced flap (1)
- coronary imaging (1)
- corpus callosum (1)
- cortex (1)
- cortical impact (1)
- corticospinal tracts (1)
- corticosteroid drugs (1)
- corticosteroids (1)
- cost analysis (1)
- cost containment (1)
- cost of illness (1)
- cost-effective (1)
- counseling (1)
- counselling (1)
- covalent drugs (1)
- criteria (1)
- critical size defect (1)
- critical-size defect (1)
- critically ill patients (1)
- cross reactivity (1)
- cross-linking (1)
- cryoelectron microscopy (1)
- cryopreservation (1)
- cyclic nucleotide analogues (1)
- cyclic nucleotide binding proteins (1)
- cyclin Y (1)
- cycling (1)
- cyclooxygenase 2 (1)
- cyclooxygenase-2 (1)
- cyclopentenone prostaglandins (1)
- cystic fibrosis (1)
- cytochrome P450 enzymes (1)
- cytochrome P450 reductase (1)
- cytochrome c oxidase (complex IV) (1)
- cytochrome c oxidase I (COI) (1)
- cytokine (1)
- cytokine storm (1)
- cytokine(s) (1)
- cytokines (1)
- cytosolic free calcium (1)
- cytotoxic T lymphocyte (1)
- cytotoxic lymphocytes (1)
- cytotoxicity (1)
- dance teacher (1)
- data analysis (1)
- data management (1)
- data quality (1)
- data repositories (1)
- data sharing (1)
- de novo transcription (1)
- death rates (1)
- debris (1)
- decision tree (1)
- decompressive craniectomy (1)
- deep learning (1)
- deep vein thrombosis (1)
- default mode network (1)
- deferred treatment (1)
- degradation (1)
- delay (1)
- delayed cerebral ischemia (DCI) (1)
- delayed diagnosis (1)
- delayed treatment (1)
- delirium (1)
- delivery mode (1)
- delta (1)
- demineralized bone matrix (1)
- dendrite morphogenesis (1)
- dendritic cell (1)
- dendritic cells (1)
- dengue vector (1)
- dental academic degrees (1)
- dental assistant (1)
- dental education (1)
- dental educationcation (1)
- dental implants (1)
- dental school (1)
- dental treatment concept (1)
- dentist (1)
- dentist’s chair design (1)
- dentoalveolar surgery (1)
- deproteinized bovine bone matrix (DBBM) (1)
- depth perception (1)
- desensitization (1)
- detection task (1)
- deubiquitylation (deubiquitination) (1)
- development (1)
- diabetes complication (1)
- diagnostic imaging (1)
- diagnostic window (1)
- diagnostics (1)
- diagnostisches Fenster (1)
- diet (1)
- differential expression (1)
- diffuse marrow involvement (1)
- diffusion-weighted magnetic resonance imaging (1)
- digital decision-support (1)
- digital one-piece casting (1)
- digital pressing technology (1)
- digital workflow (1)
- dihydrocannabidiol (1)
- diphtheria toxin (1)
- direct-acting antiviral (DAA) treatment (1)
- discontinuation (1)
- disease outbreaks (1)
- disease progression (1)
- disease vectors (1)
- dislocation (1)
- disordered iron metabolism (1)
- distributed analysis (1)
- dobutamine stress (1)
- docetaxel (1)
- docetaxel (DX) resistance (1)
- doctoral degrees (1)
- donor safety (1)
- dopamine transporter (1)
- dorsal attention network (1)
- double immune checkpoint inhibition (1)
- double negative (1)
- double-pigtail stents (1)
- downgrading (1)
- doxorubicin (1)
- doxycycline (1)
- drinking (1)
- drospirenone (1)
- drug (1)
- drug abstinence (1)
- drug discovery (1)
- drug repurposing (1)
- drug–drug interactions (1)
- drug–gene interactions (1)
- drug–g–gene interactions (1)
- dual-energy (1)
- dynamic causal modeling (1)
- dynamic system (1)
- dysbetalipoproteinemia (1)
- dysfibrinogenemia (1)
- early detection (1)
- early onset (1)
- early-onset prostate cancer (1)
- eating disorders (1)
- echo planar imaging (1)
- economic burden (1)
- edentulous (1)
- education (1)
- efferocytosis (1)
- efficiency (1)
- efflux pump (1)
- egg sampling (1)
- eicosanoid (1)
- elastin (1)
- electrical coupling (1)
- electroanatomical mapping (1)
- electrode design (1)
- electroencephalography (1)
- electroencephalography (EEG) (1)
- electrolytic cleaning (1)
- electron transfer (1)
- electron transfer chain (1)
- electronic adherence measurement (1)
- electronic diaries (1)
- electrophilic fatty acids (1)
- electrophoresis (1)
- element speciation (1)
- emergency care (1)
- emicizumab (1)
- enamel matrix derivatives (1)
- encephalopathy (1)
- endodontic curriculum (1)
- endodontic education (1)
- endodontics (1)
- endoscopic retrograde cholangiography (1)
- endothelial dysfunction (1)
- endourology (1)
- endovascular recanalization (1)
- endovascular thrombectomy (1)
- ensemble cNN (1)
- enterobacter infections; pseudomonas aeruginosa; epidemiology (1)
- environmental tobacco smoke (1)
- enzyme activity assay (1)
- epidemics (1)
- epidermal growth factor (1)
- epidural (1)
- epilepsy surgery (1)
- epileptic encephalopathy (1)
- episodic memory (1)
- epithelial-to-mesenchymal transition (EMT) (1)
- epoxyeicosatrienoic acid (1)
- erastin (1)
- erectile dysfunction (1)
- erythropoiesis (1)
- essential thrombocythemia (ET) (1)
- essential tremor (1)
- estrogen (1)
- ethanol (1)
- everyday tasks (1)
- evidence-based guideline (1)
- evolution (1)
- exclusion of very low profiles (1)
- executive functions (1)
- exosome (1)
- experimental pain models (1)
- expert witness statement (1)
- extracellular signal-regulated kinase (1)
- extraskeletal (1)
- eye movements (1)
- eye tracking (ET) (1)
- fMLP (1)
- factor V Leiden mutation (1)
- factor XIII (1)
- faecal microbiota transfer (1)
- familial amyloid nephropathy with urticaria and deafness (1)
- famotidine (1)
- fasting insulin (1)
- fat grafting (1)
- fat pad resection (1)
- fatty acid (1)
- fatty acid synthesis (1)
- feasibility study (1)
- febrile neutropenia (1)
- fecal incontinence (1)
- fecal microbiota transfer (1)
- fecal occult blood test (1)
- federated feasibility queries (1)
- feedback control (1)
- female subjects (1)
- females (1)
- fenfluramine (1)
- ferric carboxymaltose (1)
- ferric derisomaltose (1)
- ferroportin (1)
- ferroptosis (1)
- ferumoxytol (1)
- fetal loss (1)
- fibrin-glue-spray technique (1)
- fibrinolysis (1)
- fibroblasts (1)
- fibrosis imaging (1)
- first-time shoulder dislocation (1)
- fluorescence (1)
- fluorescence in situ hybridization (FISH) (1)
- focal cortical dysplasia (1)
- focal therapy (1)
- fondaparinux (1)
- fondaparinux sodium (1)
- foreign body reaction (1)
- formula diet (1)
- fractionation (1)
- fracture strength (1)
- fracture strength equation (1)
- fragile-X-associated tremor-ataxia syndrome (1)
- fragment screening (1)
- fragment-size analyses (ACE2; CQ11) (1)
- fronto-temporal lobar dementia (1)
- fronto-temporal-lobar-dementia (1)
- full-arch restoration (1)
- function (1)
- functional magnetic resonance imaging (1)
- fungal infection (1)
- fungal sinusitis (1)
- fungal sugar (1)
- fusion (1)
- fusion kinase (1)
- fäkaler okkulter Stuhltest (1)
- gait symmetry (1)
- gangliosides (1)
- gargle lavage (1)
- gasotransmitters (1)
- gastrointestinal (1)
- gastrointestinal stromal tumours (1)
- gefitinib (1)
- gel (1)
- gender (1)
- gene regulation (1)
- gene signature (1)
- general practitioners (1)
- genetic diversity (1)
- genetic variability (1)
- genetic variants (1)
- genetically caused iron imbalance (1)
- genome (1)
- genotype G (1)
- geriatric patients (1)
- geriatrics (1)
- gestational hypertension (1)
- gingival recession therapy (1)
- glioblastoma cells (1)
- glioblastoma survival (1)
- glioma microenvironment (1)
- glioma stem-like cells (1)
- global health (1)
- globosides (1)
- glomerulus (1)
- glucose and lipid metabolism (1)
- glucose-6-phosphate dehydrogenase (1)
- glucosylceramide (1)
- glucosylceramides (1)
- glutamate (1)
- glycobiology (1)
- glycoconjugate (1)
- glycoproteins (1)
- glycosyltransferase (1)
- gp100 (1)
- graft-vs-host disease (1)
- granule polarization (1)
- graphic 3D models (1)
- gravity (1)
- great height (1)
- grisel syndrome (1)
- growth inhibition (1)
- guided tissue regeneration (1)
- guideline (1)
- haNK (1)
- habitat (1)
- haemophilia (1)
- haemophilia A (1)
- harmonization (1)
- hatching (1)
- head and neck neoplasms (1)
- head and neck squamous cell carcinoma (1)
- health behavior (1)
- health care (1)
- health data (1)
- health database (1)
- health education (1)
- health information interoperability (1)
- health services research (1)
- health-related quality of life (1)
- health-relatedquality of life (1)
- healthcare personnel (1)
- healthcare system (1)
- healthcare worker (1)
- healthy control (1)
- heart neoplasms (1)
- heart rate (1)
- heart rate control (1)
- hematological (1)
- hematotoxicity (1)
- hemophilia (1)
- hemorrhagic transformation (1)
- heparan sulfate proteoglycans (1)
- heparin sensitivity (1)
- hepatic stellate cells (1)
- hepatitis (1)
- hepatitis B (1)
- hepatitis B surface antigen (1)
- hepatitis B virus (1)
- hepatitis C virus (HCV) (1)
- hepatitis D (1)
- hepatocellular cancer (1)
- hepatotoxicity (1)
- herb-induced liver injury (HILI) (1)
- hereditary dystopic lipidosis (1)
- herpes zoster (1)
- heterogeneity (1)
- hidradenitis suppurativa (1)
- hierarchical clustering (1)
- high risk (1)
- high sensitive C-reactive protein (1)
- high throughput screening (1)
- high-altitude adaptation (1)
- high-altitude pulmonary hypertension (1)
- high-content screen (1)
- high-fat-diet (1)
- high-risk (1)
- high-risk neuroblastoma (1)
- hip osteoarthritis (hip OA) (1)
- hippocampal sclerosis (1)
- histamine (1)
- histological outcomes (1)
- histology (1)
- histone deacetylase (1)
- histopathological growth pattern (1)
- home training (1)
- homeodomain protein (1)
- homeostasis (1)
- hospital admission (1)
- hospital length of stay (1)
- host matrix- pathogen interaction (1)
- host-microbe interaction (1)
- human MSCs (1)
- human allogeneic hematopoietic cell transplantation (1)
- human behaviour (1)
- human factors (1)
- human genomics (1)
- human immunodeficiency virus (1)
- human intestinal microbiota (1)
- human monoclonal antibody (1)
- human olfaction (1)
- human research (1)
- human rhabdomyosarcoma (1)
- human subjects (1)
- human-liver chimeric mouse model (1)
- humans (1)
- hybrid abutment (1)
- hybrid materials (1)
- hybrid production (1)
- hybridization (1)
- hybrids (1)
- hydrogen peroxide (1)
- hydrogen sulfide (H2S) (1)
- hydroxylation (1)
- hyperactivity (1)
- hyperalgesia (1)
- hypercholesterolemia (1)
- hypersensitivity (1)
- hypertriglyceridemia (1)
- hypnotics and sedatives (1)
- hypobaric hypoxia (1)
- hypophosphatemia (1)
- hypoxia inducible factor 1 alpha (1)
- hypoxia-inducible factor-2α (1)
- iCBT (1)
- idiopathic pulmonary fibrosis (1)
- idiosyncratic drug-induced liver injury (DILI) (1)
- image-guided tissue acquisition (1)
- imaging (1)
- imaging genetics (1)
- imaging protocol (1)
- immobilization in external rotation and abduction (1)
- immune checkpoint (1)
- immune checkpoint blockade (1)
- immune checkpoint inhibitor (ICI) (1)
- immune checkpoint inhibitors (ICI) (1)
- immune defense (1)
- immune escape (1)
- immune host defense (1)
- immune infiltration (1)
- immune monitoring (1)
- immune related adverse events (irAE) (1)
- immune therapy (1)
- immuno-oncotherapy (1)
- immunosenescence (1)
- immunosuppression (1)
- impulsivity (1)
- in silico (1)
- in situ (1)
- in vitro models (1)
- in vivo (1)
- inborn errors of immunity (1)
- incidence (1)
- incontinence (1)
- indoor air (1)
- induction chemotherapy (1)
- induction regimen (1)
- induction therapy (1)
- inertial motion capture (1)
- inertial motion units (1)
- inertial sensors (1)
- infection control (1)
- infection precaution (1)
- infectious disease (1)
- infectivity (1)
- inferior frontal gyrus (1)
- inflammasome (1)
- inflammatory reaction (1)
- informal care (1)
- infrapatellar fat pad (1)
- inguinal hernia (1)
- inherited (1)
- inhibitor (1)
- inhibitory control (1)
- inhibitory interneurons (1)
- injury (1)
- injury pattern (1)
- injury prevention (1)
- inner membrane morphology (1)
- inosine (1)
- inositol signaling (1)
- instructional film and video (1)
- insula (1)
- insulin resistance (1)
- insulin sensitivity (1)
- insurance data (1)
- integrate-and-fire (1)
- integrated stress response (1)
- integrative neuromotor training (1)
- integrin (1)
- intellectual disability (1)
- intelligence (1)
- intensive care admission and mortality (1)
- interactions (1)
- interferon induction (1)
- interferon sensitivity (1)
- interferon type III (1)
- interim positron emissiontomography (1)
- interleukin-1beta (1)
- interleukin-22 (1)
- international transport (1)
- internet (1)
- interstitial multicatheter brachytherapy (1)
- intestinal iron loss (1)
- intestinal manipulation (1)
- intracellular multiplication (1)
- intracerebral hemorrhage (ICH) (1)
- intracranial hemorrhage (1)
- intrahepatic cholangiocarcinoma (1)
- intranasal administration (1)
- intraoperatively molded (1)
- intraoral scanning (1)
- intrauterine Wachstumsretardierung (1)
- intrauterine growth restriction (1)
- intravenous iron (1)
- intravenous iron therapy (1)
- intrinsic and innate immune response (1)
- invasive fungal disease (1)
- invasive fungal infection (1)
- inverse spacer (1)
- inverse stage migration (1)
- investigational (1)
- inflammation (1)
- iron deficiency anemia (1)
- iron isomaltoside (1)
- iron-trafficking (1)
- irritable bowel syndrome (1)
- jejunoileal atresia (1)
- joint contact forces (1)
- joint innervation (1)
- joint load (1)
- juvenile myelomonocytic leukemia (1)
- keratinized mucosa (1)
- kidney function (1)
- knee adduction moment (1)
- knee osteoarthritis (1)
- laboratory testing (1)
- laboratory worker (1)
- lacto/neo-lacto series GSLs (1)
- landrace pigs (1)
- language impairment (1)
- laparoscopic inguinal hernia repair (1)
- laser-induced thermotherapy (1)
- lasso regression (1)
- latent factor mixed model (1)
- layer-specificity (1)
- learning and memory (1)
- left atrial appendage occlusion (1)
- legislation (1)
- legumain (1)
- leisure-time activity (1)
- lenalidomide (1)
- length of stay (1)
- leptin receptor-deficient mouse (1)
- leucocytes (1)
- leukemia (1)
- leukocytes (1)
- leukodystrophy (1)
- leukotriene (1)
- lichen extracts (1)
- life table (1)
- life-expectancy (1)
- lifestyle (1)
- light irradiation (1)
- limitations (1)
- lipid droplets (1)
- lipidomics (1)
- lipofilling (1)
- lipofuscin (1)
- lipoproteins (1)
- lipoxin (1)
- lipoxin A4 (1)
- lipoxygenase inhibitor (1)
- liquid chromatography–mass spectrometry (1)
- live-cell imaging (1)
- live/dead staining (1)
- liver X receptor (1)
- liver damage (1)
- liver metastasis (1)
- liver steatosis (1)
- liver stiffness (1)
- liver volume (1)
- local antibiotics (1)
- local drug delivery (1)
- local preemptive analgesia (1)
- local recurrence (1)
- local treatment (1)
- location (1)
- locator (1)
- locusts (1)
- logistic models (1)
- long non-coding RNAs (1)
- long term (1)
- long-term outcome (1)
- long-term potentiation (1)
- long-term results (1)
- loss of B-cell phenotype (1)
- loss-of-function (1)
- low density lipoprotein receptor (1)
- low risk (1)
- low-back-pain (1)
- low-carbohydrate (1)
- low-dose irradiation (1)
- lower leg fracture (1)
- lppr5 (1)
- lung fibrosis (1)
- lung function (1)
- lung tumor heterogeneity (1)
- lungs (1)
- lymph node (1)
- lymph node metastases (1)
- lymphocytes (1)
- lysophospholipids (1)
- lysosomal-dependent cell death (1)
- lysosome (1)
- mCRPC (1)
- mRNA stability (1)
- mRNA1273 (1)
- mTOR inhibitor (1)
- mTORC1 (1)
- macaque (1)
- machine learning (ML) (1)
- magnetoencephalography (1)
- male (1)
- malignancies (1)
- malignancy (1)
- malignant melanoma (1)
- mammary carcinoma (1)
- manganese (1)
- mappers (1)
- mapping-algorithms (1)
- marginal fit (1)
- marked lymph node (1)
- marker (1)
- mass spectrometry (1)
- mathematical analysis (1)
- mathematical modeling (1)
- matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (1)
- mechanical accuracy (1)
- mechanical recanalization (1)
- mechanical ventilation (1)
- mechanotransduction (1)
- medical device (1)
- medical informatics (1)
- medical risk factors (1)
- medication adherence rate (1)
- medication management (1)
- medication review (1)
- medizinische Beschäftigte (1)
- medizinisches Personal (1)
- medulloblastoma (1)
- membrane protein complex (1)
- membrane remodeling (1)
- membrane-less organelles (1)
- membranous urethra (1)
- membranous urethral stricture (1)
- meningioma (1)
- mental distress (1)
- mental health (1)
- mesangial cells (1)
- mesenchymal stromal cell (1)
- mesenchymal stromal cells (1)
- mesial temporal lobe epilepsy (1)
- meta-analysis (1)
- metabolic alterations (1)
- metabolic liver disease (1)
- metabolic rewiring (1)
- metastases (1)
- metastatic renal cell carcinoma (1)
- miR (1)
- miR-142-3p (1)
- miR-181 (1)
- miR-21 (1)
- miR-6862-5p (1)
- michael acceptor (1)
- microbial colonization (1)
- microbiology (1)
- microbiome (1)
- microcentrifugal analyzer (1)
- microdissection (1)
- microlaparoscopy (1)
- microstates (1)
- microstimulation (1)
- microsurgery (1)
- microvesicles (1)
- microwave ablation (1)
- mid-IR spectroscopy (1)
- mid-term urinary continence (1)
- migration (1)
- mild cognitive impairment (1)
- mineralization (1)
- minimal invasive (1)
- minimal residual disease (1)
- minimally invasive surgery (1)
- minimally invasive therapy (1)
- minocycline (1)
- miscarriage (1)
- mitochondrial antiviral signaling protein (MAVS) (1)
- mitochondrial disease (1)
- mitochondrial metabolism (1)
- mitochondrial morphology (1)
- mitochondrial respiration (1)
- mitral regurgitation (1)
- mitral valve surgery (1)
- mixed infection (1)
- mixed lineage kinase domain-like (1)
- model builder software (1)
- modeling (1)
- modelling (1)
- models (1)
- mold (1)
- molecular adaptation (1)
- molecular biology (1)
- molecular diagnostic techniques (1)
- molecular dynamics (1)
- molecular marker (1)
- molecular modeling (1)
- molecular neuroscience (1)
- molecular subtyping (1)
- molecular surveillance (1)
- molecular typing (1)
- monkeypox (1)
- monoacylglycerol lipase (1)
- monoclonal antibodies (1)
- monoclonal antibody (1)
- monotherapy (1)
- monotype abutment (1)
- monsoon (1)
- mood (1)
- morbidity (1)
- morphometry (1)
- mortality analysis (1)
- mortality risk (1)
- motor functions (1)
- motor-control-exercise (1)
- mouse (1)
- mouse models (1)
- mouse tumor model (1)
- mouthwash (1)
- mouthwash solution (1)
- mtLSU quality control (1)
- mucormycetes (1)
- mucormycosis (1)
- multi-material 3D printing (1)
- multi-scale models (1)
- multicenter study (1)
- multidisciplinary-therapy (1)
- multidrug resistance (1)
- multidrug resistance protein 4 (1)
- multiparametric magnetic resonance imaging (1)
- multiplex immunohistochemistry (1)
- multiplexed immunofluorescence (1)
- multisensory integration (1)
- multislice imaging (1)
- multispectral flow cytometry (1)
- multivoxel pattern analysis (1)
- musculoskeletal inflammation (1)
- musculoskeletal modeling (1)
- musculoskeletal repair (1)
- musculoskeletal system (1)
- mutation (1)
- mutism (1)
- myeloproliferative neoplasms (MPN) (1)
- myocardial efficiency (1)
- myocardial fibrosis (1)
- myocardial ischaemia (1)
- myocardial power (1)
- nNOS (1)
- nasal swab (1)
- natural killer (1)
- natural selection (1)
- natural sounds (1)
- necroptosis (1)
- needlestick injury (1)
- neoadjuvant chemoradiotherapy (1)
- neoadjuvant chemotherapy (1)
- neoadjuvant immunochemotherapy (1)
- neoadjuvant therapy (1)
- neonate (1)
- neoplasm metastasis (1)
- neovascularization (1)
- nephropathy (1)
- nerve-sparing surgery (1)
- neural correlates (1)
- neuregulin 1 (1)
- neurexin (1)
- neuroblast (1)
- neurocognition (1)
- neurocognitive outcome (1)
- neurocritical care (1)
- neurodegenerative diseases (1)
- neurodevelopment (1)
- neurodevelopmental disorde (1)
- neuroendocrine (1)
- neuroendocrine tumor (1)
- neuroethology (1)
- neurogenic bowel (1)
- neuroimaging (1)
- neurological complication (1)
- neurological manifestations (1)
- neurological side effects (1)
- neurology (1)
- neuronal silencing (1)
- neurooncology (1)
- neuropathy (1)
- neuropeptide (1)
- neuropeptides (1)
- neuroprotection (1)
- neurotransmitter (1)
- neurysmal subarachnoid hemorrhage (aSAH) (1)
- neutralizing antibody (1)
- neutropenia (1)
- neutrophil elastase (1)
- newly diagnosed glioblastoma (1)
- niedermolekulares Heparin (1)
- nitroalkene (1)
- nitroalkylation (1)
- nitroglycerin (1)
- nociceptors (1)
- nodular lymphocyte-predominant Hodgkin lymphoma (1)
- noise (1)
- nomogram (1)
- non-alcoholic fatty liver disease (1)
- non-aneurysmal (1)
- non-aneurysmal SAH (1)
- non-coding RNA (1)
- non-contact injuries (1)
- non-neutropenic episode (1)
- non-organ confined stage (1)
- non-perimesencephalic (1)
- non-small cell lung cancer (1)
- non-small-cell lung cancer (1)
- non-surgical periodontal therapy (1)
- noninvasive blood glucose analysis (1)
- nonsense-mediated mRNA decay (1)
- nontraumatic atlantoaxial rotatory subluxation (1)
- noradrenaline (1)
- norepinephrine (1)
- normal liver cells (1)
- novel technologies (1)
- nuclear cardiology (1)
- nuclear factor 2 (erythroid-derived 2-like factor) (NFE2L2) (Nrf2) (1)
- nuclear magnetic resonance (NMR) (1)
- nuclear power plant (1)
- nuclear receptor (1)
- nuclear receptor-related 1 (1)
- nucleic acid amplification test(NAT) (1)
- nucleic acid amplification test (1)
- nucleic acid docking (1)
- nucleic acid lateral flow immunoassay (1)
- nucleolus (1)
- nucleoredoxin (1)
- nutrient endocytosis (1)
- nutrition - clinical (1)
- nymphs (1)
- observational study (1)
- obstetric complications (1)
- obstetric pain (1)
- obstetrics (1)
- occupational immediate-type reactions (1)
- oedema (1)
- olfactory testing (1)
- olive mill wastewater (OMWW) (1)
- oluble epoxide hydrolase (1)
- oncogenesis (1)
- oncogenic RAS (1)
- oncogenic signaling (1)
- oncological exercise therapy (1)
- oncomodulation (1)
- online intervention (1)
- online research (1)
- online survey (1)
- open (1)
- open field behavior (1)
- open science (1)
- open skill exercise (1)
- operating microscope (1)
- optogenetics (1)
- oral and maxillofacial surgery (1)
- oral cavity cancer (1)
- oral drug products (1)
- oral health (1)
- oral health burden (1)
- oral progestins (1)
- orale Gestagene (1)
- ordinary differential equation (1)
- ordinary differential equations (ODE) (1)
- organ preservation (1)
- organic nitrates (1)
- organotypic culture (1)
- orthopaedic patients (1)
- orthopoxvirus (1)
- osteoblast (1)
- osteoclasts (1)
- osteogenic differentiation (1)
- other cause mortality (1)
- otoplasty (1)
- outbreak (1)
- outpatient care (1)
- outpatients (1)
- outside-in signaling (1)
- ovarian cancer (1)
- overdenture (1)
- overtreatment (1)
- overweight (1)
- oviposition (1)
- oviposition substrate (1)
- ovitrap (1)
- oxaliplatin (1)
- oxidized low density lipoprotein (1)
- oxythiamine (1)
- p-eIF2α (1)
- p16 (1)
- p21Cip1/CDKN1A (1)
- p38 MAPK (1)
- p53 pathway (1)
- pH (1)
- pH-dependent solubility (1)
- pad-test (1)
- pain intensity (1)
- pain management (1)
- paired samples (1)
- palliative care (1)
- palliative care services (1)
- pancreatic ductal adenocarcinoma (1)
- pannexin-1 (1)
- paper-based detection (1)
- parabolic flight (1)
- paracrine signaling (1)
- parent rating (1)
- partial differential equation (1)
- passive smoke (1)
- pathogen (1)
- pathogenicity (1)
- pathology (1)
- patient centered care (1)
- patient data (1)
- patient preferences (1)
- patient safety (1)
- patient-centred care (1)
- patient-reported outcomes (1)
- patient–doctor relationship (1)
- patient’s decree (1)
- pediatric intensive care (1)
- pediatric robotic surgery (1)
- pediatric solid tumors (1)
- pelvic trauma (1)
- pembrolizumab (1)
- pentaerythritol tetranitrate (1)
- peptide receptor radionuclide therapy (1)
- percutaneous thermal ablation (1)
- perforant path transection (1)
- peri-implant disease (1)
- peri-implantitis treatment (1)
- pericytes (1)
- periimplantitis (1)
- perimesencephalic (1)
- periodontal diseases (1)
- periodontal risk factors (1)
- periodontal treatment (1)
- periodontal– systemic disease interactions (1)
- peripheral blood stem cell collection (1)
- peripheral injury (1)
- peritoneal macrophages (1)
- peritumoral edema (1)
- peritumoral edema zone (1)
- peroxisome proliferator-activated receptor (1)
- persistent periodontal pockets (1)
- personalized (1)
- phagocytes (1)
- phantom study (1)
- pharmaco-fMRI (1)
- pharmacodynamics (1)
- pharmacoepigenetics (1)
- pharmacogenetics (1)
- pharmacological data science (1)
- pharmacological plasticity (1)
- pharmacophore model (1)
- phase I (1)
- phase IV (1)
- phenoconversion (1)
- phenotypic screening; (1)
- pheromone (1)
- phosphatidylethanolamines (1)
- phospholipid (1)
- phosphoproteomics (1)
- photodynamic therapy (1)
- photothermal detection (1)
- physical performance (1)
- physiotherapy (1)
- phytosterols (1)
- pimozide (1)
- pitch (1)
- placenta (1)
- planimetric measurement (1)
- plasma (1)
- plasma C-peptide (1)
- plasma jet (1)
- plasmid (1)
- platelet hyperactivity (1)
- platelet substitution (1)
- platelet-rich-fibrin (1)
- platinum-based chemotherapy (1)
- plppr5 (1)
- pneumocystis (1)
- point of care (1)
- point-of-care diagnostics (1)
- pole concept of goiter growth (1)
- polo-like kinases (1)
- poly(A)-tail (1)
- poly-LacNAc (1)
- polycythemia vera (PV) (1)
- polymer infiltrated ceramic network (1)
- polymeric micelle (1)
- polypept(o)ide (1)
- polyunsaturated fatty acid (1)
- portal pressure (1)
- portal vein (1)
- positron-emissions-tomography (1)
- post-caesarean uterus (1)
- post-exercise hypotension (1)
- post-transcriptional regulation (1)
- posterior circulation (1)
- posterior fossa tumor (1)
- posterior horn (1)
- posteroinferior horn (1)
- postgraduate edu (1)
- postinfectious bronchiolitis obliterans (1)
- postmonsoon (1)
- postmortem blood samples (1)
- postnatal care (1)
- postoperative radiochemotherapy (1)
- postoperative radiotherapy (1)
- posttranslational modification (PTM) (1)
- potassium channel (1)
- poxvirus (1)
- precision medicine (1)
- preclinical (1)
- prediabetes and type 2 diabetes (1)
- predictive biomarker (1)
- predictive coding (1)
- prefrontal cortex (1)
- pregnancy (1)
- prehabilitation (1)
- prenatal diagnostic (1)
- prepontine (1)
- preventive health services (1)
- preventive strategies (1)
- primary biliary cholangitis (1)
- primary health care (1)
- primary immunodeficiency (1)
- primary myelofibrosis (PMF) (1)
- primary ovarian insufficiency (1)
- print and press (1)
- private brands (1)
- product performance (1)
- production (1)
- professional soccer players (1)
- progestin mono-preparation (1)
- prognostic marker (1)
- prognostic scores (1)
- progranulin (1)
- promyelocytic leukemia nuclear bodies (1)
- prone position (1)
- propensity score matching (1)
- prostaglandin (1)
- prostate cancer (PCa) (1)
- prostate neoplasia (1)
- prostate neoplasm (1)
- prostatectomy (1)
- protease inhibitor (1)
- proteasomal processing escape (1)
- protein complexes (1)
- protein evolution (1)
- protein folding (1)
- protein phosphorylation (1)
- protein–protein interaction (1)
- proteoglycan (1)
- proteostasis (1)
- prothrombin induced by vitamin K absence-II (1)
- prothrombin mutation (1)
- proton pumping (1)
- proton-sensing GPCR (1)
- protruding ear (1)
- pseudomonas aeruginosa (1)
- psoriatic arthritis (1)
- psychiatric disorder (1)
- psychiatric disorders (1)
- psychogenic non-epileptic seizures (1)
- psychosocial factors (1)
- publication output (1)
- pulmonary failure (1)
- pulmonary fibrosis (1)
- pulmonary ventilation (1)
- pulse wave velocity (1)
- pulsed-field (1)
- purification (1)
- qRT-PCR (1)
- qualitative research (1)
- quantitative RUCAM (1)
- quantitative magnetic resonance imaging (1)
- quantum cascade laser (QCL) (1)
- query (1)
- quiescence (1)
- rRNA chaperone ERAL1 (1)
- race/ethnicity disparities (1)
- radiation-induced (1)
- radio sensitivity (1)
- radioimmunotherapy (1)
- radiomics (1)
- radiosensitization (1)
- randomized (1)
- randomized controlled trial (1)
- range expansion (1)
- rapid gastric emptying (1)
- rare disease (1)
- rare mendelian disorders (1)
- rat calvaria defect (1)
- rat femur critical size defect (1)
- rat model (1)
- rats (1)
- re-exposure (1)
- re-irradiation (1)
- reactive coordination (1)
- real world (1)
- real-world (1)
- realist synthesis (1)
- recall (1)
- rechallenge (1)
- recombinase polymerase amplification (1)
- recovery (1)
- recurrence pattern (1)
- recurrent cholangitis (1)
- recurrent urinary tract infections (1)
- red cells (1)
- redox status (1)
- reduced kidney function (1)
- reduction potential (1)
- refractive lens exchange (1)
- refractive surgery (1)
- regenerative therapy (1)
- regulatory T cell (1)
- regulatory T helper cells (1)
- reintroduction (1)
- relapsing–remitting multiple sclerosis (1)
- relaxometry (1)
- remodeling (1)
- renal dysfunction (1)
- renal failure (1)
- renal fibroblasts (1)
- renal inflammation (1)
- renal transplantation (1)
- renal tubular epithelial cells (1)
- replicative fitness (1)
- reproducibility (1)
- research database (1)
- research funding (1)
- research incentives (1)
- resectability (1)
- resin nano ceramics (1)
- resistance (1)
- resistant epilepsy (1)
- resolution (1)
- resolution of inflammation (1)
- resolvin (1)
- respiratory failure (1)
- respiratory infections (1)
- response (1)
- response inhibition (1)
- resting-state (1)
- resting-state fMRI (1)
- resveratrol (1)
- reticulocyte haemoglobin (1)
- reticulocyte hemoglobin equivalent (1)
- retrospective studies (1)
- retrovirus (1)
- reverberation (1)
- revision knee arthroplasty (1)
- reward (1)
- reward probabilities (1)
- rhabdomyosarcoma (1)
- rhinovirus (1)
- ribonucleotide reductase (1)
- rifampicin (1)
- rifampin (1)
- risk assessment (1)
- risk factor (1)
- risk of malignancy (1)
- risk stratification (1)
- rituximab (1)
- robot-guided stereotaxy (1)
- robotic-assisted (1)
- robotically assisted surgery (1)
- robotics (1)
- room simulation (1)
- rotary ATPase mechanism (1)
- rotational thromboelastometry (1)
- sEH (1)
- sRNA (1)
- sRNA tool (1)
- safety attitudes questionnaire (1)
- salience network (1)
- saliva (1)
- salvage mastectomy (1)
- salvage radical prostatectomy (1)
- sampling (1)
- sarcoma (1)
- scanner noise (1)
- scar (1)
- schizophrenia (1)
- schwangerschaftsinduzierter Hypertonus (1)
- screening (1)
- screening ELISA (1)
- screening questionnaire (1)
- searchlight analysis (1)
- seasonal adaption (1)
- second line therapy (1)
- second-line immunotherapy (1)
- second-line treatment / 2L treatment (1)
- secondary data analysis (1)
- secondary progressive multiple sclerosis (1)
- secreted Ly-6/uPAR-related protein 1 (1)
- secretory phospholipase A (1)
- seed and soil (1)
- seizures (1)
- selection (1)
- self-collected samples (1)
- semiquinone (1)
- sensorineural hearing loss (1)
- sensory loss (1)
- sensory organ development (1)
- serologic screening (1)
- severe acute respiratory syndrome coronavirus 2 (1)
- severely injured (1)
- severely injured patient (1)
- sex (1)
- sexual arousal (1)
- sexual dysfunction (1)
- sexual rehabilitation (1)
- shape (1)
- shared decision-making (1)
- shear stress (1)
- shikonin (SHI) (1)
- short bowel (1)
- short-course antibiotic therapy (1)
- short-term (1)
- shoulder instability (1)
- shoulder stabilization (1)
- siRNA analysis (1)
- siRNA lipid nanoparticles (LNPs) (1)
- siRNA quantification (1)
- sialic acid (1)
- signal transduction (1)
- signaling (1)
- simulation (1)
- single-cell RNA sequencing (1)
- single-cell proteomics (1)
- sleep deprivation (1)
- sleep disordered breathing (1)
- sleep quality (1)
- small bowel (1)
- small leucine-rich proteoglycans (1)
- small ubiquitin-related modifier (1)
- smoking behavior (1)
- smooth muscle cell (1)
- social anxiety (1)
- social communication (1)
- social recognition (1)
- socio-economic influences (1)
- socioeconomic factors (1)
- soft tissue sarcoma (1)
- software (1)
- solid tumor (1)
- sonoSens (1)
- sonography (1)
- sorafenib (1)
- sound localization (1)
- sound-induced flash illusion (1)
- spared nerve injury (1)
- sparse imaging (1)
- spatial learning (1)
- spatial specificity (1)
- specialized pro-resolving lipid mediators (SPMs) (1)
- speech and language pathologist (1)
- sphingosine (1)
- sphingosine 1-phosphate homologues (1)
- sphingosine 1-phosphate receptor (1)
- sphingosine kinase (1)
- spike mutation (1)
- spike protein (1)
- spina bifida (1)
- spinal bone metastasis (1)
- spinal infection (1)
- spinal metastasis (1)
- spine injury (1)
- splicing (1)
- split-mouth (1)
- spreading (1)
- sprouting (1)
- sprouting angiogenesis (1)
- squamous cell carcinoma (1)
- stage (1)
- stage migration (1)
- stairs (1)
- stakeholder analysis (1)
- standard value (1)
- starvation (1)
- statin (1)
- statin treatment (1)
- statins (1)
- statistics (1)
- steady-state condition (1)
- steatosis (1)
- stem cell transplantation (1)
- stem cells (1)
- stent patency (1)
- stereotactic frame (1)
- stereotactic neurosurgery (1)
- stoma (1)
- stomach neoplasms (1)
- store brands (1)
- stress granules (1)
- structure constraints (1)
- structure-function (1)
- strumpellin (1)
- study protocol (1)
- stuttering (1)
- subarachnoid hemorrhage (1)
- subdural hematoma (1)
- subgrouping (1)
- subpopulation (1)
- sudden cardiac death (1)
- sulfatides (1)
- sulfur-oxidizing symbiont (1)
- sunitinib (1)
- superficial vein (1)
- superparamagnetic iron oxide nanoparticles (1)
- support (1)
- suprachiasmatic nucleus (1)
- surface antigen mutant (1)
- surgical complications (1)
- surgical procedures (1)
- surrogate ELISA (1)
- swallowing (1)
- swarming (1)
- symbiosis (1)
- sympathetic (1)
- sympathetic nervous system (1)
- symptoms (1)
- synoviocytes (1)
- synovitis (1)
- synovium (1)
- tDCS (1)
- tVNS (1)
- tachycardia (1)
- taller-than-wide (1)
- target (1)
- targeted axillary dissection (1)
- targeted sequencing (1)
- taste buds (1)
- tauopathies (1)
- tauopathy (1)
- temporal encephaloceles (1)
- testosterone (1)
- tetracycline (1)
- tetrahydrobiopterin (1)
- tetrahydrocannabinol (1)
- theory of mind (1)
- therapeutic anticoagulation (1)
- therapy response (1)
- thermal ablation (1)
- thrombectomy (1)
- thrombin (1)
- thromboembolism (1)
- thrombophilia (1)
- thrombospondins (1)
- thromboxane (1)
- thymic selection (1)
- tibial fracture (1)
- tight junctions (1)
- tip cell filopodia formation (1)
- tissue microstructure (1)
- tissue reconstruction (1)
- tissue segmentation (1)
- tivantinib (1)
- toddler’s fracture (1)
- tolerability (1)
- tolerance (1)
- tooth transplantation (1)
- topical administration (1)
- topographical pattern (1)
- toric intraocular lens (1)
- torticollis (1)
- total knee replacement (1)
- toxic milk mice (TX mice) (1)
- toxicity (1)
- tracking (1)
- traditional Chinese medicine (TCM) (1)
- training (1)
- transcription (1)
- transcription factors (1)
- transcriptional cyclin-dependent kinase (1)
- transcriptome (1)
- transcriptomics (1)
- transduction (1)
- transfer entropy (1)
- transferrin (1)
- transforming growth factor-β (1)
- transglutaminase (1)
- transient elastography (1)
- transjugular intrahepatic portosystemic shunt (1)
- translation (1)
- translational investigation (1)
- translational study (1)
- translatome (1)
- translatomics (1)
- transmission (1)
- transovarial transmission (1)
- transplant-free survival (1)
- transplantation (1)
- transstadial transmission (1)
- trauma registry (1)
- traumatic injury (1)
- traumaticbraininjury(TBI) (1)
- treatment outcome (1)
- treatment resistance (1)
- treatment response (1)
- trials registry (1)
- triglycerides (1)
- trimeric autotransporters adhesin (1)
- trophoblast organoids (1)
- trophoblasts (1)
- trough levels (1)
- tumor (1)
- tumor growth (1)
- tumor immunity (1)
- tumor immunology (1)
- tumor spheroids (1)
- tumor stroma (1)
- tumor therapy (1)
- tumor-associated macrophages (TAM) (1)
- tunnel technique (1)
- type 1 diabetes (1)
- type 2 diabetes (1)
- tyrosine hydroxylase (1)
- tyrosine kinase inhibitor (TKI) (1)
- tyrosine kinase receptor signaling (1)
- ubiquitin hydrolase (1)
- ubiquitin ligase (1)
- ultra-high risk for psychosis (1)
- ultrasonic cleaning (1)
- unconventional T cell (1)
- undifferentiated pleomorphic sarcoma (1)
- unilateral (1)
- unilateral hip osteoarthritis (1)
- unmethylated MGMT (1)
- upstaging (1)
- urethal stricture (1)
- urethral stricture (1)
- urethroplasty (1)
- urothelial carcinoma (1)
- ursodeoxycholic acid (1)
- uterine wall (1)
- uveal melanoma (1)
- v-ATPase (1)
- vaccine uptake rates (1)
- vaccine, (1)
- vaccine-induced immune thrombotic thrombocytopenia (VITT) (1)
- vaginal breech (1)
- vaginal hysterectomy (1)
- variable silent delay (1)
- variant of concern (1)
- variants of concern (1)
- vascular disease (1)
- vascular integrity (1)
- vasodilation (1)
- vector (1)
- vemurafenib (1)
- venous thromboembolic events (1)
- venous thrombosis (1)
- ventral otoplasty (1)
- ventral striatum (1)
- ventral tegmental area (1)
- ventralis intermedius nucleus (1)
- ventricular tachycardia (1)
- vergence (1)
- vertical transmission (1)
- vertigo (1)
- very high-risk (1)
- very low density lipoproteins (1)
- vestibular function (1)
- viral fitness (1)
- viral load (1)
- viral replication (1)
- virologic failure (1)
- virus (1)
- virus isolation (1)
- visual cortex (1)
- visual search (VS) (1)
- vitamin k antagonists (1)
- volumetric measurement technology (1)
- von Willebrand disease (1)
- von Willebrand's disease (1)
- von-Willebrand-Syndrom (1)
- voxel-wise analyses (1)
- waiting time (1)
- wastewater-based epidemiology (WBE) (1)
- wearable sensors (1)
- wearable-cardioverter defibrillator (1)
- whole genome pooled sequencing (1)
- whole-genome sequencing (1)
- women (1)
- work place evaluation (1)
- workflow development (1)
- wound exudate (1)
- wound healing (1)
- wound infection (1)
- wound repair (1)
- xenograft (1)
- yellow fever mosquito (1)
- yellow flags (1)
- younger (1)
- zinc protoporphyrin (1)
- Übergewicht (1)
- ß-amyloid (1)
- β-HCG (1)
- β-ᴅ-2′-Deoxyribosides (1)
- β2-adrenoceptor (1)
- fibrogenesis (1)
- fingolimod (1)
Institute
- Medizin (1573)
- Biochemie, Chemie und Pharmazie (24)
- Biochemie und Chemie (22)
- Biowissenschaften (22)
- Georg-Speyer-Haus (20)
- Zentrum für Arzneimittelforschung, Entwicklung und Sicherheit (ZAFES) (16)
- Buchmann Institut für Molekulare Lebenswissenschaften (BMLS) (13)
- Frankfurt Institute for Advanced Studies (FIAS) (10)
- Psychologie und Sportwissenschaften (10)
- Psychologie (7)
Background and purpose: Transient splenial oedema, also known as reversible splenial lesion syndrome (RESLES), is a rare magnetic resonance imaging (MRI) finding that presents as a round or ovoid focal oedema in the posterior corpus callosum, and is associated with a wide range of clinical conditions. The aetiology of RESLES is not fully clear. We aimed to investigate conflicting pathophysiological hypotheses by measuring local glucose metabolism in patients with RESLES.
Methods: We retrospectively analysed patients with RESLES after reductions in antiseizure medications during in-hospital video electroencephalography monitoring. We measured local glucose uptake using positron emission tomography/computed tomography and compared matched cohorts of patients with and without MRI evidence of RESLES using nonparametric tests.
Results: Local glucose metabolism in the splenium of seven patients with RESLES was not significantly different from the glucose metabolism of the seven patients in the matched cohort. This was true using both regular and normalized standardized glucose uptake value calculation methods (p = 0.902 and p = 0.535, respectively).
Conclusion: We found no evidence of local glucose hypometabolism in RESLES, which supports previous pathophysiological considerations that suggest that RESLES is an intercellular, intramyelinic oedema rather than a typical intracellular cytotoxic oedema, which is not reversible.
Recent data have suggested that performing recanalizing therapies in ischemic stroke might lead to an increased risk of acute symptomatic seizures. This applies to both intravenous thrombolysis and mechanical thrombectomy. We therefore determined the frequency of acute symptomatic seizures attributable to these two recanalization therapies using a large, population-based stroke registry in Central Europe. We performed two matched 1:1 case–control analyses. In both analyses, patients were matched for age, stroke severity on admission and pre-stroke functional status. The first analysis compared patients treated with intravenous thrombolysis to a non-recanalization control group. To isolate the effect of mechanical thrombectomy, we compared patients with both mechanical thrombectomy and intravenous thrombolysis to those with only intravenous thrombolysis treatment in a second analysis. From 135,117 patients in the database, 13,356 patients treated with only intravenous thrombolysis, and 1013 patients treated with both intravenous thrombolysis and mechanical thrombectomy were each matched to an equivalent number of controls. Patients with intravenous thrombolysis did not suffer from clinically apparent acute symptomatic seizures significantly more often than non-recanalized patients (treatment = 199; 1.5% vs. control = 237; 1.8%, p = 0.07). Mechanical thrombectomy in addition to intravenous thrombolysis also was not associated with an increased risk of acute symptomatic seizures, as the same number of patients suffered from seizures in the treatment and control group (both n = 17; 1.7%, p = 1). In a large population-based stroke registry, the frequency of clinically apparent acute symptomatic seizures was not increased in patients who received either intravenous thrombolysis alone or in conjunction with mechanical thrombectomy.
Background: Tuberous sclerosis complex (TSC) is a monogenetic, multisystem disorder characterized by benign growths due to TSC1 or TSC2 mutations. This German multicenter study estimated the costs and related cost drivers associated with organ manifestations in adults with TSC.
Methods: A validated, three-month, retrospective questionnaire assessed the sociodemographic and clinical characteristics, organ manifestations, direct, indirect, out-of-pocket (OOP), and nursing care-level costs among adult individuals with TSC throughout Germany from a societal perspective (costing year: 2019).
Results: We enrolled 192 adults with TSC (mean age: 33.4 ± 12.7 years; range: 18–78 years, 51.6% [n = 99] women). Reported TSC disease manifestations included skin (94.8%) and kidney and urinary tract (74%) disorders, epilepsy (72.9%), structural brain defects (67.2%), psychiatric disorders (50.5%), heart and circulatory system disorders (50.5%), and lymphangioleiomyomatosis (11.5%). TSC1 and TSC2 mutations were reported in 16.7% and 25% of respondents, respectively. Mean direct health care costs totaled EUR 6452 (median EUR 1920; 95% confidence interval [CI] EUR 5533–7422) per patient over three months. Medication costs represented the major direct cost category (77% of total direct costs; mean EUR 4953), and mechanistic target of rapamycin (mTOR) inhibitors represented the largest share (68%, EUR 4358). Mean antiseizure drug (ASD) costs were only EUR 415 (6%). Inpatient costs (8%, EUR 518) and outpatient treatment costs (7%; EUR 467) were important further direct cost components. The mean care grade allowance as an approximator of informal nursing care costs was EUR 929 (median EUR 0; 95% CI EUR 780–1083) over three months. Mean indirect costs totaled EUR 3174 (median EUR 0; 95% CI EUR 2503–3840) among working-age individuals (< 67 years in Germany). Multiple regression analyses revealed mTOR inhibitor use and persistent seizures as independent cost-driving factors for total direct costs. Older age and disability were independent cost-driving factors for total indirect costs, whereas epilepsy, psychiatric disease, and disability were independent cost-driving factors for nursing care costs.
Conclusions: This three-month study revealed substantial direct healthcare, indirect healthcare, and medication costs associated with TSC in Germany. This study highlights the spectrum of organ manifestations and their associated treatment needs in the German healthcare setting. Trial registration: DRKS, DRKS00016045. Registered 01 March 2019, http://www.drks.de/DRKS00016045.
Proton pumping respiratory complex I (NADH:ubiquinone oxidoreductase) is a major component of the oxidative phosphorylation system in mitochondria and many bacteria. In mammalian cells it provides 40% of the proton motive force needed to make ATP. Defects in this giant and most complicated membrane-bound enzyme cause numerous human disorders. Yet the mechanism of complex I is still elusive. A group exhibiting redox-linked protonation that is associated with iron-sulfur cluster N2 of complex I has been proposed to act as a central component of the proton pumping machinery. Here we show that a histidine in the 49-kDa subunit that resides near iron-sulfur cluster N2 confers this redox-Bohr effect. Mutating this residue to methionine in complex I from Yarrowia lipolytica resulted in a marked shift of the redox midpoint potential of iron-sulfur cluster N2 to the negative and abolished the redox-Bohr effect. However, the mutation did not significantly affect the catalytic activity of complex I and protons were pumped with an unchanged stoichiometry of 4 H+/2e−. This finding has significant implications on the discussion about possible proton pumping mechanism for complex I.
Highlights
• Artificial intelligence systems for mechanically ventilated patients are increasing.
• The clinical and financial impact of these models are often unexamined.
• We developed a generic health-economic model for artificial intelligence systems.
• This model assesses the cost-effectiveness for many different scenarios.
• The developed framework is easily adjustable to other (clinical) situations.
Abstract
Purpose: The health and economic consequences of artificial intelligence (AI) systems for mechanically ventilated intensive care unit patients often remain unstudied. Early health technology assessments (HTA) can examine the potential impact of AI systems by using available data and simulations. Therefore, we developed a generic health-economic model suitable for early HTA of AI systems for mechanically ventilated patients.
Materials and methods: Our generic health-economic model simulates mechanically ventilated patients from their hospitalisation until their death. The model simulates two scenarios, care as usual and care with the AI system, and compares these scenarios to estimate their cost-effectiveness.
Results: The generic health-economic model we developed is suitable for estimating the cost-effectiveness of various AI systems. By varying input parameters and assumptions, the model can examine the cost-effectiveness of AI systems across a wide range of different clinical settings.
Conclusions: Using the proposed generic health-economic model, investors and innovators can easily assess whether implementing a certain AI system is likely to be cost-effective before an exact clinical impact is determined. The results of the early HTA can aid investors and innovators in deployment of AI systems by supporting development decisions, informing value-based pricing, clinical trial design, and selection of target patient groups.
Aim: Comparison of the clinical efficacy (digitally volumetric, aesthetic, patient-centred outcomes) of tunnel technique (TUN) with subepithelial connective tissue graft (CTG) versus coronally advanced flap (CAF) with enamel matrix derivate (EMD) 5 years after gingival recession therapy. Materials and methods: In 18 patients contributing 36 RT1 recessions, study models were collected at baseline and follow-ups. Optical scans assessed recessions computer-assisted [recession depth, recession reduction (RECred), complete root coverage (CRC), percentage of root coverage (RC), pointwise (pTHK) and mean areal (aTHK) marginal soft tissue thickness]. Root coverage aesthetic Score (RES) was used for aesthetic evaluation and visual analogue scales for patient-centred data collection applied. Results: Sixty months after surgery, 50.0% (TUN+CTG) and 0.0% (CAF+EMD) of sites showed CRC (p = 0.0118), 82.2% (TUN+CTG) and 32.0% (CAF+EMD) achieved RC, respectively (p = 0.0023). CTG achieved significantly better RECred (TUN+CTG: 1.75±0.74 mm; CAF+EMD: 0.50 ± 0.39 mm; p = 0.0009) and aTHK (TUN+CTG: 0.95 ± 0.41 mm; CAF+EMD: 0.26 ± 0.28 mm; p = 0.0013). RES showed superior outcomes (p = 0.0533) for TUN+CTG (6.86 ± 2.31) compared to CAF+EMD (4.63 ± 1.99). The study failed to find significant differences related to patient-centred outcomes (TUN+CTG: 8.30 ± 2.21; CAF+EMD: 7.50 ± 1.51; p = 0.1136). Conclusions: Five years after treatment, CTG resulted in better clinical and aesthetic outcomes than CAF+EMD. Increased THK was associated with improved outcomes for RECred and RC.
We aimed to evaluate the factors associated with hemorrhage (HA) of melanoma brain metastases (MBM) after Cyberknife stereotactic radiosurgery (SRS) in the modern era of systemic therapy. A total of 55 patients with 279 MBM were treated in 93 fractions. The median age, SRS dose, radiological follow-up, and time to HA were 60.4 years, 20 Gy, 17.7 months, and 10.7 months, respectively. Radiologically evident HA was documented in 47 (16.8%) metastases. Of the 55 patients, 25 (45.4%) suffered an HA. Among those, HA caused grade 3 toxicity in 10 patients (40%) and grade 1 symptoms in 5 patients (20%). Ten patients (40%) with HA experienced no toxicity. Logistic regression revealed the use of anticoagulants and the administration of systemic therapy within 7/15 days from SRS to be predictive for HA. When considering the HA causing grade 3 symptomatology, only the use of anticoagulants was significant, with the delivery of whole brain radiation therapy (WBRT) before the HA narrowly missing statistical significance. Our retrospective analysis showed that the administration of modern systemic therapy within 7/15 days from SRS may contribute to HA of MBM, though it appears safe, at least concerning grade 3 toxicity. The use of anticoagulants by the time of SRS significantly increased the risk of HA.
Background and Objectives: We tested if a novel combination of predictors could improve the accuracy of outcome prediction after transfemoral transcatheter aortic valve implantation (TAVI). Materials and Methods: This prospective study recruited 169 participants (49% female; median age 81 years). The primary endpoint was midterm mortality; secondary endpoints were acute Valve Academic Research Consortium (VARC)-3 complication rate and post-TAVI in-hospital length of stay (LoS). EuroSCORE II (ESII), comorbidities (e.g., coronary artery disease), eGFR (estimated glomerular filtration rate; based on cystatin C), hemoglobin, creatinine, N-Terminal pro-Brain Natriuretic Peptide (NTproBNP) levels and patient-reported outcome measures (PROMs, namely EuroQol-5-Dimension-5-Levels, EQ5D5L; Kansas City Cardiomyopathy Questionnaire, KCCQ; clinical frailty scale, CFS) at baseline were tested as predictors. Regression (uni- and multi-variate Cox; linear; binary logistic) and receiver operating characteristic (ROC)-curve analysis were applied. Results: Within a median follow-up of 439 (318–585) days, 12 participants died (7.1%). Independent predictors of mortality using multivariate Cox regression were baseline eGFR (p = 0.001) and KCCQ (p = 0.037). Based on these predictors, a Linear Prediction Score (LPS1) was calculated. The LPS1-area under the curve (AUC)-value (0.761) was significantly higher than the ESII-AUC value (0.597; p = 0.035). Independent predictors for LoS > 6 days (the median LoS) were eGFR (p = 0.028), NTproBNP (p = 0.034), and EQ5D5L values (p = 0.002); a respective calculated LPS2 provided an AUC value of 0.677 (p < 0.001). Eighty participants (47.3%) experienced complications. Male sex predicted complications only in the univariate analysis. Conclusions: The combination of KCCQ and eGFR can better predict midterm mortality than ES II alone. Combining eGFR, NTproBNP, and EQ5D5L can reliably predict LoS after TAVI. This novel method improves personalized TAVI risk stratification and hence may help reduce post-TAVI risk.
Background: The aim of this study was to identify pre-operative parameters able to predict length of stay (LoS) based on clinical data and patient-reported outcome measures (PROMs) from a scorecard database in patients with significant aortic stenosis who underwent TAVI (transfemoral aortic valve implantation). Methods: 302 participants (51.7% males, age range 78.2–84.2 years.) were prospectively recruited. After computing the median LoS value (=6 days, range = 5–8 days), we implemented a decision tree algorithm by setting dichotomized values at median LoS as the dependent variable and assessed baseline clinical variables and PROMs (Clinical Frailty Scale (CFS), EuroQol-5 Dimension-5 Levels (EQ-5D) and Kansas City Cardiomyopathy Questionnaire (KCCQ)) as potential predictors. Results: Among clinical parameters, only peripheral arterial disease (p = 0.029, HR = 1.826) and glomerular filtration rate (GFR, cut-off < 33 mL/min/1.73 m2, p = 0.003, HR = 2.252) were predictive of LoS. Additionally, two PROMs (CFS; cut-off = 3, p < 0.001, HR = 1.324 and KCCQ; cut-off = 30, p = 0.003, HR = 2.274) were strong predictors. Further, a risk score for LoS (RS_LoS) was calculated based on these predictors. Patients with RS_LoS = 0 had a median LoS of 5 days; patients RS_LoS ≥ 3 had a median LoS of 8 days. Conclusions: based on the pre-operative values of the above four predictors, a personalized prediction of LoS after TAVI can be achieved.
Endothelial tip cells are essential for VEGF-induced angiogenesis, but underlying mechanisms are elusive. The Ena/VASP protein family, consisting of EVL, VASP, and Mena, plays a pivotal role in axon guidance. Given that axonal growth cones and endothelial tip cells share many common features, from the morphological to the molecular level, we investigated the role of Ena/VASP proteins in angiogenesis. EVL and VASP, but not Mena, are expressed in endothelial cells of the postnatal mouse retina. Global deletion of EVL (but not VASP) compromises the radial sprouting of the vascular plexus in mice. Similarly, endothelial-specific EVL deletion compromises the radial sprouting of the vascular plexus and reduces the endothelial tip cell density and filopodia formation. Gene sets involved in blood vessel development and angiogenesis are down-regulated in EVL-deficient P5-retinal endothelial cells. Consistently, EVL deletion impairs VEGF-induced endothelial cell proliferation and sprouting, and reduces the internalization and phosphorylation of VEGF receptor 2 and its downstream signaling via the MAPK/ERK pathway. Together, we show that endothelial EVL regulates sprouting angiogenesis via VEGF receptor-2 internalization and signaling.
Membrane-Phloretin Interaction, Infrared Raman, ESR Spectroscopy The transport inhibitor phloretin was bound to human red cell membrane and the concomitant structural changes were observed by spectroscopic methods. By the spin labeling method a decrease in fluidity of the membrane was found at 1 and 10 |iM concentrations of the reagent. This result was obtained with the 2-(3-Carboxypropyl)-4,4-dimethyl-2-tridecyl-3-oxazolidinyloxyl, and the 2-(14-Carboxytetradecyl)-2-ethyl-4,4-dimethyl-3-oxazolidinyloxyl lipid spin labels. Infrared spectroscopy of modified membranes revealed an intensity increase of the POO~ band at about 1250 cm-1. Moreover, a shift of the peak at 1050 cm -1 to 1100 cm-1 was observed in the presence of phloretin. Raman spectroscopy of the membranes did not contradict the results found with infrared and ESR spectroscopy: In the phloretin modified membrane we observed a lack of the band at 1085 cm-1, which leads to suggest that the POO" and/or C-C regions are less fluid. Changes of the extracted red cell membrane lipids were less characteristic, and the results differed from those found in red cell membrane.
Patients with ataxia-telangiectasia (A-T) suffer from progressive cerebellar ataxia, immunodeficiency, respiratory failure, and cancer susceptibility. From a clinical point of view, A-T patients with IgA deficiency show more symptoms and may have a poorer prognosis. In this study, we analyzed mortality and immunity data of 659 A-T patients with regard to IgA deficiency collected from the European Society for Immunodeficiencies (ESID) registry and from 66 patients with classical A-T who attended at the Frankfurt Goethe-University between 2012 and 2018. We studied peripheral B- and T-cell subsets and T-cell repertoire of the Frankfurt cohort and survival rates of all A-T patients in the ESID registry. Patients with A-T have significant alterations in their lymphocyte phenotypes. All subsets (CD3, CD4, CD8, CD19, CD4/CD45RA, and CD8/CD45RA) were significantly diminished compared to standard values. Patients with IgA deficiency (n = 35) had significantly lower lymphocyte counts compared to A-T patients without IgA deficiency (n = 31) due to a further decrease of naïve CD4 T-cells, central memory CD4 cells, and regulatory T-cells. Although both patient groups showed affected TCR-ß repertoires compared to controls, no differences could be detected between patients with and without IgA deficiency. Overall survival of patients with IgA deficiency was significantly diminished. For the first time, our data show that patients with IgA deficiency have significantly lower lymphocyte counts and subsets, which are accompanied with reduced survival, compared to A-T patients without IgA deficiency. IgA, a simple surrogate marker, is indicating the poorest prognosis for classical A-T patients. Both non-interventional clinical trials were registered at clinicaltrials.gov 2012 (Susceptibility to infections in ataxia-telangiectasia; NCT02345135) and 2017 (Susceptibility to Infections, tumor risk and liver disease in patients with ataxia-telangiectasia; NCT03357978)
Introduction: Cesarean section (CS) rates are increasing worldwide. One constant indication is the breech presentation at term. By offering external cephalic version (ECV) and vaginal breech delivery CS rates can be further reduced. Objective: This study aimed to analyze the ECV at 38 weeks of gestation with the associate uptake rate, predicting factors, success rate, and complications at a tertiary healthcare provider in Germany specializing in vaginal breech delivery. Methods: We conducted a prospective cohort study with retrospective data acquisition. All women with a singleton fetus in breech presentation presenting after 34 weeks of gestation for counseling between 2013 and 2017 were included. ECV impact factors were analyzed using logistic regression. Results: A total of 1,598 women presented for breech birth planning. ECV was performed on 353 patients. The overall success rate was 22.4%. A later week of gestation (odds ratio [OR] 1.69), an abundant amniotic fluid index (AFI score) (OR 5.74), fundal (OR 3.78) and anterior (OR 0.39) placental location, and an oblique lie (OR 9.08) were significantly associated with successful ECV in our population. No major complications were observed. The overall vaginal delivery rates could be increased to approximately 14% with ECV. Conclusion: The demand for alternative birth modes other than CS for breech birth is high in the area of Frankfurt, Germany. Our study offers evidence of the safety of ECV at 38 weeks. Centers with expertise in vaginal breech delivery and ECV can reduce CS-rates. To further establish vaginal breech delivery and ECV as alternate options, the required knowledge and skill should be implemented in the revised curricula.
The cell—cell signaling gene CDH13 is associated with a wide spectrum of neuropsychiatric disorders, including attention-deficit/hyperactivity disorder (ADHD), autism, and major depression. CDH13 regulates axonal outgrowth and synapse formation, substantiating its relevance for neurodevelopmental processes. Several studies support the influence of CDH13 on personality traits, behavior, and executive functions. However, evidence for functional effects of common gene variation in the CDH13 gene in humans is sparse. Therefore, we tested for association of a functional intronic CDH13 SNP rs2199430 with ADHD in a sample of 998 adult patients and 884 healthy controls. The Big Five personality traits were assessed by the NEO-PI-R questionnaire. Assuming that altered neural correlates of working memory and cognitive response inhibition show genotype-dependent alterations, task performance and electroencephalographic event-related potentials were measured by n-back and continuous performance (Go/NoGo) tasks. The rs2199430 genotype was not associated with adult ADHD on the categorical diagnosis level. However, rs2199430 was significantly associated with agreeableness, with minor G allele homozygotes scoring lower than A allele carriers. Whereas task performance was not affected by genotype, a significant heterosis effect limited to the ADHD group was identified for the n-back task. Heterozygotes (AG) exhibited significantly higher N200 amplitudes during both the 1-back and 2-back condition in the central electrode position Cz. Consequently, the common genetic variation of CDH13 is associated with personality traits and impacts neural processing during working memory tasks. Thus, CDH13 might contribute to symptomatic core dysfunctions of social and cognitive impairment in ADHD.
Proton-pumping complex I of the mitochondrial respiratory chain is among the largest and most complex membrane protein complexes. The enzyme contributes substantially to oxidative energy-conversion in eukaryotic cells. Its malfunctions are implicated in many hereditary and degenerative disorders. Here, we report the X-ray structure of mitochondrial complex I at 3.6- 3.9 Å resolution describing in detail the central subunits that execute the bioenergetic function. A continuous axis of basic and acidic residues running centrally through the membrane arm connects the ubiquinone reduction site in the hydrophilic arm to four putative proton-pumping units. The binding position for a substrate analogous inhibitor and blockage of the predicted ubiquinone binding site provide a model for the ‘deactive’ form of the enzyme. The proposed transition into the active form is based on a concerted structural rearrangement at the ubiquinone reduction site rendering support for a two-state stabilization-change mechanism of protonpumping.
Highlights
• Deletion of SPPL3 promotes resistance of malignant B cells to NK cell cytotoxicity
• Loss of SPPL3 blocks ligand binding to NK receptors via increased N-glycosylation
• B3GNT2 deletion reduces LacNAc addition and restores SPPL3-KO cell sensitivity to NK cells
• SPPL3-deficient cells are enriched in tetra-antennary N-glycans with LacNAc elongations
Summary
Natural killer (NK) cells are primary defenders against cancer precursors, but cancer cells can persist by evading immune surveillance. To investigate the genetic mechanisms underlying this evasion, we perform a genome-wide CRISPR screen using B lymphoblastoid cells. SPPL3, a peptidase that cleaves glycosyltransferases in the Golgi, emerges as a top hit facilitating evasion from NK cytotoxicity. SPPL3-deleted cells accumulate glycosyltransferases and complex N-glycans, disrupting not only binding of ligands to NK receptors but also binding of rituximab, a CD20 antibody approved for treating B cell cancers. Notably, inhibiting N-glycan maturation restores receptor binding and sensitivity to NK cells. A secondary CRISPR screen in SPPL3-deficient cells identifies B3GNT2, a transferase-mediating poly-LacNAc extension, as crucial for resistance. Mass spectrometry confirms enrichment of N-glycans bearing poly-LacNAc upon SPPL3 loss. Collectively, our study shows the essential role of SPPL3 and poly-LacNAc in cancer immune evasion, suggesting a promising target for cancer treatment.
Thioredoxin 1 and thioredoxin 2 have opposed regulatory functions on hypoxia-inducible factor-1α
(2007)
Hypoxia inducible factor 1 (HIF-1), a key regulator for adaptation to hypoxia, is composed of HIF-1alpha and HIF-1beta. In this study, we present evidence that overexpression of mitochondria-located thioredoxin 2 (Trx2) attenuated hypoxia-evoked HIF-1alpha accumulation, whereas cytosolic thioredoxin 1 (Trx1) enhanced HIF-1alpha protein amount. Transactivation of HIF-1 is decreased by overexpression of Trx2 but stimulated by Trx1. Inhibition of proteasomal degradation of HIF-1alpha in Trx2-overexpressing cells did not fully restore HIF-1alpha protein levels, while HIF-1alpha accumulation was enhanced in Trx1-overexpressing cells. Reporter assays showed that cap-dependent translation is increased by Trx1 and decreased by Trx2, whereas HIF-1alpha mRNA levels remained unaltered. These data suggest that thioredoxins affect the synthesis of HIF-1alpha. Trx1 facilitated synthesis of HIF-1alpha by activating Akt, p70S6K, and eIF-4E, known to control cap-dependent translation. In contrast, Trx2 attenuated activities of Akt, p70S6K, and eIF-4E and provoked an increase in mitochondrial reactive oxygen species production. MitoQ, a mitochondria specific antioxidant, reversed HIF-1alpha accumulation as well as Akt activation under hypoxia in Trx2 cells, supporting the notion of translation control mechanisms in affecting HIF-1alpha protein accumulation.
Background: Compound flaps offer the advantage of one stage defect reconstruction respecting all relevant tissues and early functional recovery by optimal vascularity of all components. Due to its specific vascular anatomy and the three-dimensional donor site, compound flaps with bone components may result in higher complication rates compared to soft tissue compound flaps. The meta-analysis summarizes the available evidence and evaluates whether bone components are a risk factor for periprocedural complications in upper extremity multidimensional defect reconstruction. Method: PubMed and Embase were searched for all publications addressing compound free flaps for upper extremity defect reconstruction with bone or soft tissue components published between January 1988 and May 2018. The methodological quality was assessed with the American Society of Plastic Surgeons Evidence Rating Scale for Therapeutic Studies. Flap loss, thrombosis rate, early infection, hematoma, seroma, as well as donor site complications were extracted and analyzed. Results: Twelve out of 1157 potentially eligible studies (evidence-III) comprising 159 patients were finally included with publication bias for all summarized complication rates. Complication rates for flaps with/ without bone components were: total flap loss 5%, 95% CI = 3%–10% (6%/5%); partial flap loss 8%, 95% CI = 5%–15%, (9%/8%); arterial/venous thrombosis 7%, 95% CI = 4%–12%, (8%/5%)/14%, 95% CI = 9%–21% (16%/6%, P < .05) with higher risk for flaps with bone components; infection 6%, 95% CI = 3%–12% (6%/6%); hematoma 6%, 95% CI = 3%–11% (6%/5%); seroma 5%, 95% CI = 3%–10% (5%/5%); dehiscence 10%, 95% CI = 6%–17% (11%/9%). Conclusion: Compound flaps for upper extremity defect reconstruction including bone components have a higher venous thrombosis rate compared to compound soft-tissue flaps.
Forewarned is forearmed
(2009)
Simple Summary: Treatment of metastatic renal cell carcinoma (mRCC) remains a challenge due to the lack of biomarkers indicating the optimal drug for each patient. This study analyzed blood samples of patients with predominant clear cell mRCC who were treated with the mTOR inhibitor everolimus after failure of one prior tumor therapy. In an exploratory approach, predictive blood biomarkers were searched. We found lower levels of the protein thrombospondin-2 (TSP-2) at the start of the therapy and higher lactate dehydrogenase (LDH) levels in serum two weeks after therapy initiation to be associated with therapy response. Of note, these blood biomarkers had a higher predictive value than baseline patient parameters or risk classifications. Polymorphisms in the mTOR gene appeared to be associated with therapy response, but were not significant. To conclude, it seems feasible to identify patients showing longtime responses to everolimus and possible to increase tumor therapy response rates based on biomarkers for individual therapy selection.
Abstract: There is an unmet need for predictive biomarkers in metastatic renal cell carcinoma (mRCC) therapy. The phase IV MARC-2 trial searched for predictive blood biomarkers in patients with predominant clear cell mRCC who benefit from second-line treatment with everolimus. In an exploratory approach, potential biomarkers were assessed employing proteomics, ELISA, and polymorphism analyses. Lower levels of angiogenesis-related protein thrombospondin-2 (TSP-2) at baseline (≤665 parts per billion, ppb) identified therapy responders with longer median progression-free survival (PFS; ≤665 ppb at baseline: 6.9 months vs. 1.8, p = 0.005). Responders had higher lactate dehydrogenase (LDH) levels in serum two weeks after therapy initiation (>27.14 nmol/L), associated with a longer median PFS (3.8 months vs. 2.2, p = 0.013) and improved overall survival (OS; 31.0 months vs. 14.0 months, p < 0.001). Baseline TSP-2 levels had a stronger relation to PFS (HR 0.36, p = 0.008) than baseline patient parameters, including IMDC score. Increased serum LDH levels two weeks after therapy initiation were the best predictor for OS (HR 0.21, p < 0.001). mTOR polymorphisms appeared to be associated with therapy response but were not significant. Hence, we identified TSP-2 and LDH as promising predictive biomarkers for therapy response on everolimus after failure of one VEGF-targeted therapy in patients with clear cell mRCC.
Objectives: To discuss optimal management of recurrent urinary tract infections (UTIs) in women. About every second woman experiences at least one UTI in her lifetime, of those 30% experience another UTI, and 3% further recurrences. Especially young healthy women without underlying anatomical deficiencies suffer from recurrent UTIs (rUTI), which are associated with significant morbidity and reduction in quality of life.
Methods: This is a narrative review, investigating publications dealing with recurrent UTI in women. Risk factors and options for management are discussed.
Results: The increased susceptibility of women to rUTI is based on the female anatomy in addition to behavioural, genetic, and urological factors. However, why some women are more likely than others to develop and maintain rUTI remains to be clarified. Invasive characteristics of certain uropathogenic Escherichia coli that are able to form extra- and intracellular biofilms and may therefore cause delayed release of bacteria into the bladder, may play a role in this setting. Treatment recommendations for an acute episode of rUTI do not differ from those for isolated episodes. Given the nature of rUTI, different prophylactic approaches also play an important role. Women with rUTI should first be counselled to use non-antibiotic strategies including behavioural changes, anti-adhesive treatments, antiseptics, and immunomodulation, before antibiotic prophylaxis is considered. In addition to the traditional treatment and prophylactic therapies, new experimental strategies are emerging and show promising effects, such as faecal microbiota transfer (FMT), a treatment option that transfers microorganisms and metabolites of a healthy donor’s faecal matter to patients using oral capsules, enemas, or endoscopy. Initial findings suggest that FMT might be a promising treatment approach to interrupt the cycle of rUTI. Furthermore, bacteriophages, infecting and replicating in bacteria, have been clinically trialled for UTIs.
Conclusion: Due to the limitation of available data, novel treatment options require further clinical research to objectify the potential in treating bacterial infections, particularly UTIs.
Druggability Evaluation of the Neuron Derived Orphan Receptor (NOR-1) Reveals Inverse NOR-1 Agonists
(2022)
The neuron derived orphan receptor (NOR-1, NR4A3) is among the least studied nuclear receptors. Its physiological role and therapeutic potential remain widely elusive which is in part due to the lack of chemical tools that can directly modulate NOR-1 activity. To probe the possibility of pharmacological NOR-1 modulation, we have tested a drug fragment library for NOR-1 activation and repression. Despite low hit-rate (<1 %), we have obtained three NOR-1 ligand chemotypes one of which could be rapidly expanded to an analogue comprising low micromolar inverse NOR-1 agonist potency and altering NOR-1 regulated gene expression in a cellular setting. It confirms druggability of the transcription factor and may serve as an early tool to assess the role and potential of NOR-1.
In dengue-endemic countries such as Indonesia, Zika may be misdiagnosed as dengue, leading to underestimates of Zika disease and less foreknowledge of pregnancy-related complications such as microcephaly. Objective: To assess the attitudes of frontline physicians in a dengue-endemic country toward testing for Zika infection among patients with dengue-like illnesses. Methods: A cross-sectional online survey was conducted among general practitioners (GPs) in Indonesia. The survey assessed their attitude and also collected sociodemographic data, characteristics of their medical education, professional background, and workplace, and exposure to Zika cases. A two-step logistic regression analysis was used to assess possible variables associated with these attitudes. Results: A total of 370 GPs were included in the final analysis of which 70.8% had good attitude. Unadjusted analyses suggested that GPs who were 30 years old or older and those who had medical experience five years or longer had lower odds of having a positive attitude compared to those who aged younger than 30 years and those who had medical experience less than five years, OR: 0.58; 95%CI: 0.37, 0.91 and OR: 0.55; 95%CI: 0.35, 0.86, respectively. No explanatory variable was associated with attitude in the fully adjusted model. Conclusion: Our findings point to younger GPs with a shorter medical experience being more likely to consider testing for Zika infection among their patients presenting with dengue-like illnesses. Strategic initiatives may be needed to enhance older or longer-experienced physicians' capacity in diagnosing Zika infection.
The adult heart has a limited capacity to replace or regenerate damaged cardiac tissue following severe myocardial injury. Thus, therapies facilitating the induction of cardiac regeneration holds great promise for the treatment of end-stage heart failure, and for pathologies invoking severe cardiac dysfunction as a result of cardiomyocyte death. Recently, a number of studies have demonstrated that cardiac regeneration can be achieved through modulation and/or reprogramming of cardiomyocyte proliferation, differentiation, and survival signaling. Non-coding RNAs (ncRNAs), including microRNAs (miRNAs), long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs), are reported to play critical roles in regulating key aspects of cardiomyocyte physiologic and pathologic signaling, including the regulation of cardiac regeneration both in vitro and in vivo. In this review, we will explore and detail the current understanding of ncRNA function in cardiac regeneration, and highlight established and novel strategies for the treatment of heart failure through modulation of ncRNAs-driven cardiac regeneration.
Diabetes results from a decline in functional pancreatic β-cells, but the molecular mechanisms underlying the pathological β-cell failure are poorly understood. Here we report that large-tumor suppressor 2 (LATS2), a core component of the Hippo signaling pathway, is activated under diabetic conditions and induces β-cell apoptosis and impaired function. LATS2 deficiency in β-cells and primary isolated human islets as well as β-cell specific LATS2 ablation in mice improves β-cell viability, insulin secretion and β-cell mass and ameliorates diabetes development. LATS2 activates mechanistic target of rapamycin complex 1 (mTORC1), a physiological suppressor of autophagy, in β-cells and genetic and pharmacological inhibition of mTORC1 counteracts the pro-apoptotic action of activated LATS2. We further show a direct interplay between Hippo and autophagy, in which LATS2 is an autophagy substrate. On the other hand, LATS2 regulates β-cell apoptosis triggered by impaired autophagy suggesting an existence of a stress-sensitive multicomponent cellular loop coordinating β-cell compensation and survival. Our data reveal an important role for LATS2 in pancreatic β-cell turnover and suggest LATS2 as a potential therapeutic target to improve pancreatic β-cell survival and function in diabetes.
Background & Aims: Liver fibrosis arises from long-term chronic liver injury, accompanied by an accelerated wound healing response with interstitial accumulation of extracellular matrix (ECM). Activated hepatic stellate cells (HSC) are the main source for ECM production. MicroRNA29a (miR-29a) is a crucial antifibrotic miRNA that is repressed during fibrosis, resulting in up-regulation of collagen synthesis.
Methods; Intracellular and extracellular miRNA levels of primary and immortalized myofibroblastic HSC in response to profibrogenic stimulation by transforming growth factor β (TGFβ) or platelet-derived growth factor-BB (PDGF-BB) or upon inhibition of vesicular transport and autophagy processes were determined by quantitative polymerase chain reaction. Autophagy flux was studied by electron microscopy, flow cytometry, immunoblotting, and immunocytochemistry. Hepatic and serum miR-29a levels were quantified by using both liver tissue and serum samples from a cohort of chronic hepatitis C virus patients and a murine CCl4 induced liver fibrosis model.
Results: In our study, we show that TGFβ and PDGF-BB resulted in decrease of intracellular miR-29a and a pronounced increase of vesicular miR-29a release into the supernatant. Strikingly, miR-29a vesicular release was accompanied by enhanced autophagic activity and up-regulation of the autophagy marker protein LC3. Moreover, autophagy inhibition strongly prevented miR-29a secretion and repressed its targets’ expression such as Col1A1. Consistently, hepatic miR-29a loss and increased LC3 expression in myofibroblastic HSC were associated with increased serum miR-29a levels in CCl4-treated murine liver fibrosis and specimens of hepatitis C virus patients with chronic liver disease.
Conclusions: We provide evidence that activation-associated autophagy in HSC induces release of miR-29a, whereas inhibition of autophagy represses fibrogenic gene expression in part through attenuated miR-29a secretion.
Pathologies associated with tissue ischemia/reperfusion (I/R) in highly metabolizing organs such as the brain and heart are leading causes of death and disability in humans. Molecular mechanisms underlying mitochondrial dysfunction during acute injury in I/R are tissue-specific, but their details are not completely understood. A metabolic shift and accumulation of substrates of reverse electron transfer (RET) such as succinate are observed in tissue ischemia, making mitochondrial complex I of the respiratory chain (NADH:ubiquinone oxidoreductase) the most vulnerable enzyme to the following reperfusion. It has been shown that brain complex I is predisposed to losing its flavin mononucleotide (FMN) cofactor when maintained in the reduced state in conditions of RET both in vitro and in vivo. Here we investigated the process of redox-dependent dissociation of FMN from mitochondrial complex I in brain and heart mitochondria. In contrast to the brain enzyme, cardiac complex I does not lose FMN when reduced in RET conditions. We proposed that the different kinetics of FMN loss during RET is due to the presence of brain-specific long 50 kDa isoform of the NDUFV3 subunit of complex I, which is absent in the heart where only the canonical 10 kDa short isoform is found. Our simulation studies suggest that the long NDUFV3 isoform can reach toward the FMN binding pocket and affect the nucleotide affinity to the apoenzyme. For the first time, we demonstrated a potential functional role of tissue-specific isoforms of complex I, providing the distinct molecular mechanism of I/R-induced mitochondrial impairment in cardiac and cerebral tissues. By combining functional studies of intact complex I and molecular structure simulations, we defined the critical difference between the brain and heart enzyme and suggested insights into the redox-dependent inactivation mechanisms of complex I during I/R injury in both tissues.
Autism spectrum disorders (ASD) are highly heritable and are characterized by deficits in social communication and restricted and repetitive behaviors. Twin studies on phenotypic subdomains suggest a differing underlying genetic etiology. Studying genetic variation explaining phenotypic variance will help to identify specific underlying pathomechanisms. We investigated the effect of common variation on ASD subdomains in two cohorts including >2500 individuals. Based on the Autism Diagnostic Interview-Revised (ADI-R), we identified and confirmed six subdomains with a SNP-based genetic heritability h2SNP = 0.2–0.4. The subdomains nonverbal communication (NVC), social interaction (SI), and peer interaction (PI) shared genetic risk factors, while the subdomains of repetitive sensory-motor behavior (RB) and restricted interests (RI) were genetically independent of each other. The polygenic risk score (PRS) for ASD as categorical diagnosis explained 2.3–3.3% of the variance of SI, joint attention (JA), and PI, 4.5% for RI, 1.2% of RB, but only 0.7% of NVC. We report eight genome-wide significant hits—partially replicating previous findings—and 292 known and novel candidate genes. The underlying biological mechanisms were related to neuronal transmission and development. At the SNP and gene level, all subdomains showed overlap, with the exception of RB. However, no overlap was observed at the functional level. In summary, the ADI-R algorithm-derived subdomains related to social communication show a shared genetic etiology in contrast to restricted and repetitive behaviors. The ASD-specific PRS overlapped only partially, suggesting an additional role of specific common variation in shaping the phenotypic expression of ASD subdomains.
The compulsive habit of cars
(2014)
The car dependence of people living in contemporary cities is a major concern for policy makers, who often find it difficult to persuade people into more sustainable transport modes. By contrast, recent insights from neuroscience have shown that a broad spectrum of behaviors can become habitual and, thus, resistant to change. Here, we outline the potential of collaboration between neuroscience and human geography aiming at a better understanding of habits that determine everyday commuting routines.
Introduction: The concurrent presence of both central nervous system (CNS) tumors and multiple sclerosis (MS) poses various diagnostic and therapeutic pitfalls and makes the clinical management of such patients challenging.
Methods: In this retrospective, single-center cohort study, we searched our clinical databases (2006–2019) for patients with concurrent CNS tumors and MS and described their disease courses. Age at diagnosis of the respective disease and probabilities for MS disease activity events (DAEs) with vs. without prior tumor-specific therapy were tested pairwise using t-test for dependent samples and exact binomial test.
Results: N = 16 patients with concurrent CNS tumors and MS were identified. MS diagnosis preceded the CNS oncological diagnosis by an average of 9 years (p = 0.004). More DAEs occurred in patients without prior chemotherapy (83.3%) than in patients with prior chemotherapy (16.7%; p = 0.008). This effect did not reach significance for patients with prior radiation therapy/radiosurgery (66.7% vs. 33.3%, p = 0.238). The average interval between DAEs and the last documented lymphopenia was 32.25 weeks.
Conclusions: This study describes the clinical and demographic features of patients with concurrent CNS tumors and MS and suggests several practical approaches to their clinical management. Our findings suggest that adding a disease-modifying MS therapy to the regimen of patients treated with chemotherapy is necessary only if the patient suffers from a highly active, aggressive course of MS. In view of the lack of prospective trials, individual risk assessments should remain the foundation of the decision on MS treatment in concurrent CNS tumor diseases.
Sphingosylphosphorylcholine (SPC) is a bioactive lipid that binds to G protein-coupled-receptors and activates various signaling cascades. Here, we show that in renal mesangial cells, SPC not only activates various protein kinase cascades but also activates Smad proteins, which are classical members of the transforming growth factor-β (TGFβ) signaling pathway. Consequently, SPC is able to mimic TGFβ-mediated cell responses, such as an anti-inflammatory and a profibrotic response. Interleukin-1β-stimulated prostaglandin E2 formation is dose-dependently suppressed by SPC, which is paralleled by reduced secretory phospholipase A2 (sPLA2) protein expression and activity. This effect is due to a reduction of sPLA2 mRNA expression caused by inhibited sPLA2 promoter activity. Furthermore, SPC upregulates the profibrotic connective tissue growth factor (CTGF) protein and mRNA expression. Blocking TGFβ signaling by a TGFβ receptor kinase inhibitor causes an inhibition of SPC-stimulated Smad activation and reverses both the negative effect of SPC on sPLA2 expression and the positive effect on CTGF expression. In summary, our data show that SPC, by mimicking TGFβ, leads to a suppression of proinflammatory mediator production and stimulates a profibrotic cell response that is often the end point of an anti-inflammatory reaction. Thus, targeting SPC receptors may represent a novel therapeutic strategy to cope with inflammatory diseases.
Sulforaphane (SFN) is a natural glucosinolate found in cruciferous vegetables that acts as a chemopreventive agent, but its mechanism of action is not clear. Due to antioxidative mechanisms being thought central in preventing cancer progression, SFN could play a role in oxidative processes. Since redox imbalance with increased levels of reactive oxygen species (ROS) is involved in the initiation and progression of bladder cancer, this mechanism might be involved when chemoresistance occurs. This review summarizes current understanding regarding the influence of SFN on ROS and ROS-related pathways and appraises a possible role of SFN in bladder cancer treatment.
In this comprehensive review, we will dissect the impact of research on proteoglycans focusing on recent developments involved in their synthesis, degradation, and interactions, while critically assessing their usefulness in various biological processes. The emerging roles of proteoglycans in global infections, specifically the SARS-CoV-2 pandemic, and their rising functions in regenerative medicine and biomaterial science have significantly affected our current view of proteoglycans and related compounds. The roles of proteoglycans in cancer biology and their potential use as a next-generation protein-based adjuvant therapy to combat cancer is also emerging as a constructive and potentially beneficial therapeutic strategy. We will discuss the role of proteoglycans in selected and emerging areas of proteoglycan science, such as neurodegenerative diseases, autophagy, angiogenesis, cancer, infections and their impact on mammalian diseases.
Background: To examine overall survival rates within a large cohort of German prostate cancer (PCa) patients and to compare these with life-expectancy (LE) predictions derived from German life tables. We hypothesized that the advantage of good general health in radical prostatectomy (RP) patients combined with favorable cancer outcomes might lead to even higher overall survival rates over 10 years compared to the LE of a general population.
Methods: A total of 6483 patients were treated with RP between 1992 and 2007 at the Martini-Klinik Prostate Cancer Center. Preoperative risk classification was performed according to D'Amico. Postoperative risk classification was performed according to the Cancer of the Prostate Risk Assessment score (CAPRA-S). A simulated cohort was created that resembled the exact age distribution of the RP population using Monte Carlo simulation which was based on data derived from official male German life tables (1992–2017). Markov chain was used to represent natural age progression of the simulated cohort. Kaplan–Meier plots were created to display the differences between 10-year observed overall survival (OS) and the simulated, predicted LE.
Results: For D'Amico low risk and intermediate risk, 10-year OS was 12.0% and 9.2% above predicted LE in the simulated cohort, respectively. For D'Amico high risk, OS was virtually the same as predicted LE (0.8% difference in favor of RP treated patients). For CAPRA-S low and intermediate risk, OS was 11.8% and 9.7% above predicted LE. For CAPRA-S high risk, OS was virtually the same as predicted LE (0.3% difference in favor of the simulated cohort).
Conclusions: Low- and intermediate risk PCa patients treated with RP can expect a very favorable overall survival, that even exceeds LE predictions. High risk patients' overall survival perfectly aligns with LE predictions.
Objectives: To test the effect of race/ethnicity on cancer-specific mortality after radical prostatectomy or external beam radiotherapy in localized prostate cancer patients. Methods: In the Surveillance, Epidemiology and End Results database 2004–2016, we identified intermediate-risk and high-risk white (n = 151 632), Asian (n = 11 189), Hispanic/Latino (n = 20 077) and African American (n = 32 550) localized prostate cancer patients, treated with external beam radiotherapy or radical prostatectomy. Race/ethnicity-stratified cancer-specific mortality analyses relied on competing risks regression, after propensity score matching for patient and cancer characteristics. Results: Compared with white patients, Asian intermediate- and high-risk external beam radiotherapy patients showed lower cancer-specific mortality (hazard ratio 0.58 and 0.70, respectively, both P ≤ 0.02). Additionally, Asian high-risk radical prostatectomy patients also showed lower cancer-specific mortality than white patients (hazard ratio 0.72, P = 0.04), but not Asian intermediate-risk radical prostatectomy patients (P = 0.08). Conversely, compared with white patients, African American intermediate-risk radical prostatectomy patients showed higher cancer-specific mortality (hazard ratio 1.36, P = 0.01), but not African American high-risk radical prostatectomy or intermediate- and high-risk external beam radiotherapy patients (all P ≥ 0.2). Finally, compared with white people, no cancer-specific mortality differences were recorded for Hispanic/Latino patients after external beam radiotherapy or radical prostatectomy, in both risk levels (P ≥ 0.2). Conclusions: Relative to white patients, an important cancer-specific mortality advantage applies to intermediate-risk and high-risk Asian prostate cancer patients treated with external beam radiotherapy, and to high-risk Asian patients treated with radical prostatectomy. These observations should be considered in pretreatment risk stratification and decision-making.
Objectives: To test the effect of race/ethnicity on cancer-specific mortality after radical prostatectomy or external beam radiotherapy in localized prostate cancer patients. Methods: In the Surveillance, Epidemiology and End Results database 2004–2016, we identified intermediate-risk and high-risk white (n = 151 632), Asian (n = 11 189), Hispanic/Latino (n = 20 077) and African American (n = 32 550) localized prostate cancer patients, treated with external beam radiotherapy or radical prostatectomy. Race/ethnicity-stratified cancer-specific mortality analyses relied on competing risks regression, after propensity score matching for patient and cancer characteristics. Results: Compared with white patients, Asian intermediate- and high-risk external beam radiotherapy patients showed lower cancer-specific mortality (hazard ratio 0.58 and 0.70, respectively, both P ≤ 0.02). Additionally, Asian high-risk radical prostatectomy patients also showed lower cancer-specific mortality than white patients (hazard ratio 0.72, P = 0.04), but not Asian intermediate-risk radical prostatectomy patients (P = 0.08). Conversely, compared with white patients, African American intermediate-risk radical prostatectomy patients showed higher cancer-specific mortality (hazard ratio 1.36, P = 0.01), but not African American high-risk radical prostatectomy or intermediate- and high-risk external beam radiotherapy patients (all P ≥ 0.2). Finally, compared with white people, no cancer-specific mortality differences were recorded for Hispanic/Latino patients after external beam radiotherapy or radical prostatectomy, in both risk levels (P ≥ 0.2). Conclusions: Relative to white patients, an important cancer-specific mortality advantage applies to intermediate-risk and high-risk Asian prostate cancer patients treated with external beam radiotherapy, and to high-risk Asian patients treated with radical prostatectomy. These observations should be considered in pretreatment risk stratification and decision-making.
Background: A trend towards inverse stage migration in prostate cancer (PCa) was reported. However, previous analyses did not take into account potential differences in sampling strategies (number of biopsy cores), which might have confounded these reports.
Material and Methods: Within our single-institutional database we identified PCa patients treated with radical prostatectomy (RP) between 2000 and 2020 (n = 21,646). We calculated the estimated annual percentage change (EAPC) for D'Amico risk groups, biopsy Gleason Grade Group (GGG), PSA and cT stage as well as postoperative RP GGG and pT stage relying on log linear regression methodology. Subsequently, we repeated the analyses after adjustment for number of cores obtained at biopsy.
Results: Absolute rates of D'Amico low risk decreased (−30.1%), while intermediate and high risk increased (+21.2% and +9.0%, respectively). Rates of GGG I decreased (−50.0%), while GGG II–V increased, with the largest increase in GGG II (+22.5%). This trend, albeit less pronounced, was also recorded after adjusted EAPC analyses (p < .05). Specifically, EAPC values for D'Amico low vs intermediate vs high risk were −1.07%, +0.37%, +0.45%, respectively, and EAPC values for GGG ranged between −0.71% (GGG I) and +0.80% (GGG IV). Finally, an increase in ≥cT2 (EAPC: +3.16%) was displayed (all p < .001). These trends were confirmed in EAPC calculations in RP GGG and pT stages (p < .001).
Conclusion: Our findings confirm the trend towards less frequent treatment of low risk PCa and more frequent treatment of high risk PCa, also after adjustment for number of biopsy cores.
Ataxia telangiectasia (A-T) is a devastating multi-system disorder characterized by progressive cerebellar ataxia and immunodeficiency. The neurological decline may be caused by multiple factors of which ongoing inflammation and oxidative stress may play a dominant role. The objective of the present investigation was to determine cerebrospinal fluid (CSF) proteins and possible low-grade inflammation and its relation to age and neurological deterioration. In the present study, we investigated 15 patients with A-T from 2 to 16 years. Our investigation included blood and CSF tests, clinical neurological examination, A-T score, and MRI findings. The albumin ratio (AR) was analyzed to determine the blood–brain-barrier function. In addition, inflammatory cytokines (IL-1α, IL-6, IL-8, IL-12 p40, IL-17A, IFN-γ, TNF-α) were measured by the multiplex cytometric bead array. We compared the results with those from an age-matched control group. Three of the A-T patients were analyzed separately (one after resection of a cerebral meningioma, one after radiation and chemotherapy due to leukemia, one after stem cell transplantation). Patient had significantly more moderate and severe side effects due to CSF puncture (vomiting, headache, need for anti-emetic drugs) compared with healthy controls. Total protein, albumin, and the AR increased with age indicating a disturbed blood barrier function in older children. There were no differences for cytokines in serum and CSF with the exception of IL-2, which was significantly higher in controls in serum. The AR is significantly altered in A-T patients, but low-grade inflammation is not detectable in serum and CSF.
The analysis of ethanol and of its congeners in blood plays an important role in forensic cases, especially when allegations are made that alcohol has been consumed after an accident. In alcoholic beverages, congener alcohols are by-products and are generated during fermentation. The assay of these compounds in serum samples and beverages has been previously performed using headspace-gas chromatography-flame ionization detection methods (HS-GC-FID). As an alternative, a robust headspace-gas chromatography-mass spectrometry (HS-GC-MS) procedure was developed and validated, which has the following advantages:
- Simultaneous determination of ethanol, congener alcohols and other
endogenous substances.
- Reduction of matrix interference by increasing selectivity and
specificity.
- Clear separation of the positional isomers 3-methyl-1-butanol and
2-methyl-1-butanol.
Highlights
• This current review covers studies that have identified long non-coding RNAs in aortic aneurysm development and progression.
• We separately discuss transcripts and mechanisms of importance to thoracic as well as abdominal aortic aneurysms.
• Functional data on lncRNAs being identified are highlighted.
• Some have been studied in human as well as experimental models of the disease pathology.
Abstract
Aortic aneurysm (AA) is a complex and dangerous vascular disease, featuring progressive and irreversible vessel dilatation. AA is typically detected either by screening, or identified incidentally through imaging studies. To date, no effective pharmacological therapies have been identified for clinical AA management, and either endovascular repair or open surgery remains the only option capable of preventing aneurysm rupture. In recent years, multiple research groups have endeavored to both identify noncoding RNAs and to clarify their function in vascular diseases, including aneurysmal pathologies. Notably, the molecular roles of noncoding RNAs in AA development appear to vary significantly between thoracic aortic aneurysms (TAAs) and abdominal aortic aneurysms (AAAs). Some microRNAs (miRNA - a non-coding RNA subspecies) appear to contribute to AA pathophysiology, with some showing major potential for use as biomarkers or as therapeutic targets. Studies of long noncoding RNAs (lncRNAs) are more limited, and their specific contributions to disease development and progression largely remain unexplored. This review aims to summarize and discuss the most current data on lncRNAs and their mediation of AA pathophysiology.
To clip or coil has been matter of debates for several years and is the domain of interdisciplinary decision making. However, the microsurgical outcome has still been elusive concerning wide neck aneurysms (WNA). A retrospective single center study was performed with all patients with ruptured WNA (rWNA) and unruptured WNA (uWNA) admitted to author´s institute between 2007–2017. Microsurgical outcome was evaluated according to Raymond-Roy occlusion grade and follow-up angiography was performed to analyze the stability of neck/aneurysm remnants and retreatment poverty. Of 805 aneurysms, 139 were rWNA (17.3%) and 148 uWNA (18.4%). Complete occlusion was achieved in 102 of 139 rWNA (73.4%) and 112 of 148 uWNA (75.6%). Neck remnants were observed in 36 patients with rWNA (25.9%) and 30 patients with uWNA (20.3%), 1 (0.7%) and 6 (4.1%) patients had aneurysmal remnant, respectively. Overall complication rate was 11.5%. At follow-up (939/1504 months), all remnants were stable except for one, which was further conservatively treated with marginal retreatment rate under 1%. Even the risk of de-novo aneurysm was higher than the risk for remnant growth (2.6% vs 0% in rWNA; 8.7% vs 5.3% in uWNA) without significant difference. Microsurgical clipping is effective for complete occlusion of r/uWNA with low complication. Furthermore, the risk of remnant growth is marginal even lower than the risk of de-novo rate low retreatment rate.
Introduction: Dysphagia is a common and severe symptom of traumatic brain injury (TBI) affecting up to 78% of patients. It is associated with pneumonia, increased morbidity, and mortality. Although subdural hematoma (SDH) accounts for over 50% of TBI, the occurrence of dysphagia in this subtype has not been investigated yet.
Methods: All patients with SDH admitted to the author's institution between the years 2007 and 2020 were included in the study. Patients with SDH and clinical suspicion for dysphagia received a clinical swallowing assessment by a speech and language pathologist (SLP). Furthermore, the severity of dysphagia was rated according to swallowing disorder scale. Functional outcome was evaluated by the Glasgow outcome scale (GOS).
Results: Out of 545 patients with SDH, 71 patients had dysphagia (13%). The prevalence of dysphagia was significantly lower in the surgical arm compared to the conservative arm (11.8 vs. 21.8%; OR 0.23; p = 0.02). Independent predictors for dysphagia were GCS < 13 at admission (OR 4.17; p < 0.001), cardiovascular disease (OR 2.29; p = 0.002), and pneumonia (OR 2.88; p = 0.002), whereas the operation was a protective factor (OR 0.2; p < 0.001). In a subgroup analysis, right-sided SDH was an additional predictor for dysphagia (OR 2.7; p < 0.001). Overall, patients with dysphagia improved significantly under the SLP treatment from the initial diagnosis to hospital discharge (p < 0.01). However, a subgroup of patients with the most severe grade of dysphagia showed no significant improvement. Patients with dysphagia had significantly worse outcomes (GOS 1–3) compared to those without dysphagia (48.8 vs. 26.4%; p < 0.001).
Conclusion: Dysphagia is a frequent symptom in SDH, and the early identification of dysphagia is crucial regarding the initiation of treatment and functional outcome. Surgery is effective in preventing dysphagia and should be considered in high-risked patients.
Purpose: Acute-on-chronic subdural hematoma (acSDH) describes acute bleeding into a chronic subdural hematoma (SDH), after surgery or second trauma. Because seizures are a well-known complication of SDH, associated with substantial morbidity and mortality, we aimed to analyze the incidence of acute symptomatic seizures (ASz), including status epilepticus, and determine the functional outcomes in this specific cohort of patients.
Methods: A retrospective analysis was performed, including patients with acSDH who were admitted to our department between 2010 and 2019. The incidence and timely onset of ASz and status epilepticus were evaluated. Functional outcomes at discharge and at 3–6 month follow-up were analyzed based on the modified Rankin scale.
Results: Of 506 patients with chronic SDH, 29 patients (5.7%) were diagnosed with acSDH. The overall incidence of ASz and status epilepticus were 72.4% and 10.3%, respectively. Favorable outcomes were identified in 11 patients (52.4%) in the ASz group compared with 6 patients (75%) in the non-ASz group. The mortality rate was higher in the ASz group compared with that in the control group (29% vs 0%). At follow-up, favorable outcomes were similar to those observed at discharge (52.4% in the ASz group and 71.4% in the control group). The mortality rate was still higher in the ASz group, at 32% compared with 14% for the control group.
Conclusion: AcSDH has a high risk for ASz, including status epilepticus, and is associated with unfavorable outcomes and high mortality. Thus, prophylactic treatment with antiepileptic drugs should be considered among this specific cohort of patients.
Post-exercise hypotension (PEH) is the phenomenon of lowered blood pressure after a single bout of exercise. Only a fraction of people develops PEH but its occurrence correlates well with long-term effects of sports on blood pressure. Therefore, PEH has been suggested as a suitable predictor for the effectivity of exercise as therapy in hypertension. Local vascular bioactive lipids might play a potential role in this context. We performed a cross-over clinical pilot study with 18 healthy volunteers to investigate the occurrence of PEH after a single short-term endurance exercise. Furthermore, we investigated the plasma lipid profile with focus on arachidonic acid (AA)-derived metabolites as potential biomarkers of PEH. A single bout of ergometer cycling induced a significant PEH in healthy volunteers with the expected high inter-individual variability. Targeted lipid spectrum analysis revealed significant upregulation of several lipids in the direct post-exercise phase. Among these changes, only 15- hydroxyeicosatetranoic acid (HETE) correlated significantly with the extent of PEH but in an AA-independent manner, suggesting that 15-HETE might act as specific PEH-marker. Our data indicate that specific lipid modulation might facilitate the identification of patients who will benefit from exercise activity in hypertension therapy. However, larger trials including hypertonic patients are necessary to verify the clinical value of this hypothesis.
Mutations in the Von Hippel–Lindau (VHL) gene are the driving force in many forms of clear cell renal cell carcinoma (ccRCC) and promote hypoxia-inducible factor (HIF)-dependent tumor proliferation, metastasis and angiogenesis. Despite the progress that has already been made, ccRCC generally remain resistant to conventional therapies and ccRCC patients suffer from metastasis and acquired resistance, highlighting the need for novel therapeutic options. Cysteinyl leukotriene receptor 1 (CysLTR1) antagonists, like zafirlukast, are administered in bronchial asthma to control eicosanoid signaling. Intriguingly, long-term use of zafirlukast decreases cancer risk and leukotriene receptor antagonists inhibit tumor growth, but the mechanisms still remain unexplored. Therefore, we aim to understand the mechanisms of zafirlukast-mediated cell death in ccRCC cells. We show that zafirlukast induces VHL-dependent and TNFα-independent non-apoptotic and non-necroptotic cell death in ccRCC cells. Cell death triggered by zafirlukast could be rescued with antioxidants and the PARP-1 inhibitor Olaparib, and additionally relies on HIF-2α. Finally, MG-132-mediated proteasome inhibition sensitized VHL wild-type cells to zafirlukast-induced cell death and inhibition of HIF-2α rescued zafirlukast- and MG-132-triggered cell death. Together, these results highlight the importance of VHL, HIF and proteasomal degradation in zafirlukast-induced oxidative cell death with potentially novel therapeutic implications for ccRCC.